Finding regions of aberrant DNA copy number associated with tumor phenotype by Tolosi, Laura
Finding Regions of Aberrant
DNA Copy Number Associated with
Tumor Phenotype
Author
Laura Toloşi
Dissertation
zur Erlangung des Grades
des Doktors der Naturwissenschaften (Dr. rer. nat.)
der Naturwissenschaftlich–Technischen Fakultäten
der Universität des Saarlandes
Saarbrücken
2012
Tag des Kolloquiums: 27.09.2012
Dekan: Prof. Dr. Mark Groves
Vorsitzender des Prüfungsausschusses: Prof. Dr. Matthias Hein
Berichterstatter: Prof. Dr. Thomas Lengauer, Ph.D.
Prof. Dr. Hans-Peter Lenhof
Prof. Dr. Jörg Rahnenführer
Beisitzer: Dr. Nico Pfeifer
Eidesstattliche Versicherung
Hiermit versichere ich an Eides statt, dass ich die vorliegende Arbeit selbstständig und
ohne Benutzung anderer als der angegebenen Hilfsmittel angefertigt habe. Die aus anderen
Quellen oder indirekt ubernommenen Daten und Konzepte sind unter Angabe der Quelle
gekennzeichnet. Die Arbeit wurde bisher weder im In- noch im Ausland in gleicher oder
ähnlicher Form in einem Verfahren zur Erlangung eines akademischen Grades vorgelegt.
Saarbrücken, den
Laura Toloşi
iii
iv
Abstract
DNA copy number alterations are a hallmark of cancer. Understanding their role in tu-
mor progression can help improve diagnosis, prognosis and therapy selection for cancer
patients and can contribute to the development of personalised therapies. High-resolution,
genome-wide measurements of DNA copy number changes for large cohorts of tumors are
currently available, owing to the rapid development of technologies like microarray-based
array comparative hibridization (arrayCGH). In this manuscript, we introduce a compu-
tational pipeline for statistical analysis of tumor cohorts, which can help extract relevant
patterns of copy number aberrations and infer their association with various phenotypical
indicators. The pipeline makes use of machine learning techniques for classification and
feature selection, with emphasis on interpretable models (linear models with penalties,
tree-based models).
The main challenges that our methods meet are the high dimensionality of the arrays
compared to the small number of tumor samples available, as well as the large correlations
between copy number estimates measured at neighboring genomic locations. Consequently,
feature selection is unstable, depending strongly on the set of training samples, leading to
un-reproducible signatures across different clinical studies. We also show that the feature
ranking given by several widely-used methods for feature selection is biased due to the
large correlations between features. In order to correct for the bias and instability of
the feature ranking, we introduce a dimension reduction step in our pipeline, consisting of
multivariate segmentation of the set of arrays. We present three algorithms for multivariate
segmentation, which are based on indentifying recurrent DNA breakpoints or DNA regions
of constant copy number profile. The multivariate segmentation constitutes the basis for
computing a smaller set of super-features, by summarizing the DNA copy number within
the segmentation regions. Using the super-features for supervised classification, we improve
the interpretability and stability of the models, where the baseline for comparison consists
of classification models trained on probe data.
We validated the methods by training models for prediction of the phenotype of breast
cancers and neuroblastoma tumors. We show that the multivariate segmentation step
affords higher model stability and it does not decrease the accuracy of the prediction. We
obtain substantial dimension reduction (up to 200-fold less predictors), which recommends
the multivariate segmentation procedures not only for the purpose of phenotype prediction,
but also as preprocessing step for downstream integration with other data types.
The interpretability of the models is also improved, revealing important associations
between copy number aberrations and phenotype. For example, we show that a very in-
formative predictor that distinguishes between inflammatory and non-inflammatory breast
cancers with ERBB2 amplification is the co-amplification of the genomic region located in
the immediate vicinity of the ERBB2 gene locus. Therefore, we conclude that the size of
the amplicon is associated with the cancer subtype, a hypothesis present elsewhere in the
literature. In the case of neuroblastoma tumors, we show that patients belonging to differ-
ent age subgroups are characterized by distinct copy number patterns, especially when the
subgroups are defined as older or younger than 16-18 months. Indeed, considering a large
set of age cutoffs, our prediction models are most accurate if the cutoff is around 16-18
months. We thereby confirm the recommendation for a higher age cutoff than 12 months
v
(current clinical practice) for differential diagnosis of neuroblastoma.
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Kurzfassung
Die abnormale Multiplizität bestimmter Segmente der DNS (copy number aberrations)
ist eines der hervorstechenden Merkmale von Krebs. Das Verständnis der Rolle dieses
Merkmals für das Tumorwachstum könnte maßgeblich zur Verbesserung von Krebsdiagno-
se, -prognose und -therapie beitragen und somit bei der Auswahl individueller Therapien
helfen. Micoroarray-basierte Technologien wie ‘Array Comparative Hybridization’ (array-
CGH) erlauben es, hochauflösende, genomweite Kopiezahl-Karten von Tumorgeweben zu
erstellen. Gegenstand dieser Arbeit ist die Entwicklung einer Software-Pipeline für die
statistische Analyse von Tumorkohorten, die es ermöglicht, relevante Muster abnormaler
Kopiezahlen abzuleiten und diese mit diversen phänotypischen Merkmalen zu assoziieren.
Dies geschieht mithilfe maschineller Lernmethoden für Klassifikation und Merkmalselek-
tion mit Fokus auf die Interpretierbarkeit der gelernten Modelle (regularisierte lineare
Methoden sowie Entscheidungsbaum-basierte Modelle).
Herausforderungen an die Methoden liegen vor allem in der hohen Dimensionalität der
Daten, denen lediglich eine vergleichsweise geringe Anzahl von gemessenen Tumorproben
gegenüber steht, sowie der hohen Korrelation zwischen den gemessenen Kopiezahlen in
benachbarten genomischen Regionen. Folglich hängen die Resultate der Merkmalselekti-
on stark von der Auswahl des Trainingsdatensatzes ab, was die Reproduzierbarkeit bei
unterschiedlichen klinischen Datensätzen stark einschränkt. Diese Arbeit zeigt, dass die
von diversen gängigen Methoden bestimmte Rangfolge von Features in Folge hoher Kor-
relationskoeffizienten einzelner Prädiktoren stark verfälscht ist. Um diesen ‘Bias’ sowie die
Instabilität der Merkmalsrangfolge zu korrigieren, führen wir in unserer Pipeline einen
dimensions-reduzierenden Schritt ein, der darin besteht, die Arrays gemeinsam multivariat
zu segmentieren. Wir präsentieren drei Algorithmen für diese multivariate Segmentierung,
die auf der Identifikation rekurrenter DNA Breakpoints oder genomischer Regionen mit
konstanten Kopiezahl-Profilen beruhen. Durch Zusammenfassen der DNA Kopiezahlwerte
innerhalb einer Region bildet die multivariate Segmentierung die Grundlage für die Be-
rechnung einer kleineren Menge von ‘Super-Merkmalen’. Im Vergleich zu Klassifikations-
verfahren, die auf Ebene einzelner Arrayproben beruhen, verbessern wir durch überwachte
Klassifikation basierend auf den Super-Merkmalen die Interpretierbarkeit sowie die Stabi-
lität der Modelle.
Wir validieren die Methoden in dieser Arbeit durch das Trainieren von Vorhersagemodel-
len auf Brustkrebs und Neuroblastoma Datensätzen. Hier zeigen wir, dass der multivariate
Segmentierungsschritt eine erhöhte Modellstabilität erzielt, wobei die Vorhersagequalität
nicht abnimmt. Die Dimension des Problems wird erheblich reduziert (bis zu 200-fach
weniger Merkmale), welches die multivariate Segmentierung nicht nur zu einem probaten
Mittel für die Vorhersage von Phänotypen macht.Vielmehr eignet sich das Verfahren dar-
überhinaus auch als Vorverarbeitungschritt für spätere integrative Analysen mit anderen
Datentypen.
Auch die Interpretierbarkeit der Modelle wird verbessert. Dies ermöglicht die Identifi-
kation von wichtigen Relationen zwischen Änderungen der Kopiezahl und Phänotyp. Bei-
spielsweise zeigen wir, dass eine Koamplifikation in direkter Nachbarschaft des ERBB2
Genlokus einen höchst informativen Prädiktor für die Unterscheidung von entzündlichen
und nicht-entzündlichen Brustkrebsarten darstellt. Damit bestätigen wir die in der Lite-
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ratur gängige Hypothese, dass die Größe eines Amplikons mit dem Krebssubtyp zusam-
menhängt. Im Fall von Neuroblastoma Tumoren zeigen wir, dass Untergruppen, die durch
das Alter des Patienten definiert werden, durch Kopiezahl-Muster charakterisiert werden
können. Insbesondere ist dies möglich, wenn ein Altersschwellenwert von 16 bis 18 Monaten
zur Definition der Gruppen verwandt wird, bei dem außerdem auch die höchste Vorher-
sagegenauigkeit vorliegt. Folglich geben wir weitere Evidenz für die Empfehlung, einen
höheren Schwellenwert als zwölf Monate für die differentielle Diagnose von Neuroblastoma
zu verwenden.
viii
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1. Introduction
The decades after the Human Genome Project have changed the perspectives on cancer
therapy dramatically. Genome-wide technologies like microarrays and next-generation se-
quencing have revealed unprecedented insights into the cancer genome, epigenome and
transcriptome (in short, cancer omics). It has become clear that cancer is a vastly complex
disease, exhibiting a plethora of abnormalities in the function of many genes, which can
arise by gradual accumulation of genetic aberrations or by disruption of epigenetic regu-
lation. The research community must now find ways of translating the multidimensional
omics data into efficient cancer therapy.
The large number of cancer genomes already available display highly heterogeneous ab-
normalities, some being essential for tumor progression (driver alterations) and others
being spurious, harmless events (passenger alterations). The discrimination between these
two categories is essential, but has been recognized as a very difficult problem. In the field
of cancer research, the task of identifying key events that have an impact on tumor phe-
notype is called biomarker discovery. The identification of biomarkers is a necessary step
towards improved diagnosis and prognosis, as well as towards genotype-informed therapy
(or personalized therapy), which aims at administering drugs that target specific aberra-
tions that the patient’s cancer cells rely on for proliferation. So far, biomarker discovery
has been driven mainly by the goal of finding new drug targets, but more recent studies
also propose diagnostic and prognostic biomarkers, which can shed light on the degree of
tumor progression, tumor subtype or on the expected survival of the patient.
The computational task of biomarker discovery is based on inferring the statistical de-
pendence between tumor phenotype and tumor genotype. In most of the studies the de-
pendence is measured univariately, e.g. between single gene mutations and the phenotype.
Such an approach can detect strong univariate associations, but will not reveal a more com-
plex interplay between multiple genes, which would result for example as a consequence
of a disrupted pathway. A far more powerful instrument which allows for multivariate
inference is supervised learning, a technique that allows for modeling of the phenotype as
a (potentially complex) function of genotype factors. Such models, also called complex
biomarkers, can help predict the phenotype of new tumors, such as for example response
to certain drugs, expected survival, lymph node spread, presence or absence of metastasis
and others. However, despite the fact that supervised modeling for phenotype prediction
has been proposed in many studies during the past years (mainly based on gene expression
data), the gained knowledge has rarely entered clinical practice. One of the major reasons
is the lack of biological reasoning in the prediction process, which understandably worries
the clinician who has to take responsibility for the outcome of the treatment.
In this context, simple and biologically interpretable models are better received by the
medical community than sophisticated and more accurate, not interpretable statistical
models. Following these requirements, the work proposed in this thesis presents meth-
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ods for supervised classification, which deliver sparse, robust and interpretable models.
We restrict our experiments to classification of tumors based on their DNA copy number
alterations, which are manifested by gain or loss of genetic material during tumor develop-
ment and progression. We used high-resolution, microarray-based data such as array-based
comparative genomic hybridization data for validation. This type of data has been rarely
approached with supervised classification techniques before, mainly due to the increased
focus on classification of expression data. As a consequence, the accuracy of phenotype
prediction based on copy number alterations is largely unknown in the community.
The challenges that supervised classification faces when applied to copy number data
can be summarized into two main aspects:
• the large number of features (genomic loci) compared to the small number of available
samples (tumors), well known as the curse of dimensionality ;
• the large correlations between genomic loci, in particular between probes located
closely in the genome sequence.
High dimensionality requires feature selection methods for sparse modeling. We use
lasso-penalized logistic regression models, for sparsity and interpretability. We also in-
troduce a novel method for assigning p-values to features in random forest models. By
selecting only the features that exceed a significance threshold, we mimic sparsity in ran-
dom forest (non-linear) models.
We show that correlation between features is dangerous as it can bias feature ranking.
We demonstrate that an effective way of dealing with correlation is correlation-based fea-
ture grouping. Specifically, features that are highly correlated are grouped together into
super-features, which are used for classification. Feature grouping achieves both dimen-
sion reduction and removes correlation bias. In our algorithms for feature grouping, we
speculate on the local correlation between genomic loci.
In a comprehensive application study to breast cancer and neuroblastoma, we show that
prediction of tumor phenotype based on copy number alterations can achieve reasonable
accuracy, even when the training set is relatively small. We also show that model in-
terpretability and stability are improved by feature grouping, while preserving prediction
accuracy. We also present important biological insights revealed by our models, thereby
demonstrating that computational models are capable and ready to assist the biomedical
community in improving cancer understanding and treatment.
Outline
In Chapter 2 we begin with an introduction to cancer, in which we describe the current
clinical practice, including a short overview on the current treatment options and the
standard classification at diagnosis. Then, we continue with presenting the most intensively
studied types of molecular changes that are linked to tumorigenesis, including genomic,
epigenomic and transcriptomic alterations. We describe in more details the molecular
mechanisms that underlie the formation of genomic aberrations that lead to copy number
imbalances. Towards the end of Chapter 2, we review the experimental technologies that
are currently used for genome-wide measurement of copy-number alterations.
9Chapter 3 reviews the existing pipelines that have been proposed for computational
analysis of copy number alterations. The general goal of most pipelines is to identify copy
number alterations that play a role in tumor onset and progression. To this end, pipelines
generally consist of successive steps of reducing the dimension of the data, in which data
features are selected in an unsupervised manner, based on assumptions argued biologically.
We thereby suggest a novel pipeline, that makes use of minimal assumptions and processing
steps in oder to select and rank the most relevant copy number aberrations from a tumor
set. The selection is data-driven: a phenotypic indicator of the tumor such as grade, stage,
metastasis status, etc. is used as a response variable for a supervised learning model, where
the predictors are the copy number aberration profiles. The key step of our pipeline is the
consensus segmentation, namely the task of estimating a consensus partition of the tumor
genomes into regions of almost constant copy number. In Chapter 3, we only present
the steps of the pipeline schematically and argue about its qualitative advantages against
traditional pipelines.
In Chapter 4, we define consensus segmentation and introduce three algorithms for this
task. The algorithms work by estimating consensus regions of almost constant copy num-
ber. The copy-number data of the tumor samples can be represented in the reduced space of
the consensus regions without substantial loss of information. We compare the algorithms
for consensus segmentation on seven publicly available arrayCGH datasets pertaining to
five cancer types. We thereby show that consensus segmentation can achieve a substantial
dimension reduction of the genome-wide copy-number data by reducing the correlation
between loci, therefore facilitating supervised prediction tasks.
Chapter 5 introduces the supervised learning techniques that we used for prediction of
tumor phenotype based on copy number data. We considered only binary classification
tasks. We comment on the central problem of classification based on genome-wide omics
data, namely the high dimensionality compared to the relatively small sample sizes and the
high correlations between the features. We also stress the importance of interpretability of
classification models and formulate a set of requirements that a good model should comply
with. We show how most widely-used classification models do not comply with these
requirements and in this context we define correlation bias – a type of bias that causes
large groups of correlated features to receive small weights. We show with simulations that
consensus segmentation successfully removes correlation bias.
Chapter 6 contains two applications of our pipeline, to breast cancer and to neuroblas-
toma. We trained modes for prediction of several phenotypical indicators that are relevant
for the respective tumor types. In Chapter 6 we comment on the accuracy of prediction and
analyzed the feature ranking that was given by the models. We comment on the biological
relevance of our findings and conclude with comments on the strengths and weaknesses of
our approaches.
Chapter 7 concludes this thesis and provides an outlook on further directions of improve-
ment.
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2. DNA Copy Number Aberrations and Cancer
I have called this principle, by which
each slight variation, if useful, is
preserved, by the term of Natural
Selection.
Charles Darwin
2.1. Cancer overview
Cancer is the generic name given to a wide class of genetic diseases which display an
uncontrolled growth of cells. Cancer can affect most organs of the human body (com-
monly breast, lung, skin, bone, blood, liver, pancreas, ovaries, brain). In order to evade
the regulatory mechanisms that prohibit uncontrolled proliferation by inducing apoptosis
(programmed cell death), the cancerous cells acquire molecular abnormalities via a process
of microevolution similar to the Darwinian evolution (Nowell, 1976). Specifically, during
cancer progression, selective pressure acts on cells by promoting molecular changes that
disrupt regulatory mechanisms and allow the cells to escape apoptosis. Eventually, the
mass of cancerous cells becomes very large, threatening the function of the affected organ,
or that of the nearby organs, or can spread to more distant parts of the body via the
lymphatic system and bloodstream (process referred to as metastasis). Metastases are the
main cause of death from cancer.
The causes of cancer are diverse. Heredity plays an important role, studies showing
that 5 to 10% of the breast cancers run in families (Colditz et al., 1993). Advanced age
is frequently associated with cancer, due to DNA degradation. Exposure to radiation and
other environmental pollutants can cause leukemia (Richardson et al., 2009), skin can-
cer (Narayanan et al., 2010), lung cancer (Cardis et al., 2007; Kreisheimer et al., 2003),
among others. Tobacco use accounts for about 80% of lung cancers (Parkin, 2011). In-
appropriate diet and obesity has been linked to stomach and colon cancer (Huang and
Chen, 2009; Frezza et al., 2006), as has been the lack of physical activity. Viral infections
have been indicated as possible causative agents for several cancers including cervical, oral,
breast, prostate cancers or lymphoma (Sarid and Gao, 2011) and intense research is being
dedicated to tracing viral agents in other tumors. In this context, we have studied the
transcriptome of a small set of 14 neuroblastoma tumors and were not able to identify
transcripts that could unequivocally be attributed to viral agents and not to human ho-
mologs. The methodological work and a positive validation to cervical cancer with HPV
are presented in Schelhorn et al. (2012). For many cancers, the causes remain unknown
(for example glioblastoma).
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(a) (b)
Figure 2.1.: Estimated world-wide age-standardized incidence and mortality rates per
100000 for cancer, according to the WHO and GLOBOCAN (http://globocan.iarc.fr) a)
by geographical region and b) by cancer type. Blue shows incidence, red shows mortality
rates.
The incidence of cancer worldwide is unevenly distributed, highly developed countries
facing higher rates than underdeveloped regions (Figure 2.1a), probably due to the envi-
ronmental factors (pollutants), diet and increased lifespan. The quality of the health care
systems in developed countries however compensates for the higher incidence, resulting in
comparatively lower mortality rates (Figure 2.1a). Cancer incidence and mortality also
varies with the organ affected (lung, liver, stomach and breast yield highest mortality, see
Figure 2.1b), age (risk of cancer generally increases with age), sex, genetic makeup of the
patient, etc.
Due to the persistent high incidence and mortality rate, cancer has been and continues to
be a very important focus of research worldwide. According to the World Health Organi-
zation (WHO), cancer is a leading cause of death. In highly developed countries, mortality
due to cancer is second only to heart disease. Despite large investments in cancer research
over the past century, development of new treatments has been slow and often unreward-
ing, owing to the overwhelming heterogeneity of the disease. Remarkable improvements in
early diagnosis (e.g. imaging) have allowed for detection of the disease at a stage where
treatment is efficient, thus decreasing mortality rates.
2.1.1. Cancer treatment
Several therapeutical options exist currently for cancer patients, the most widely used
being chemotherapy, radiation therapy and surgery.
Chemotherapy consists of administering one or more drugs that interfere with tumor
development. Older drugs have the general effect of slowing down cell replication in the
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body of the patient, for example by interfering with mitosis or promoting apoptosis. Such
drugs can damage healthy cells as well, especially those that divide rapidly such as bone
marrow or hair, which leads to severe side effects. Modern drugs are designed to target
specific protein mutations that occur in cancer cells and thus have fewer side effects.
Drugs are administered either by intravenous injection or taken orally as pills. Through
the bloodstream, the drug can reach tumor cells located in various parts of the body,
making chemotherapy the main treatment against metastatic cancer.
Radiation therapy uses ionizing radiation directed towards the tumor in order to damage
the DNA of tumor cells. When the DNA is damaged beyond repair, the cells die. Radi-
ation is used when the tumor is localized (not against metastasis), sometimes in order to
shrink the tumor for follow-up surgery. Although radiation therapy is directed towards the
cancerous cells, healthy cells situated close to the tumor can be damaged as well. Modern
technologies (such as proton beam radiation therapy, radioimmunotherapy, brachytherapy)
are becoming better at targeting only cancerous cells while delivering a higher amount of
radiation.
Surgery is the foundation of cancer treatment, being used for multiple purposes during
patient care. Surgery is helpful for diagnosis (biopsy), when a part of the tumor or the
entire tumor is removed and then studied under a microscope and classified (cancerous,
non-cancerous, stage). Surgery is currently the best option for primary treatment of many
cancers, especially if the cancer has not spread. When it is not possible to remove the entire
tumor, then surgery is an option for removing part of the mass of cells that hinder the
functioning of the neighboring organs. Sometimes, surgery is used for relieving symptoms
or side effects, for example when the tumor is pressing on a nerve and causes pain. In some
cases, surgery can be used for cancer prevention, if a high probability exists that a tumor
will develop and the removal of the anatomical part under risk is possible (for example
masectomy, prostatectomy).
Other treatment options include immunotherapy (designed to induce the patient’s own
immune system to recognize and fight the tumor), hormone therapy (in hormone-dependent
cancers, blocking of growth hormones can significantly slow tumor development) or inhibit-
ing angiogenesis (prevent the growth of blood vessels that supply the tumor with nutrients).
Upon the discovery of viral agents responsible for increased tumor susceptibility, vaccines
have been designed for cancer prevention.
2.1.2. Cancer classification
Cancer classification is presently carried out in clinics in order to assign a specific tumor to a
known subgroup and thereby allow for selecting the most suitable therapy and prognosis.
Classification usually follows several criteria: by site of origin (histology), by degree of
differentiation of the cells (grade) or by degree of progression (stage).
Common histological types are:
• Adenocarcinoma – originates in glandular tissue;
• Blastoma – originates in embryonic tissue of organs;
• Carcinoma – originates in epithelial tissue (i.e., tissue that lines organs and tubes);
• Leukemia – originates in tissues that form blood cells;
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• Lymphoma – originates in lymphatic tissue;
• Myeloma – originates in bone marrow;
• Sarcoma – originates in connective or supportive tissue (e.g., bone, cartilage, muscle).
Depending on the anatomy of the affected organ, histological subtypes may be defined.
For example, ductal carcinoma is a common histological subtype of breast cancer that
forms in the lining of the milk ducts, while lobular carcinoma is another subtype that
originates in the lobules of the breast, where milk is produced.
Tumor grading requires a biopsy and the examination of tumor tissue under the micro-
scope. Grading is carried out by an experienced pathologist, who evaluates the degree of
differentiation of the cells. Poor cell differentiation (anaplasia) and abnormal appearance
of the cells is specific to aggressive forms of cancer. The standard system comprises four
grades, determined as follows:
• Grade 1 – cells slightly abnormal and well differentiated;
• Grade 2 – cells more abnormal and moderately differentiated;
• Grade 3 – cells highly abnormal and poorly differentiated;
• Grade 4 – cells highly abnormal and undifferentiated.
The stage (or TNM stage) provides a measure of the extent of the spread of the tumor.
Several indicators are typically used, including tumor size (T), spread to lymph nodes (N)
and metastasis (M).
Tumor size can take one of the following values:
• Tx – tumor cannot be evaluated;
• T0 – no evidence of tumor;
• Tis – carcinoma in situ (limited to surface cells of the organ);
• T1-4 – increasing tumor size and involvement.
The degree of spread to lymph nodes is one of the following:
• Nx – lymph nodes cannot be evaluated;
• N0 – tumor cells absent from regional lymph nodes;
• N1 – regional lymph node metastasis present;
• N2 – tumor spread to an extent between N1 and N3;
• N3 – tumor spread to more distant or numerous regional lymph nodes.
The indicator of metastasis can be either
• Mx – distant metastasis cannot be evaluated;
• M0 – no distant metastasis;
• M1 – metastasis to distant organs (beyond regional lymph nodes).
The T, N and M markers are combined to form a tumor stage indicator, as follows:
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• Stage 0 – cancer in situ (limited to surface cells);
• Stage I – cancer limited to the tissue of origin, evidence of tumor growth;
• Stage II – limited local spread of cancerous cells;
• Stage III – extensive local and regional spread;
• Stage IV – distant metastasis.
Depending on the organ affected, tumor stage can take different values, necessary for the
better description of the particular cancer. For example, neuroblastoma staging involves a
subdivision of stage 4 into stage 4 and stage 4S (special), depending on the age of the patient
and the location of distant metastases. The staging of ovarian cancer is refined, each main
stage I-IV being further indexed with A, B or C, depending on the anatomic characteristics
of the spread. A similar subdivision is met in breast cancer staging. Adaptations of the
general staging to particular cancer types have the purpose of improving therapy selection
and prognosis and is mainly based on empirical observations.
It is obvious that tumor classification according to the above mentioned criteria allows
for subjective judgement. Moreover, the need for adapting the definition of the classes to
particular cancer subtypes (see staging above) indicates that a very general system is not
performant enough (cancer is not only one disease!) and a more specific stratification of
patients is needed. In this context, it has become clear that phenotypic indicators such as
tumor size, cell differentiation, tumor spread or age of the patient are not specific enough
and thus insufficient for good cancer treatment. As a response to these shortcomings,
the field of cancer research is currently driven by the discovery of molecular biomarkers
– genetic, epigenetic, transcriptomic (and other) aberrations that are mechanistically di-
rectly accountable for the response to treatment, patient survival, etc. The discovery of
molecular biomarkers and their inclusion in common clinical practice are a necessary step
towards personalized cancer therapy, which approaches each tumor as a distinct disease
and composes a combination of therapeutical targeting the particular molecular aberrations
displayed.
The task of biomarker discovery is difficult, due to the large amount and variety of aber-
rations occurring in tumors. The next section addresses the most intensely studied types
of aberrations frequently occurring in the cancer genome, epigenome or transcriptome and
describes some of the known associations between them. The relevance of the aberrations
in relation to tumor phenotype is discussed.
In what follows, we will use the short term cancer omics for referring to the combined
fields of cancer genomics, epigenomics and transcriptomics.
2.1.3. Molecular hallmarks of cancer
Molecular changes that characterize cancer cells can be irreversible, such as genetic aberra-
tions or reversible, for example epigenetic changes (Chin and Gray, 2008). These changes
alter the expression and function of genes and regulatory factors (Figure 2.2a). In gen-
eral, of highest relevance is the gain of function of proto-oncogenes and loss of function
of tumor suppressors. Proto-oncogenes code for proteins that include the group of growth
factors (have the role of inducing cell proliferation), receptor tyrosine kinases (cell surface
receptors for growth factors) and others. Gain of function of proto-oncogenes transforms
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Figure 2.2.: a) Cancer omics (adapted from Chin and Gray (2008)): A) somatic point
mutations; B) translocation; C) amplification; D) DNA methylation and histones. b)
Types of structural aberrations.
these genes into oncogenes and contributes to tumorigenesis. Tumor suppressors and the
proteins they code for have a repressive role in cell proliferation by regulating the cell cycle
or by inducing apoptosis. Loss of function of tumor suppressors can trigger carcinogenesis.
The most intensively studied alterations that lead to gain and loss of function are somatic
point mutations, deletions, duplications, amplifications, insertions, inversions, transloca-
tions, polysomies, histone modifications, DNA methylation.
Point mutations consist of exchanges of a single base nucleotide for another, for example a
T-A pair mutates into a C-G pair. If the mutation changes the amino-acid code and the new
amino-acid has different properties than the wild type, then the function of the resulting
protein can be altered. Mutations of oncogenes are often associated with cancer onset and
large efforts are being made for designing drugs that target the mutated trnscripts. For
example, a mutation of the EGFR (Epidermal Growth Factor Receptor) gene that leads
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to increased cell proliferation is frequently observed in non-small-cell lung cancers (Pao
et al., 2004). The drugs gefitinib and erlotinib have been designed to inhibit the EGFR
protein product and studies show that patients with EGFR mutations respond better to the
treatment with these drugs than the those without mutations (Pao et al., 2004; Lynch et al.,
2004). In Sos et al. (2009), we show that mutations of the gene KRAS in non-small-cell
lung cancers influence the response to Hsp90 (heat shock protein 90) inhibitors. Another
prominent example is the proto-oncogene BRAF that codes for a serine/threonine-protein
kinase, which is mutated in 60% of the malignant melanomas, 10% of colorectal cancers
and smaller proportion of other cancers (Davies et al., 2002). Much research is currently
driven by the goal of designing BRAF inhibitors (King et al., 2006). PTEN (phosphatase
and tensin homolog) tumor suppressor gene, involved in cell cycle regulation, is frequently
inactivated by mutation in gliomas (Duerr et al., 1998), endometrial cancer (Tashiro et al.,
1997), prostate cancer (Gray et al., 1998) and bladder cancers (Cairns et al., 1998).
Deletion occurs when a DNA segment is missing from a chromosome, possibly leading to
the loss of function of genes located within this region (Figure 2.2b), via under-expression.
Deletions of tumor suppressors are early events in cancer progression (Dong, 2001). For
example, the gene CDKN2A (cyclin-dependent kinase-4 inhibitor) coding for the INK4A
protein is a tumor suppressor frequently deleted in human cancers such as melanomas,
gliomas, lung cancers, leukemias (Nobori et al., 1994), bladder cancer (Williamson et al.,
1995) and others. The tumor suppressor gene PTEN is inactivated via deletion in many
cancers (as well as by mutations, see above) (Wang et al., 1998; Cairns et al., 1998) and
the deletion is usually associated with poor outcome. Frequent deletion of the 1p36 locus
is reported in cancer studies dedicated to colorectal cancer, breast cancer, cervical cancer,
neuroblastoma, leukemias and lymphomas (Bagchi and Mills, 2008). Although the search
for tumor suppressors located within this region continues, several candidates have been
proposed (Bagchi and Mills, 2008). Neuroblastomas with 1p36 deletions are reported to
have worse outcome than the ones without this deletion (Attiyeh et al., 2005). Gene
deletions are difficult to correct by drug therapy, therefore currently they are only used as
diagnosis and prognosis markers.
Duplications and amplifications consist of the existence of two or more copies of a DNA
sequence in the cancer genome (Figure 2.2b), leading to gain of function of dosage-sensitive
genes located within the sequence, due to over-expression. Amplification of oncogenes is
thought to be one mechanism through which tumors acquire drug resistance. A well
known amplification occurring in 30% of the primary breast cancers involves the oncogene
ERBB2, usually associated with short survival time, short time to relapse (Slamon et al.,
1987) and resistance to tamoxifen, a drug commonly prescribed to estrogen positive tumors.
The drug transtuzumab was developed to treat breast tumors with ERBB2 amplification
(Pegram and Slamon, 2000). Amplification of the members of the MYC gene family c-MYC
(8q24.21) or n-MYC (2p24.3) which code for transcription factors is another prominent
event in solid tumors. n-MYC (or MYCN) is amplified in neuroblastomas and is associated
with poor outcome (Brodeur et al., 1984). c-MYC is amplified in breast (Varley et al.,
1987) and lung cancers (Little et al., 1983).
Insertion refers to the displacement of a DNA sequence from one location (chromosome)
and its insertion to another location (chromosome) (Figure 2.2b). If translated together
with the new surrounding sequence, the insertion can alter the resulting protein and its
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function.
Aneuploidy and polyploidy occur when the wrong number of chromosomes is present in
a cancerous cell. In normal cells, each autosome exists in two copies (homologous chro-
mosomes). Aneuploidy entails the gain or loss of individual chromosomes and polyploidy
involves extra copies of the entire genome, often three (triploidy) or four (tetraploidy).
Polyploidy is believed to increase the potential of the cell to generate heterogeneity (Merlo
et al., 2010; Risques et al., 2001). In a review article, (Merlo et al., 2010) observe that
more than two copies of the DNA ensure the existence of all necessary elements for the
viability of the cell, while providing extra copies for mutations and aberrations. Studies
have shown that tetraploidy is an early event in tumorigenesis (Olaharski et al., 2006) and
it is believed to precede aneuploidy, which arises from a tetraploid state after chromosomal
loss (Merlo et al., 2010; Olaharski et al., 2006).
The mechanisms through which aneuploidy and polyploidy relate to tumor progression
are difficult to assess, mainly because it is difficult to identify causative genes (Merlo et al.,
2010). Aneuploidy is a very common event (Sen, 2000) in solid tumors and it is in gen-
eral associated with poor patient outcome (Barlogie et al., 1980). More recent studies use
high-resolution experiments for establishing a more precise relation between aneuploidy
and survival, for example in the case of non-small lung cancer (Choma et al., 2001) or
endometrial cancer (Suehiro et al., 2008). However, there are tumor types for which it
has been shown that polyploidy and to a lesser extent, aneuploidy are associated with a
favorable outcome and increased survival. Such is the case of childhood acute lymphoblas-
tic leukemia (Raimondi et al., 2006) and neuroblastoma (Kaneko and Knudson, 2000;
Nakazawa, 1993). In neuroblastoma, the favorable outcome correlates with polyploidy
mostly for patients younger than two years and the biological basis of the association is
still not understood.
Translocations occur when DNA segments are interchanged between non-homologous
chromosomes (Figure 2.2b). A negative effect can occur if the displaced segments are
subject to new regulatory mechanisms, which can lead to gain and loss of function. The
first translocation linked to cancer was the so called ‘Philadelphia chromosome’ (Nowell,
2007), consisting of an interchange between chromosome 9 and 22 which leads to the
formation of the BCR-ABL gene fusion of oncogenic nature. ABL is a proto-oncogene
with role in cell division, which is turned into an oncogene after the juxtaposition to
the BCR gene. The fused gene BCR-ABL codes for a tyrosine-kinase that inhibits DNA
repair and promotes genomic instability. The Philadelphia chromosome is observed in the
majority of the patients with chronic myeloid leukemia (CML) and its transcript is targeted
by the drug imatinib mesylate (Druker et al., 2001), which is a tyrosine-kinase inhibitor.
Another well studied translocation involves the relocation of the c-MYC proto-oncogene to
a locus nearby the promoter of the IGH (immunoglobulin heavy locus) gene, resulting in
overexpression of c-MYC in Burkitt’s lymphoma (Taub et al., 1982; Kanungo et al., 2005).
DNA methylation is a mechanism for regulating gene expression that typically involves
the addition of a methyl group to a cytosine (C) in a CpG dinucleotide context. CpGs in
the genome are not randomly distributed, but tend to agglomerate within CpG rich regions
called CpG islands. In normal somatic cells, CpG islands are predominantly unmethylated.
However, methylation of promoter CpG islands occurs, with the purpose of suppressing
gene expression. In cancer cells, hypermethylation and hypomethylation is observed, as
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mechanisms of gene silencing (and loss of function) and of gene activation (and gain of
function), respectively. Hypermethylation of the promoter region was reported to activate
the tumor-suppressors RB (retinoblastoma) by Sakai et al. (1991), VHL (von Hippel-
Lindau tumor suppressor) by Herman et al. (1994), CDKN2A by Herman et al. (1995);
Merlo et al. (1995) and BRCA1 by Esteller et al. (2000). Mitotic recombination has been
shown to favorably occur in hypomethylated regions, leading to deletions and translocations
(Eden et al., 2003). Hypomethylation can also disrupt genomic imprinting (silencing of
one allele via methylation), as in the case of the IGF2 gene (insulin-like growth factor),
which plays a role in the formation of colorectal cancer (Cui et al., 2003) or Wilms tumor
(Feinberg, 1999).
Histones are proteins which are normally found in structural units called nucleosomes,
around which the DNA is wound for the purpose of packing it into chromatin. They
are grouped into several families: H1, H2A, H2B, H3 and H4, located at different posi-
tions in the nucleosome and having different functions. Histones participate in the regula-
tion of gene expression through post-translational modifications such as lysine acetylation,
arginine and lysine methylation and serine phosphorylation in their tails (Esteller, 2008).
Acetylation of histone lysines (K) is generally associated with transcriptional activation.
The effect of histone acetylation and methylation depends on the residue (lysine or argi-
nine) and also on the location (e.g. K4, K9, K20). Methylation of H3 at K4 has been
shown to activate transcription, whereas methylation of H3 at K9 or K27 or H4 at K20
is generally associated with repressed transcription (Esteller, 2008). It has been observed
that hypermethylation of CpG island promoters of tumor suppressor genes is usually as-
sociated with deacetylation of H3 and H4, loss of trimethylation at K4 of H3 and gain
of H3 trimethylation at K9 and K27(Jones and Baylin, 2007; Ballestar et al., 2003). In
the absence of CpG islands, tumor suppressors can be inactivated by hypo-acetylation and
hypermethylation of the H3 and H4 histones (Richon et al., 2000). Certain cancers disrupt
the normal function of certain histone modifying genes, for example through translocation
events and gene fusion as reported in leukemias and sarcomas (Esteller, 2007).
The studies cited above reveal the tight interplay between the various types of alterations
occurring in cancers. The activation of an oncogene or the inactivation of a tumor sup-
pressor may be realized by different mechanisms, which may be specific to the anatomic
location of the cancer or they may not. Moreover, it is common that upon treatment
with an inhibitor, an oncogene would acquire mutations or start producing more onco-
proteins via amplification, allowing the tumor to become resistant to treatment (Nardi
et al., 2004). Some authors believe that effective cancer treatment should be an iterative
process in which first, second, third generation inhibitors should be administered for coun-
teracting the mechanisms of resistance acquired by the tumors (Chin and Gray, 2008). For
such an approach to come into practice, biomarkers should be identified for each stage of
tumor progression.
Luckily, owing to the rapid development of biotechnology, the field of cancer omics
benefits now from a large amount of experimental evidence that is rich in two respects:
the measurements are genome-wide and high-resolution and the cohorts of tumors become
larger and larger. Consortia such as The Cancer Genome Atlas1 (TCGA) or the Cancer
1http://cancergenome.nih.gov
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Genome Project2 (CGP) have dedicated large resources to harvesting multidimensional
omics data that are now public. The bioinformatic analysis of these data in concert will
surely allow for the identification of key biomarkers and would be the basis of a successful
battle against cancer.
2.2. Molecular mechanisms of formation of copy number
alterations
The mechanisms through which cells acquire structural aberrations are in tight connection
with the mechanisms of DNA repair, which have the role of counteracting various types
of DNA damage (or lesions). Such processes are necessary, because in highly complex
genomes like the human genome, DNA damage in cells occurs very often, from 1000 up
to a million lesions per cell per day (Lodish et al., 2003). The causes of DNA damage
are various, from normal metabolic activities to environmental factors (such as radiation).
Some of the lesions are harmless, occurring without disruption of essential function, are
passed on to daughter cells and may even lead to DNA mutations beneficial for evolution.
Other lesions are harmful, affecting the survival of daughter cells. In such cases, DNA
repair processes are activated for restoring the integrity of the DNA and ensuring the
normal functioning of the cell. Occasionally, DNA repair mechanisms fail to re-establish
the proper functioning of the cell. In such cases, the cell’s fate takes one of the following
courses: it either enters a state of senescence, which means that it loses the ability to
replicate but continues to exist because its physical presence is required by the organism
for spatial reasons, or undergoes apoptosis (programmed cell death). Rarely, DNA repair
mechanisms re-construct the DNA incorrectly, which allows the cell to continue to divide
and proliferate aberrations that can lead to the formation of tumors. Below we present
types of DNA damage and erroneous DNA repair which can lead to structural aberrations
and tumorigenesis.
Double-strand breaks (DSB) are lesions of the DNA in which both strands of the double
helix are damaged. DBSs are troublesome because neither strand can be used as a template
for repair. Several cellular mechanisms can be activated for re-constructing the DNA
upon DBSs, among which the best understood are homologous recombination(HR), non-
homologous end joining(NHEJ) and microhomology-mediated end joining(MMEJ). These
alternative processes are activated in different stages of the cell cycle, generally involve
different molecular pathways and thus proteins, have different degrees of repair accuracy
and substitute for each other if one or more mechanisms become dysfunctional (Pastink
et al., 2001).
HR uses existing homologous sequences situated on the sister chromatid, homologous
chromosomes or elsewhere in the genome as templates for restoring the broken DNA site.
A simplified illustration of HR is shown in Figure 2.3a (Sharan and Kuznetsov, 2007): as a
consequence of damage (B), the DSB locus is first subject to resectioning, which consists of
DNA degradation from the 5’ end towards the 3’ end, producing single-stranded overhangs
at the 3’ ends (C). The RPA protein then binds the 3’ overhangs (Wold, 1997) and together
with the Rad51 protein and several other proteins, forms a filament of nucleic acid and
2http://www.sanger.ac.uk/genetics/CGP/
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Figure 2.3.: a) Schematic representation of homologous recombination (Sharan and
Kuznetsov, 2007). b) Schematic representation of unequal crossover. c) Schematic il-
lustration of the single-strand annealing and of microhomology-mediated end joining.
protein (Sharan and Kuznetsov, 2007). This nucleoprotein filament searches for DNA
sequences homologous to that of the 3’ overhang. When such a sequence is found (D), the
single-stranded nucleoprotein filament invades the homologous DNA in a process called
strand invasion (E). The missing DNA sequence is synthesized (F). This process leads
to the formation of two cross-structures that hold the two chromosomes together (called
Holliday junctions, first introduced in Holliday (1964)) (G). The Holliday junctions are
resolved by cleavage, which can result either in non-crossover (H) or crossover products
(I).
Usually, HR is a very efficient and accurate mechanism, especially when it relies on
the sister chromatid for repair, which offers an identical template. As a consequence, HR
works best in the S (synthesis) and G2 (pre-mitotic) stages of the cell cycle, when the sister
chromatid is accessible. If the sister chromatid is not available and a homologous chro-
mosome is used as a template, HR may lead to loss of heterozygozity (LOH)3 by copying
the undamaged allele. LOH is a structural aberration often responsible for tumorigenesis,
because it can activate a mutant recessive allele (Pastink et al., 2001). If a direct repeat
is used as homologous template – a process called non-allelic homologous recombination –
unequal crossover can occur. Figure 2.3b illustrates the mechanism of unequal crossover:
assume the DSB site is located within a repeat, marked in the figure by x. During DNA
3Loss of heterozygosity (LOH) in a cell represents the loss of normal function of one allele of a gene in
which the other allele was already inactivated.
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repair via homologous recombination, it can happen that the homologous DNA used for
repair is misaligned (Figure 2.3b), which results into two crossover products containing a
deletion and a duplication, respectively. At the next division of the cell, the two products
are transferred to daughter cells, which leads to copy number is changes (Hastings et al.,
2009).
It has been shown that HR is vulnerable to sequence repeats, which can mislead ho-
mology search (Hastings et al., 2009). For example, an alternative type of HR called
single-strand annealing (Figure 2.3c) occurs when homologous sequences flank the DSB
site – a situation which can easily occur if the DSB lies within repeats. In this case, the
two ends anneal after the DNA has been resectioned, which leads to the deletion of the
region enclosed between the homologous sequences. Figure 2.3c illustrates the steps of
SSA: a DSB occurring between two homologous sequences (A) is subject to resectioning
(B), exposing the two homologous sequences; the DNA complementary strands anneal to
form a double-stranded helix (C), the remaining flaps are removed, the missing regions are
filled in by synthesis and ligation completes the process of DNA repair (D). SSA requires
at least 30bp homology in order to take place (McVey and Lee, 2008). The SSA pathway
in eukaryotes involves the protein RAD52, which is required for the annealing if the single
stranded DNA, as well as the RAD59 protein.
A similar process to the SSA is the MMEJ (McVey and Lee, 2008), which relies on
different proteins and on much shorter homologous sequences (5-25bp) for re-joining the
DNA strands. MMEJ results in deletions in the same way that SSA does (Figure 2.3c).
Many DNA breaks do not present enough homology at the ends, which triggers NHEJ
processes which need no homology or very little homology to match the end sequences
(0-5bp) (McVey and Lee, 2008). Consequently, the DNA repair process may not be very
accurate (full complementarity is not ensured) and may require the deletion or insertion
of several bases (1-4bp)(McVey and Lee, 2008; Hastings et al., 2009). NHEJ is therefore
not as accurate as HR, but it has the advantage that it can function throughout the cell
cycle (HR is limited to stages S or G2) and in extreme cases when no homology is available
(Lieber, 2007).
A special type of DNA damage that results in gene amplification affects the ends of the
chromosomes called telomeres. Telomeres are 6bp repeat sequences that are associated
with special chromatin proteins that protect the ends of the chromosomes. In germline
cells, the existence of the telomeres is ensured by the activity of the telomerase protein,
which has the role of re-constructing the telomeres if shortened or deleted. In somatic cells,
the telomerase is not expressed and with every cell division, the telomeres are shortened
and not restored. This mechanism marks the age of the cell and thus allows old cells
to be recognized and become senescent or undergo apoptosis. Cancer cells try to avoid
cellular death due to telomere loss, which frequently leads to chromosome fusion (Lo
et al., 2002). Fusion or bridging between two chromosomes lacking a telomere results in
the formation of a dicentric chromosome (with two centromeres) with telomeres at both
ends. During anaphase, the two centromeres are pulled apart and the dicentric chromosome
breaks, resulting in another chromosome lacking a telomere. The cycle is repeated, causing
amplification. First described by McClintock (1941), this mechanism of amplification is
called breakage-fusion-bridge cycle (B/F/B). We show a schematic illustration of B/F/B in
Figure 2.4a. There is evidence that B/F/B is responsible for low-copy gene amplification
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in cancer cells and may be an early step in high-copy gene amplification (Singer et al.,
2000; Toledo et al., 1993).
Figure 2.4b depicts the formation of so called homogeneously staining regions(HSR),
very long regions of amplification which have been frequently observed in tumors. The
name reflects their appearance,which is uniform in color after fluorescent staining, due to
abundant and homogeneous gene content.
During B/F/B, recombination can occur between the homologous sequences involved in
amplification , resulting in double minute chromosomes (DM) 2.4. DMs are ring-shaped
DNA segments that exist in tumor cells despite not having a centromere or telomeres. They
generally consist of a large number of copies of an oncogene, sometimes rearranged, with or
without the sequence around it, the existence of which appear to confer selective advantage
to the cell. DMs have been first reported to occur in tumors of neuroectodermal origin such
as neuroblastoma or gliomas, but have been identified in many other tumor types thereafter
(Hahn, 1993). They have been frequently associated with oncogene overexpression and drug
resistance. Figure 2.4c shows the MYCN oncogene (red) amplified in four neuroblastoma
cell lines via DM and HSR, clearly noticeable by FISH experiments (see Section 2.3 for
details on FISH experiments).
DNA lesions and misfunctioning of the repair machinery are responsible for segmental
copy number changes. Whole chromosome gains and losses (aneuploidy), which represent
a large part of the common aberrations occurring in cancer, arise via different molecular
mechanisms. These mechanisms are consequences of the disfunction of the mitotic cycle,
which consists of the following phases: interphase, prophase, prometaphase, metaphase,
anaphase, telophase and cytokinesis. In the phases preceeding metaphase, the DNA con-
tent is duplicated, the chromatin is condensed into chromsomes, the nuclear membrane is
disintegrated and a molecular machinery is created which generates the forces necessary to
separate correctly the DNA and pull apart the new cells. At metaphase, the mitotic spindle
is formed: subject to tension towards two opposite poles of the cell, the chromosomes align
such that their centromeres lie along the equatorial plane, an imaginary line equidistant to
the two poles. At anaphase, the sister chromatid is cleaved and the resulting chromosomes
start migrating towards the poles of the cell. At telophase, the decondensing chromsomes
are encapsulated in the nuclear membrane. Cytokinesis is the last phase of mitosis, during
which a cleavage furrow forms at the former location of the metaphase equator, separating
the two nuclei. The cleavage furrow develops into a cell wall, which separates the two
daughter cells and ends the mitosis.
One of the cellular mechanisms which ensure the correct alignment of the chromosomes
at the equatorial plane and the correct separation of the DNA content at metaphase is the
mitotic spindle checkpoint (Pellman, 2007). The protein CENP-E (centromere protein)
plays a role in this process and it has been observed that heterozygozity of the correspond-
ing gene (only one working copy) can lead to the failure of the mitotic spindle checkpoint.
In Figure 2.5a, bottom row (Pellman, 2007), the incorrect alignment at the equatorial
plane is illustrated, with the consequence of aneuploidy in the daughter cells.
Pellman (2007) describe alternative mechanisms of formation of aneuploidy, caused by
overexpression of the MAD2 protein, which is also involved in the mitotic spindle check-
point. Due to misalignment at the equatorial plane, the cleavage furrow is retracted and
the cytokinesis phase is not completed (Figure 2.5b, top row). A tetraploid cell forms and
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Figure 2.4.: a) Breakage-fusion-bridge cycle (Tanaka and Yao, 2009). A chromosome break
near the telomere is marked by asterisk and a DNA sequence located in the vicinity of the
break is indicated by x. After cell replication, the two chromosome copies lacking telomeres
fuse, forming dicentric chromosomes. The centromeres are pulled apart at anaphase and an
uneven break occurs. Consequently, two asymmetric chromosomes are formed, one laking
the sequence x and the other containing a duplication of x. The duplication is palindromic,
meaning that the two copies are oriented differently. The chromosome containing the du-
plication is further replicated in the daughter cell. Because they lack telomeres, the two
sister chromosomes fuse again and the cycle continues, leading to amplification. b) Homo-
geneously staining regions consisting of high amplification of a particular DNA sequence as
a result of repeated B/F/B. Recombination can occur between the homologous sequences
involved in the amplification (marked with X), leading to the formation of double-minute
chromosomes (Tanaka and Yao, 2009). c) FISH experiments showing amplification of the
MYCN gene in four neuroblastoma cell lines via DM and HSR (Storlazzi et al., 2010).
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Figure 2.5.: Formation of aneuploidy (Pellman, 2007). a) Normal separation of chromo-
some copies during mitosis. b) In CENP-E heterozygous cells, incorrect positioning of the
chromosomes during the mitotic spindle gives rise to aneuploidy in daughter cells. c) In
cells with MAD2 overexpression, cytokinesis failure can occur (top row), meaning that the
cell fails to divide and the duplicated DNA content gives rise to tetraploid cells, which
later on can lead to aneuploidy by loss of DNA. The bottom row illustrates how anaphase
lag can lead to the isolation of a chromosome into a micronucleus, which is lost from the
daughter cell and leads to aneuploidy.
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Figure 2.6.: a) Schematic illustration of the FISH procedure. Image from Wikipedia
(http://en.wikipedia.org/wiki/Fluorescence_in_situ_hybridization). b) Amplification of
HER-2 gene detected by FISH. Image from a study by Shigematsu et al. (2011). c)Deletion
of 5q detected with FISH. Image from Cerveira et al. (2003).
after subsequent deletions, aneuploid cells emerge. Alternatively, incorrect separation of
the chromosomes can occur due to anaphase lag, which consists of delayed movement of
a chromosome towards the corresponding pole. In such a case, the lagging chromosome is
isolated into a micronucleus and lost from the daughter cell, causing aneuploidy.
2.3. Experimental assays for determining DNA copy number
aberrations
Below we present the technologies that allow for the estimation of DNA copy number, from
the earliest to the most modern approaches. We pay particular attention to the arrayCGH
assays, because the bioinformatics methods presented in this thesis have been validated
on arrayCGH data. However, the most efficient technology for genome-wide DNA copy
number measurements, albeit more expensive at the moment, is the recent next generation
sequencing (NGS).
2.3.1. Fluorescence in situ hybridization (FISH)
Fluorescence in situ hybridization has been developed in the early 1980’s (Langer-Safer
et al., 1982). It has been used and continues to be used for detecting the presence or
absence of a particular DNA sequence in the genomes of cells. Figure 2.6a presents the
main steps of this procedure. The target probes, corresponding for example to a gene
of interest, are isolated, purified and amplified, then they are tagged with fluorochromes.
Fluorochromes are small molecules that form covalent bounds with the DNA fragments
and emit light at specific wavelengths, which can be detected by fluorescence microscopy.
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The probes of interest are hybridized onto metaphase chromosomes, which are fixed on
glass slides and after about 12 hours the partially hybridized or the unhybridized probes
are washed away. With image analysis, the abundance of the DNA sequence of interest
is detected. For example, in Figure 2.6b, amplification of the HER-2 gene located on
chromosome 17 in a population of breast cancer cells is evident by the uneven proportion of
red spots (corresponding to the HER-2 sequence) and green spots (marking the centromeres
of the pair of chromosomes 17), respectively. Similarly, deletion of chromosome arm 5q is
observable in Figure 2.6c, where two signals corresponding to the control loci at 5p15 are
visible in green, but only one signal corresponding to a probe located at 5q33-34 locus is
present (in orange).
FISH assays are suitable for investigating the copy number state of a known biomarker,
for instance in cancer diagnostics. For the purpose of biomarker discovery and in general,
genome-wide copy-number analysis, an extension of the FISH technology called Compar-
ative Genomic Hybridization (CGH) has been proposed.
2.3.2. Comparative genomic hybridization (CGH)
The first efficient technique for genome-wide copy number measurement was called CGH
and was proposed for the first time in 1992 by Kallioniemi et al. (1992). The experiment
consists of the following steps (see also Figure 2.7 for schematic representation): first,
DNA from tumor and normal tissue is separately isolated and tagged with different fluo-
rescent labels (for example, red and green in the figure). The labeled DNA is mixed and
hybridized onto metaphase chromosomes. The core principle of this technique is therefore
DNA hybridization, which refers to the property of complementary DNA sequences to pair
with each other forming hydrogen bonds. The last step is image analysis, which is used to
determine the ratio of hybridization intensities (red/green) along the chromosomes, which
ideally mimics the true ratio of DNA copy number between the tumor and control tissue.
Using metaphase chromosomes was one of the main tools for cytogenetic studies in the
early 1990s. However, the chromosomes are highly coiled and therefore the resolution of the
copy number measurements is not very high. It is appreciated that high-level amplifications
(tens or hundreds of copies) can be detected by CGH if their length is larger than roughly
1Mb, whereas deletions must be at least 5 to 10Mb long in order to be identified. Figure
2.7b shows an example output of a CGH experiment: images of chromosomes give a gross
indication of neutral, loss or gain regions.
2.3.3. arrayCGH
Array-based comparative genomic hybridization (arrayCGH or aCGH) uses similar prin-
ciples as classical CGH, but affords much higher resolution by replacing the metaphase
chromosomes with microarray plates as hybridization base. The technique was described
first in 1997, by Solinas-Toldo et al. (1997) and Pinkel et al. (1998). The main steps of
array-based CGH are schematically shown in Figure 2.8. Generally, tumor and control
DNA are labeled with different fluorochromes (usually from the group of cyanines) and are
co-hybridized onto DNA microarray plates, then a special scanner measures the intensities
of each fluorochrome separately. The ratio of these intensities is ideally proportional to
the true copy number.
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Figure 2.7.: a) Schematic illustration of the CGH. Image from Wikipedia
(http://en.wikipedia.org/wiki/Comparative_genomic_hybridization). b) Typical low-
resolution signal obtained by CGH experiments. Image from an early study by Rao et al.
(1998).
A DNA microarray consists of a large number of DNA spots called probes or targets,
attached to a solid surface. Each spot contains many copies of a specific DNA sequence,
which is typically a part of a gene or other sequence of interest. Several types of DNA mi-
croarrays exist, depending on how the target sequences are obtained. The initial technique
that was proposed by Solinas-Toldo et al. (1997) and Pinkel et al. (1998) makes use of large
BAC clones (bacterial artificial chromosome), which can be up to a few hundred kilobases
long. A BAC is an engineered DNA molecule used to clone DNA sequences in bacterial
cells (for example in E. coli). Although high-resolution BAC arrays for many mammalian
genomes are being produced, a large effort is required for obtaining enough DNA sequences
to make one array (Pinkel and Albertson, 2005) and alternative methods have been pro-
posed. For example, a very popular technique is that based on synthesis of oligonucleotides
– short nucleic acid polymers of about fifty or fewer bases. Oligonucleotides are assembled
base-by-base in an iterative process that is error-prone and sets limits to the length of the
polymer. Although they are easier to obtain, the small size of the oligonucleotides and
therefore decreased complexity lead to less specific hybridization, meaning that similar
sequences located elsewhere in the genome can bind to a specific probe. This drawback
is often compensated for by a higher resolution which can be afforded by oligonucleotide
arrays.
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Figure 2.8.: Schematic illustration of the arrayCGH experiment. Image adapted from
Theisen (2008).
Several factors influence the success of arrayCGH experiments. Among those, we men-
tion the heterogeneity of tumor specimens, which refers to the existence of normal cells or
cells in different stages in the tumor tissue. Such mixture introduces biases in the copy
number measurements (Pinkel and Albertson, 2005). Under the simplified assumption
that the mixture contains only normal and tumor cells in the same stage of progression,
a correction is possible if the proportion of normal cells in the tumor specimen can be
estimated.
The phenomenon of signal saturation is another source of bias in arrayCGH experi-
ments. Saturation affects probes against which a very large number of DNA fragments
hybridize, for example those located in highly amplified regions with hundreds of copies
in the tumor. In such cases, the scanner truncates the fluorescence signal with important
negative consequences for the downstream analysis. Hsiao et al. (2002) propose a method
for identification of probes likely to be affected by signal saturation. Other sources of bias
are the proportion of repetitive content in sequence, which, if high, can lead to unspecific
hybridization, or the reassociation of double-stranded nucleic acids during hybridization.
BAC arrays and oligonucleotide arrays are unequally affected by these biases and thus, for
each particular application, the more appropriate arrayCGH technology must be carefully
chosen (Pinkel and Albertson, 2005).
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Figure 2.9.: Lowess normalization. Image adapted from Grant et al. (2001). a) M-A plot
presenting the dependence between the signal intensity A = log2(R ∗G) and the log-ratio
M = log2(R/G). The Lowess regression line and the horizontal through zero are shown.
b) After normalization, the Lowess regression matches the null horizontal.
Low-level processing of array CGH data
The ratio between the two color intensities – let them be red (R) and green (G) for
convenience – expresses the ratio of abundance of a specific sequence between the tumor and
the control DNA. Traditionally, the ratio is transformed by applying the base-2 logarithm
and the measurement is called log-ratio or log2ratio. A log-ratio of value log2R/G = 0
corresponds to a target sequence that is equally abundant in tumor and control cells. An
number of four copies results in a log-ratio of 1 and the loss of one copy results in a log-ratio
of −1. An alternative transformation using the arsinh function instead of the logarithm
has been proposed for expression data analysis (Huber et al., 2002), motivated by more
accurate estimation of weak expression signals, however evidence that such transformation
would improve copy number estimates has not been published yet.
Technology-specific biases affect the log-ratios and various normalization methods for
bias removal have been proposed. The final purpose of normalization is to make comparison
between different experiments more meaningful (Quackenbush, 2002). The most frequently
performed normalization consists of centering the log-ratios around zero by subtracting
the median value from all log-ratios. This procedure is based on the assumption that the
majority of the probes have a neutral copy number. rarely, this assumption does not hold,
for example in the case of near diploid or triploid cancer genomes.
Another well studied phenomenon is the dependence between the log-ratio (log2(R/G))
and signal intensity (log2(R ∗ G)). Specifically, large intensity associates with larger log-
ratio and low intensity associates with smaller log-ratio. Such undesired dependence can
be removed for example by using Lowess regression (Smyth and Speed, 2003). Lowess
(locally weighted least squares regression) is a technique for locally fitting a smooth curve
to a set of observations. The normalization based on Lowess regression transforms the
data such that the regression curve corresponds to the null horizontal line (see Figure
2.9 for an illustration). Other sources of bias are the labeling scheme, meaning that log-
ratio measurements depend on whether the tumor is labeled with green and control with
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red or viceversa or spatial biases, which affect probes located next to each-other on the
microarray.
In general, the most widely used methods for normalization of arrayCGH data have been
borrowed from the field of expression data analysis. It has been observed in articles that this
may not be a good practice, due to different distributions of the log-ratios and consequently
arrayCGH-specific algorithms have been proposed. Neuvial et al. (2006) present MANOR,
an algorithm which extends Lowess regression to accept as input two-dimensional log-ratio
data, corresponding to physical locations on the CGH microarray. This way, MANOR
can correct for spatial biases. Staaf et al. (2007) use a clustering approach for stratifying
the log-ratios into three clusters (likely corresponding to neutral, gained and lost target
sequences). Then, they use only the largest group for Lowess normalization, evidently
assuming that the majority of the probes are in a normal copy number status. Despite
the better performance, application studies have not adopted the normalization methods
especially designed for arrayCGH data, but have continued to use the more established
methods designed for expression arrays.
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3. Computational analysis of DNA Copy
Number Aberrations
Number is the ruler of forms and
ideas, and the cause of gods and
demons.
Pythagoras
3.1. Introduction
Most types of cancers accumulate during progression a large number of copy number aber-
rations (CNAs), affecting genomic regions of very small size (a few Kbp) to large regions
spanning whole chromosomes or chromosome arms. The high genomic instability and the
selective pressure acting on the tumor cells lead to very complex patterns of CNAs, that
can be either common to a large subset of samples belonging to a tumor type or subtype
(recurrent aberrations) or particular to an individual tumor sample or to a very small sub-
set of them. A common assumption in the research field is that the recurrent CNAs are
accountable for the tumor phenotype, whereas the spurious CNAs have a lesser role. Most
bioinformatics methods for computational analysis of CNAs are driven by the two-fold
objective of identifying recurrent CNAs in a collection of samples belonging to a tumor
type or subtype and characterizing their influence on tumor phenotype.
Over the last decade, many methods for computational analysis of CNAs were published,
advertising their ability of identifying CNA signatures characterizing tumor types or sub-
types. However, despite the intense research, very few of these signatures are currently
used in clinical practice for diagnosis, prognosis or treatment. The main critique of the
studies that propose CNA signatures is their lack of reproducibility (Ein-Dor et al., 2005).
Specifically, under variations of the tumor cohort investigated and of the parameters of the
methods, the CNA signatures change significantly. Two possible reasons can explain the
instability of the CNA signatures: first, the biological diversity of the tumor set, which
cannot be corrected and second, the complexity and lack of robustness of the computa-
tional pipeline used for identifying CNA signatures. The latter source of variance can be
corrected, if more robust computational pipelines are proposed. Existing pipelines apply
successive processing steps, at every step making assumptions about the nature of the
data. These assumptions, depending on how restrictive or permissive they are, can affect
downstream analysis by obstructing relevant information or adding false information. The
effects of the processing steps on stability of the signatures under variability of the tumor
set are largely uncharacterized in scientific studies.
In this chapter, we first give a detailed overview of the computational pipelines commonly
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used for addressing the objective of identifying and characterizing CNAs (Background
Section). Then, we introduce a modified pipeline, which makes less restrictive assumptions
about the nature of the data. We give a high-level description of the main steps of the
pipeline. In the following two chapters (Chapter 4 and 5), we will describe these steps and
the corresponding algorithms in detail.
3.2. Background
Up to present, the problem of automatically identifying CNAs and characterizing their
impact on phenotype remains a challenge. Despite numerous approaches proposed in the
literature, there exists no methodological gold standard, that has been proven to be ap-
plicable to a large number of different cancers (Rueda and Díaz-Uriarte, 2010). Statistical
modeling becomes very difficult because of the high dimensionality of the measurements
compared to the relatively small number of tumor samples available and the notorious
heterogeneity of CNAs. Most computational approaches consist of pipelines involving suc-
cessive steps of data processing and dimension reduction. The general workflow can be
summarized by several alternative pipelines, the steps of which are schematically presented
in Figure 3.1. Most of the methods adopt a two-stage pipeline, namely single-array analysis
and multiple-array analysis.
The single-array analysis addresses one of the first computational challenges of array-
CGH analysis: the identification of all CNAs that a particular tumor harbors, given the
normalized log-ratios measured by an arrayCGH experiment.
The multiple-array analysis makes use of large collections of arrays obtained from the
same type of tumor in order to identify recurring CNAs and to characterize their impact
on tumor phenotype.
Below we present each step of the pipeline in details. We summarize the most pop-
ular methods that address their problematics and we comment on their advantages and
drawbacks.
3.2.1. Segmentation
As already shown in chapter 2, various types of stochastic noise and bias from experimental
and biological sources affect the true copy number ratios, in such a way that the experi-
mentally determined ratios do not take discrete values of the form n/2, corresponding to
n copies of DNA. Figure 3.2a shows the normalized log-ratios from an arrayCGH experi-
ment. The single-array segmentation algorithms make the first step towards inferring the
true copy number from the normalized log-ratios. Specifically, they estimate an optimal
partition of the genome into intervals of constant copy number. The boundaries of the in-
tervals mark locations of copy number change, which are called breakpoints. Formally, the
segmentation algorithm assumes that the true log-ratio depends on the genomic location
x via a step function θ as follows:
θ : X → R, θ(x) =
p∑
k=1
ak1Ik(x) (3.1)
where X denotes the set of all genomic positions and I1, ..., Ip are disjoint intervals that
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Figure 3.1.: Computational pipelines for characterizing the associations between of CNAs
and tumor phenotype. In 3D boxes, the type of input/output data involved in the various
steps are shown. In colored boxes, algorithms which perform the corresponding steps are
shown.
cover all genome X = ⋃pk=1 Ik. The number of intervals p ∈ N, the intervals I1, ..., Ip and
the constants a1, ...ap ∈ R are parameters of the function θ.
Assume that we have given an array α consisting of normalized log-ratio values α1, ..., αd
measured at d genomic loci P1 < ... < Pd. Under the model assumption given by (3.1),
the true log-ratio at Pi is θ(Pi). The observed log-ratio at Pi is αi. The purpose of array
segmentation is to use the observations (P1, α1), ..., (Pd, αd) for estimating the parameters
of the true model θ. Figure 3.2b, illustrates array segmentation by an intuitive example.
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In a review article, Lai et al. (2005) summarize the most popular methods for array
segmentation and compare their performance on simulations and real cancer data. A large
class of nonparametric solutions use appropriate smoothing or denoising techniques in
order to obtain a simpler signal that is closer to the true piece-wise constant model θ. The
smoothing algorithms minimize some loss function, which evaluates the distance between
the observed log-ratios and the estimated log-ratios. In order to avoid oversegmentation,
which decreases the loss function but increased model complexity and leads to overtraining,
penalties are used to keep the number of segments p small. For example, Eilers and
de Menezes (2005) use a quantile smoothing technique which minimizes the penalized L1
distance between the observations and the estimated model, which is shown to result in
sharp boundaries between segments. This approach is called Quantreg. Hsu et al. (2005)
propose Wavelet, a method based on denoising by wavelets. Both Wavelet and Quantreg
are shown to perform well on arrays with large signal-to-noise ratio (Lai et al., 2005),
however they are not easy to interpret because they leave to the user the task of deciding
whether a jump in the smoothed signal is large enough to be considered a breakpoint.
A large class of parametric methods model the observed log-ratios as the sum of the true
signal, given by the function θ and Gaussian noise. Formally, for all probes i = 1, ..., d,
αi = θ(Pi) + εi,
where εi are i.i.d N (0, σ). Then, a model θˆ is estimated that maximizes the likelihood of
the observed data. The likelihood function is usually penalized, such that the number of
segments is kept small and overfitting is avoided. In Hupé et al. (2004), a weighted likeli-
hood function is maximized in the neighborhood of each genomic position. The weights are
iteratively updated, such that they reflect the maximal neighborhood of constant log-ratio.
The updating of the weights follows closely the Adaptive Weights Smoothing procedure
by Polzehl and Spokoiny (2002). The algorithm is called GLAD. In an evaluation on real
data, GLAD has been shown to return segments consisting of single-probe outliers, which
are most likely bad probes (Lai et al., 2005). An improved method is CGHseg, presented
by Picard et al. (2005), based on a likelihood model with a novel penalty that is chosen
such as to avoid overestimation of the number of constant intervals.
Wang et al. (2005) present the algorithm CLAC, based on hierarchical clustering of the
observed log-ratios along the chromosomes, using a special distance between consecutive
probes. Then, a heuristic is used for selecting clusters corresponding to segments of large
or small copy number.
A different approach using Hidden Markov Models (HMM) is presented by Fridlyand
et al. (2004). The authors assume that the underlying log-ratios are successive states of
an HMM with a certain transition probability. The states are chosen to represent the
underlying copy number: one, two, three, etc. copies. An HMM is trained to estimate the
state of each probe and the transitions between different states (the breakpoints). However,
the method is slow in practice and it does not perform well on real data (Lai et al., 2005).
The most frequently used and cited procedure for array segmentation is presented by
Olshen et al. (2004). The authors adapt the binary segmentation procedure by Sen and
Srivastava (1975), which can identify a change in mean (breakpoint) in a series of observa-
tions, to the task of discovering an arbitrarily large number of breakpoints. Their approach
is called Circular Binary Segmentation (CBS). The CBS algorithm uses a statistic, which
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tests the hypothesis that the interval between probes i and j has a different log-ratio mean
than the rest of the chromosome. The null distribution of the test statistic is obtained via
random permutations. In the review article by Lai et al. (2005), CBS is shown to perform
consistently well, both on artificial and on real cancer data, the only reported drawback
being the relatively slow running time. Later, the authors of CBS introduced a faster
version of their method (Venkatraman and Olshen, 2007), which scales to the needs of the
high-throughput arrays.
The advantage of performing segmentation as part of the analysis pipeline is two-fold:
first, the noise is substantially reduced and the true log-ratio signal is revealed, which
is beneficial for downstream analysis. Second, segmentation affords significant dimension
reduction, which helps in the analysis of multiple tumors. Specifically, while the probe-data
live in a d-dimensional space, the segmented data can be represented in the p-dimensional
space of the intervals of constant log-ratio. In the context of the model described by (3.1),
the array (α1, ..., αd) can be replaced by (a1, ..., ap). The latter representation is more
meaningful, because it reflects the genomic instability of the tumor investigated, and not
the resolution of the microarray technology used.
Segmentation can also lead to information loss, for example if the segmentation procedure
fails to detect low-amplitude changes, or intervals consisting of very few probes. In high-
throughput arrays however, the probes cover the genome so densely that enough evidence
is available for a very accurate segmentation.
3.2.2. Aberration call
Aberration calling is the task of assigning a discrete copy number state to each interval of
constant copy number: loss, neutral or gain. Calling aberrations is frequently formulated
as a problem of assessing statistical significance. For example, a segmented log-ratio value
larger than zero, but small enough, can be still attributed to experimental bias (for example
differences in dye incorporation efficiency) and therefore should be classified as neutral. In
contrast, segments of log-ratio significantly larger or smaller than zero should be classified
as loss or gain.
A large class of methods for aberration calling are based on choosing significance thresh-
olds for loss and gain. In the context of the segmentation model given in (3.1), let gain_thr
and loss_thr be such thresholds. Then:
interval Ik is classified as

gain, if ak > gain_thr
neutral, if loss_thr ≤ ak ≤ gain_thr
loss, if ak < loss_thr
, k = 1, ..., P
In figure 3.2c, we show an example of aberration thresholds.
The statistical significance is determined by taking into account the background dis-
tribution and the variability of the log-ratios in arrayCGH experiments. For example,
some authors use normal-to-normal hybridizations 1 in order to isolate the variability in-
troduced by the experiments, in the absence of copy number aberrations (Wang et al.,
2005). Veltman et al. (2003) choose the loss_thr and gain_thr such that only a very small
1Hybridization of normal tissue versus normal tissue.
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(a)
(b)
(c)
Figure 3.2.: ArrayCGH experiment on a neuroblastoma tumor. a) Normalized log-ratios,
ordered along the genome. Each grey dot corresponds to a probe on the microarray. The
blue horizontal line corresponds to a log-ratio equal to zero and indicates a normal copy
number. b) Segmented log-ratios: the red line represents the piecewise constant model
fitted to the observed log-ratios. 3) Aberration call: the blue dotted lines mark the gain
and loss thresholds.
percentage of the normal-to-normal log-ratios fall outside the interval [loss_thr , gain_thr ].
Other authors estimate the standard deviation SD of normal-to-normal log-ratios and de-
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fine the gain threshold gain_thr by 3SD and the loss threshold loss_thr by −3SD (Nakao
et al., 2004; Hodgson et al., 2001). However, using normal-to-normal hybridizations require
supplementary expenses and identical experimental conditions as the normal-to-tumor hy-
bridizations, which are difficult to ensure.
Hupé et al. (2004) use directly the tumor arrays for estimating the variation of the
experimental noise. They propose to use the interquartile range2 of the differences be-
tween successive log-ratios as a robust measure of variance. Then, the authors cluster the
segmented log-ratios into three classes corresponding to loss, neutral and gain status.
In the case of most cancers, the three copy number states discussed above are insufficient
for capturing the landscape of copy number alterations (Wu et al., 2009), which may
range from zero to tens of copies. Therefore, in more recent articles, authors prefer to
use multiple copy number levels. Guttman et al. (2007) split the gain class into two
subclasses, in order to differentiate between low-amplitude aberrations and high-amplitude
aberrations. Van de Wiel et al. (2007) propose the method called CGHcall, which clusters
the segmented log-ratios into six classes, two for each type of signal: loss, neutral and
gain. In a different publication (van de Wiel and van Wieringen, 2007), the same group
of authors also suggest that the segmented log-ratios are grouped into four states: loss,
neutral, gain and amplification, where amplification indicates a large copy number, of at
least four copies. Willenbrock and Fridlyand (2005) propose the method MergeLevels,
which iteratively joins intervals, the log-ratios of which cannot be distinguished based on a
Wilcoxon rank sum test3. Aguirre et al. (2004) also propose four states (method cghMCR):
gain (segmented log-ratio ≥ 4 standard deviations from the median), loss (segmented log-
ratio ≤ 4 standard deviations from the median), amplification (segmented log-ratio ≥ 97%
quantile) and deletion (segmented log-ratio ≥ 3% quantile).
Regardless of the granularity of the copy number classes, the main weakness of aberration
calling is that it relies on hard thresholding. The intervals of log-ratio close to the threshold
values have a high risk of being wrongly classified. These errors are propagated through
the next steps of the pipeline. Moreover, aberrations of low amplitude are ignored, despite
the fact that in many studies, recurrent low-amplitude aberrations across many tumors
constitute evidence of positive selection and thus potential impact on phenotype.
3.2.3. Identification of recurrent CNAs in a set of tumors
The most difficult and the most intensely explored problem in the field of DNA copy
number analysis is the identification of recurrent CNAs in a set of tumors. Its biologically
motivated goal is to single out the driver aberrations, which play an important role in
tumor development, from the passenger aberrations, which occur as a consequence of the
high genomic instability, but have no impact on tumor progression. The high recurrence (or
frequency) of a CNA is generally accepted as evidence of relevance, because it suggests that
the respective CNA plays a favorable role in the survival and proliferation of the tumor cell,
being consistently selected for during tumor progression. Additionally, recurrent CNAs are
most likely to harbor disease-critical genes that can be targeted by therapies.
2The interquartile range is a measure of statistical dispersion and is defined as the difference between the
third and first quartiles of a distribution.
3Wilcoxon rank sum test is a non-parametric statistical hypothesis test, which is used for assessing
whether two populations have equally large values.
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Figure 3.3.: Examples of recurrent CNAs in various types of cancers. The samples are
arranged on the vertical axis, the probes are represented along the horizontal axis, or-
dered according to their genomic position. The color scale encodes the smooth log-ratio
values: red stands for gain, blue stands for loss and white represents neutral copy num-
ber. With black segments, we mark genomic regions that, based on visual inspection and
human judgment, are considered recurrent CNAs. a) Deletions of chromosome 9 segments
in Glioblastoma, concentrated around the CDKN2A tumor suppressor gene. b) Amplifi-
cations of the MYCN and ALK gene loci in certain tumors and of a larger region in other
tumors, in a Neuroblastoma cohort. c) Recurrent amplifications with various boundaries
in chromosome 17 from Neuroblastoma. d)Deletion with highly variable boundaries on the
right side, overlapping with gain regions, in ovarian cancer.
To this date, automated identification of recurrent CNAs remains very challenging. In
a review paper, Rueda and Díaz-Uriarte (2010) observe that the difficulty of the problem
stems mainly from the lack of agreement on what constitutes a recurrent CNA region.
For an intuitive understanding of the difficulty, we illustrate in Figure 3.3 several types of
recurrent CNAs that occur in tumors. In Figure 3.3a, a recurring deletion on chromosome
5 in a Glioblastoma cohort is shown, which can be easily recognized by visual inspection.
The frequency of deletion is very high, occurring in more than 50% of the samples. The
challenge in this case consists of precisely defining the genomic interval (or region) which
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is most likely to contain the genetic factors involved in tumor progression. In Figure
3.3a, one can observe the high variability of the location and length of deletions among
samples. Some samples exhibit a very short deletion at the locus marked in the figure by
‘R1’. Other samples appear to have, additionally, a larger deletion, overlapping with ‘R1’,
which can be summarized, for example, by interval ‘R2’. Progressively larger deletions are
suggested by ‘R3’ and ‘R4’. From a biological perspective, it is not clear which region is
most relevant and should be selected as a recurrent CNA. Many authors prefer ‘R1’, which
is the sub-region with maximal recurrence, meaning that it occurs in a maximal subset of
samples. Such a maximally recurrent region is also the shortest of the stack of overlapping,
recurrent CNAs, therefore it is often referred to as the ‘minimal recurrent region’ (Rouveirol
et al., 2006; Rueda and Díaz-Uriarte, 2010). The minimal recurrent region is attractive
because it narrows down maximally the search for disease-associated genes. Indeed, in
the example discussed, R1 harbors the tumor suppressor gene CDKN2A. However, tumors
with a larger deletion around the CDKN2A locus may have a different phenotype, or may
have progressed in a different way, which can shed light on tumor evolution. Therefore,
the larger regions must not be discarded.
Figure 3.3b shows gains and amplifications on chromosome 2 from a Neuroblastoma
cohort. Regions ‘R1’ and ‘R2’ approximate the locations of two recurrent amplifications,
containing the oncogenes MYCN and ALK, respectively. In this case, very little evidence
(4 samples out of 150) supports region R2, however the boundaries of the amplifications are
in high agreement, which makes it improbable that the aberrations co-localize by chance.
Additionally, some samples that do not have amplifications at R1 and R2 locations harbor
longer gains (of lower copy number), suggested by regions ‘R3’ and ‘R4’. It is necessary
that both the gain and amplification are detected, since they are likely to belong to two
different tumor subtypes.
In Figure 3.3c, chromosome 17 from a Neuroblastoma cohort is shown. Disregarding
the samples exhibiting whole chromosome gain, a shorter recurrent gain with variable
boundaries on the left is apparent. Despite the variability, accumulations of breakpoints
around several sites, for example as defined by regions ‘R1’, ‘R2’ and ‘R3’, point to locations
in which the DNA is more vulnerable and easy to break. Identifying all these sites, where
breakpoints accumulate, can reveal alternative mechanisms of copy number alteration.
Finally, Figure 3.3d presents recurrent deletions and gains on chromosome 5 from a set
of ovarian tumors. The deletions marked by region ‘R3’ overlap with the gains marked
by ‘R2’. Unlike in the previous scenarios discussed above, it is very hard to decide which
region is likely to harbor disease-related factors using human judgment (hence the dotted
line, marking uncertainty).
In the light of the examples above, it is obvious that giving a formal definition of a
recurrent region is a very difficult task. In general, authors formulate their preferred
criteria for selecting recurrent regions and propose algorithms that are guided by these
criteria. In what follows, we summarize the most frequently cited works in the literature.
These approaches, together with their input formats are schematically presented in Figure
3.1.
Aguirre et al. (2004) propose cghMCR, which is one of the first algorithms for identifi-
cation of recurrent CNAs. The algorithm is applied to called data (i.e. some aberration
call method has been applied to the arrays), with a separate handling of low magnitude
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gains and losses, and of high amplitude amplifications and deletions. The goal of the algo-
rithm is to identify ‘Minimal Common Regions’ (MCRs), which are defined by the authors
as continuous segments that are altered in at least a fraction of the samples (recurrence
threshold), the value of which is defined by the user. However, it is not clear which recur-
rence threshold results in best performance and no optimization scheme is suggested. The
authors also make some ad-hoc decisions, such as joining altered segments that are closer
than 500kbp, and MCRs that are separated by only one probe. Rueda and Díaz-Uriarte
(2010) observe that the method is very sensitive to changes of these parameters.
Lipson et al. (2006) present the method IntervalScores, which works directly on normal-
ized data. The authors formulate a scoring function that can be applied to any genomic
interval I and any set of samples S, which consists of a normalized sum of all log-ratios
within I and over all samples in S. Significantly large or small scores indicate recurrent
CNAs. The significance of the score is obtained by comparison to a null score, which stems
from a parametric model of the log-ratios under the assumption than no recurrent aber-
ration is present. The authors provide an efficient algorithm for identifying the interval
of maximum score, then re-iterate the procedure on the left and right side of the optimal
interval. Despite the strong theoretical support for the algorithm, the method has limita-
tions, in that the authors do not make qualitative statements with respect to the biological
meaning of their scoring schemes.
The algorithm STAC, introduced by Diskin et al. (2006), is applied to called data. It
makes use of two statistics: the ‘frequency statistic’, which is calculated as a simple count
of aberrations at each probe, and the ‘footprint statistic’, which is a score that is large if
the boundaries of recurrent aberrations are tightly aligned. The idea of the authors is that
a recurrent CNA should be either highly frequent in the pool of samples, or well aligned
at the boundaries (for example, region R2 from Figure 3.3b). In order to identify regions
with significant frequency or footprint statistic, the authors construct a null model, which
does not contain recurrent aberrations, by randomly permuting the altered segments of
each array. For this reason, the algorithm is slow, in practice. The authors propose a
faster approach, called MSA, in Guttman et al. (2007).
Rouveirol et al. (2006) make the first attempt towards a rigorous definition of recurrent
CNAs. Based on called data, the authors define ‘minimal alteration regions’ (MAR). In a
simplified view, a MAR is very similar in concept to a bicluster (Mirkin, 1996), consisting of
a subset of consecutive probes all of which are altered over a subset of samples. Observing
that the number of MARs occurring in a real data set is too large, the authors introduce
CMAR (constrained minimal alteration regions), which comprise only those MARs which
occur with a particular minimum frequency, have a minimum or maximum size and are
aligned well enough. However, the formal framework is too complicated and examples
are insufficient, which is probably the reason that the MAR and CMAR methods did not
become too popular in the applied research.
One of the most widely used methods is GISTIC (Genomic Identification of Significant
Targets in Cancer) (Beroukhim et al., 2007; Weir et al., 2007). The authors of GISTIC use
segmented data to compute the ‘G-score’, a simple statistic that sums the log-ratios over all
samples. The G-score captures both the frequency and the amplitude of aberration, in such
a way that either few high-magnitude alterations or many low-magnitude alterations can
result in a high score. In order to identify regions with significantly high score, the authors
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of GISTIC use a permutation scheme for computing null G-scores, then use multiple testing
correction for controlling the False Discovery Rate (FDR) (Benjamini and Hochberg, 1995)
and report a q-value for significance.
The CoCoA method (Ben-Dor et al., 2007) applies to segmented data and is based on a
statistic that, for a specific CNA region and a specific tumor sample, quantifies how likely
it is that an amplitude as high is attained by an arbitrary region of the same size. For
multiple samples, the probability of observing at least a minimum number of CNAs at a
specific location is estimated based on an adjusted binomial distribution.
Shah et al. (2007) introduce the H-HMM (Hierarchical HMM) method, which extends
the single-array method for segmentation and aberration calling based on Hidden Markov
Models (Fridlyand et al., 2004). A ‘master process’ is accountable for switching between
driver alterations and passenger alterations in the cohort of tumors. An HMM is used for
inferring the master process, which uses the normalized data of all samples simultaneously.
A direct limitation of the method is that infrequent recurrent aberrations cannot be de-
tected (Shah, 2008). Also, a drawback of this method is that it reports recurrent probes,
and not recurrent regions.
RAE (Taylor et al., 2008) is a very interesting approach, because it combines unprece-
dently many biological assumptions regarding the sources of variations affecting CNAs
and statistical methodology. The method is applied to segmented data. Motivated by
the difference in biological mechanisms, RAE treats low-level and high-level aberrations
differently and handles deletions and amplifications separately. The scoring function used
by RAE is very similar to that used by GISTIC (Beroukhim et al., 2007), namely the
average over the segmented log-ratios of all samples. The significance is determined in
reference to a null case, obtained by an elaborate permutation scheme, which incorporates
knowledge on recombination hotspots for a more realistic randomization. Incorporating
complex biological assumptions into the method can be truly advantageous, however the
assumptions may not hold always, which can result in erroneous results.
Klijn et al. (2008) present the method KC-SMART, which is applied directly to normal-
ized data. At each probe location, a weighted average over all samples of the log-ratios in
the neighborhood gives an informative score. The weights are given by a flat-top Gaussian
kernel centered at the current probe, which affords a smooth definition of the neighbor-
hood and ensures that probes in the immediate vicinity bring more information to the score
than the remote probes. Reference null scores are obtained via a permutation scheme. By
varying the width of the kernel, the method is able to detect both large and small CNAs.
The main limitation of the method is that it is not able to detect recurrent CNAs that
affect only a small fraction of the samples.
DiNAMIC (Walter et al., 2011) is among the most recent methods for identifying re-
current CNAs. It can be applied to any kind of input (normalized, segmented, called).
DiNAMIC uses the same scoring function as GISTIC and RAE, namely the sum of log-
ratios at each probe, over all samples. The novelty is brought by the permutation scheme
that is used for assessing significance: the authors use circular permutations on each sam-
ple independently, in order to preserve the spatial relationship between the log-ratios. The
drawback of the method is that it cannot detect low-frequency CNAs.
To this date, there exists no gold-standard algorithm for detection of recurrent CNAs,
because no comparative study has been published. Two review articles (Shah, 2008; Rueda
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and Díaz-Uriarte, 2010) comment on the approaches, however, only qualitatively, stating
strengths and possible limitations. We think that a quantitative comparison is difficult, for
at least three reasons: first, the lack of benchmark datasets with annotated recurrent CNAs,
second, the lack of agreement to what constitutes a recurrent CNA (different approaches
have different goals) and third, the code unavailability of many of the methods.
3.2.4. Quantifying the association of a recurrent CNA with the phenotype
The ultimate goal of studies on copy number aberrations is to bring to light mechanisms of
tumor progression that can be directly addressed by drug therapies. To this end, two main
directions have been undertaken in the literature: genetic marker discovery and tumor
subtype discovery (Kallioniemi, 2008).
In the context of DNA copy number analysis, genetic marker discovery refers to the task
of identifying cancer-associated genes, that can be either targeted by drugs, or that can help
predict patient survival, or response to a particular therapy, or can suggest the progression
status of the tumor. In other words, given a phenotypic label such as survival, treatment
response or tumor progression, genomic loci are identified, the copy number of which
significantly associate with the respective phenotype. More recently, a secondary topic has
emerged, closely related to genetic marker discovery, namely genetic pattern discovery. It
extends the problem of identification of single-gene markers to sets of probes (or genes)
that, combined in a meaningful way, can help predict tumor phenotype. In general, genetic
marker discovery consists of a univariate selection of informative probes, whereas pattern
discovery requires multivariate data analysis. From a computational perspective, genetic
marker and pattern discovery can be formulated as a supervised feature selection problem.
Tumor subtype discovery refers to the problem of discovering cancer subtypes based on
specific copy number aberration profiles. This task is unsupervised and it generally implies
the usage of some clustering technique.
Further on in this thesis, we will present in great detail the problems of supervised
feature selection and unsupervised classification, because our contributed work adopts
such techniques (see Chapters 4 and 5). In this section, we will only briefly mention the
most highly acknowledged publications dedicated to the task of genetic marker discovery
and tumor subtype discovery.
The most widely used tool for marker discovery is statistical hypothesis testing. The
typical setting assumes that copy number measurements at a number of loci are given. The
measurements can be in various stages of pre-processing: raw (normalized), segmented or
called. A phenotype variable is also given, usually binary (0/1), such that a value of 1
stands for a progressed tumor, or a therapy-resistant tumor, etc. For each locus, a statis-
tical test is carried out, which evaluates the difference between the copy number estimate
of the tumors labeled with 0 and the ones labeled with 1. If the copy number is given as a
continuous value (for example, normalized or segmented data), a t-test (Student, 1908) is
usually carried out, for finding whether the difference between the means of the two pop-
ulations is significant or not (Kresse et al., 2010; Fridlyand et al., 2006; Spitz et al., 2006).
If the method is applied to called data, a Fisher’s exact test (Fisher, 1922) can be applied
to the contingency table between the phenotype and the called copy number data (Joosse
et al., 2009; Tagawa et al., 2005). Applying significance tests at many genomic loci simul-
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taneously increases the chance of incorrectly rejecting the null hypothesis (type I error). A
common statistical practice which keeps the type I error low is multiple testing correction,
which can be carried out by means of various methods (Benjamini and Hochberg, 1995;
Holm, 1979; Hochberg, 1988). However, most methods for multiple testing correction are
based on the assumption that the tests are independent, which does not hold if applied to
copy number alteration data. The strong correlations between neighboring loci make the
traditional correction methods too conservative. van de Wiel and van Wieringen (2007)
notice this problem and propose a dedicated method, however only applicable to called
data.
Statistical models that characterize the association between the copy number changes at
a certain locus and patient survival are a very popular tool for marker discovery (Kresse
et al., 2010; Idbaih et al., 2008; Carrasco et al., 2006; Tagawa et al., 2005). A typical
application is the following: the tumors are divided into two groups, according to the
presence or absence of a particular CNA. The distributions of patient survival data (Kaplan
and Meier, 1958) in these two subgroups are compared by a log-rank test (Mantel, 1966).
For the extended purpose of pattern discovery, multivariate regression to survival data
can be performed by Cox proportional hazard models (Cox, 1972). For example, Kresse
et al. (2010) and Idbaih et al. (2008) report on combinations between CNAs and clinico-
pathological indicators that are predictive of survival in malignant fibrous histiocystomas
and gliomas, respectively.
Pattern discovery is commonly approached by statistical learning methods for classi-
fication and feature selection. Specifically, the copy number measurements (normalized,
segmented or called) are used as features for predicting a (binary) phenotypical outcome.
To this date, only a few publications have proposed classifiers that are tailored to the
particularities of copy number data. Liu et al. (2008) describe an SVN classifier (Vapnik,
1998) with a specialized kernel called Raw. The kernel is based on the count of common
aberrations between two tumor samples. The drawback of the Raw kernel is that the clas-
sification model is not directly interpretable, namely one cannot assess the contribution of
particular features to the prediction. The authors propose MIFS (maximum influence fea-
ture selection), which is an iterative method for selecting most useful features in a greedy
fashion. Here, the main limitation of the feature selection approach is that it cannot guar-
antee that at least a local minimum has been attained. Rapaport et al. (2008) introduce
the fusedSVM, a linear SVN with a Lasso and a fused penalty. Conceptually, the fusedSVN
maximizes the separation margin between the outcome classes, with L1 constraints on the
number of features that participate in the model (Lasso penalty) and the difference be-
tween the weights of subsequent features (fused penalty). The strength of this approach is
that it can be applied directly to normalized data and it can automatically discover regions
of (almost) constant copy number that are predictive of phenotype. However, in this thesis
we show that the feature selection with fused SVM is biased towards short regions (Toloşi
and Lengauer, 2011). Barutcuoglu et al. (2009) construct a special Hidden Conditional
Random Field (HCRF) model (Lafferty et al., 2001), in which the observed log-ratios, the
underlying copy numbers and the phenotype are the vertices of a network. The topology of
the HCRF is chosen to best capture the structure of copy number data. A gradient Lasso
(Kim and Kim, 2004) algorithm is used for estimating optimal parameters of the HCRF.
Other authors borrow methods tailored to expression analysis and apply them directly to
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copy number data: Joosse et al. (2009) use Shrunken Centroids (Tibshirani et al., 2003)
for discriminating between two subtypes of breast cancer. Bergamaschi et al. (2006) use
Significance Analysis for Microarrays (SAM) (Tusher et al., 2001) to identify significant
associations between CNAs and clinico-pathological parameters in breast cancer.
Tumor subtype discovery is usually approached by unsupervised clustering techniques.
Specifically, a partitioning of the tumor samples into several groups is performed, based on
similarity of their copy number profiles. Fridlyand et al. (2006) and Kresse et al. (2010) use
agglomerative hierarchical clustering (Hastie et al., 2003) with Pearson correlation distance
between samples and Ward distance (Ward, 1963) between clusters, and conclude that
the breast cancer cohort investigated exhibits three main subtypes. van Wieringen et al.
(2007) perform hierarchical clustering with a new similarity measure and a new linkage
method, that take into account the structure of copy number data. Cheung et al. (2009)
use Partitioning Around Medoids (PAM) (Kaufman and Rousseeuw, 1990), with Hamming
distance (Hamming, 1950) between a case and a medoid. The authors choose five clusters
and argue that they represent distinct subtypes of follicular lymphoma. Shah et al. (2009)
introduce a new clustering technique based on Hidden Markov Models (HMM) and estimate
the optimal number of clusters via Silhouette values (Rousseeuw, 1987). Carrasco et al.
(2006) use Non-negative Matrix Factorization (NMF) (Brunet et al., 2004), a technique for
deriving a small number of feature representatives that summarize the original data well,
in order to partition a set of multiple myeloma patients into two and four clusters. André
et al. (2009) also use NMF, but in addition, the optimal number of clusters was estimated
by calculating the cophenetic correlation coefficient of the cluster assignment (Sneath and
Sokal, 1962).
3.3. A new pipeline based on supervised selection of CNAs
relevant for tumor phenotype
Our main criticism of the traditional pipeline for analysis of CNAs is directed towards
the steps: aberration call and identification of recurrent CNAs in a set of tumors. The
aberration call step uses hard thresholds to classify probes into loss, neutral or gain. The
probes with log-ratio close to the threshold values have a high risk of being wrongly classi-
fied. These errors are propagated and their effect is potentially amplified in the subsequent
steps of the pipeline. Considering that aberration call is essential for data interpretation,
we believe that it should be one of the last steps of the pipeline. Similarly, the step for
identification of recurrent CNAs in a set of tumors involves making implicit or explicit
assumptions on their structure, on the minimal frequency of a recurrent CNA, etc. Such
assumptions disfavor CNAs characteristic to rare subtypes, or disregard larger aberrations
in favor of the minimal recurrent region (as we showed in Figure 3.3a). This type of
unsupervised selection of regions, based solely on human judgment, may run the risk of
information loss.
In contrast, we believe that array segmentation is beneficial for downstream analysis and
should be part of any efficient pipeline, because it eliminates a type of experimental noise
that is relatively well understood and thoroughly investigated (for example, via normal-
to-normal hybridization). No less importantly, segmentation affords significant dimension
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Figure 3.4.: A modified pipeline for inferring CNAs associated with tumor phenotype.
reduction, in the following way: the probes that yield identical smoothed log-ratio in all
arrays can be joined into a single interval. Here, we call this procedure compression. By
compression, the dimension of the data is no longer determined by the resolution of the
experimental technology, but by the number of breakpoints characteristic of the tumor
investigated.
Following these considerations, we propose a new pipeline for genetic marker and genetic
pattern discovery, which performs data driven selection of the most informative genomic re-
gions with respect to a specific phenotype. Figure 3.4 summarizes the steps of the pipeline:
1) segmentation, 2) consensus segmentation, 3) region selection and 4) aberration call. The
pipeline applies directly to normalized log-ratios. The purpose of the segmentation and
48 3 Computational analysis of DNA Copy Number Aberrations
Figure 3.5.: An example of consensus segmentation. Chromosome 17 from a neuroblastoma
cohort is partitioned into the following regions of almost constant profile: R1, R2, R3 and
R4.
consensus segmentation steps is to achieve dimension reduction with minimal information
loss. We suggest that the segmentation step is carried out by CBS, which is recommended
by its top performance (as discussed earlier in this chapter).
The consensus segmentation step is a multivariate generalization of the single-array
segmentation. Given a set of arrays, the goal is to partition the genome into a set of regions
R1, ..., Rm, m ≥ 1 of almost constant profile. By region of almost constant profile, we
mean a genomic interval R contained in one chromosome, with the property that the true
copy number of each array stays constant within interval R. Any observed copy number
change within interval R is therefore attributed to noise. For the purpose of dimension
reduction, we require that the number of almost constant regions is small.
For example, we reexamine the stack of amplifications with varying boundaries from
Figure 3.3c. A possible outcome of the consensus segmentation procedure is given in Fig-
ure 3.5. In this case, a possible consensus segmentation consists of four distinct consensus
regions R1, R2, R3 and R4, delimited by B1, B2 and B3, which we call consensus break-
points. The advantage of this procedure over the frequently used minimal common region
is that it allows all regions to become marker candidates. Hence, it is possible to evaluate
the relevance of larger amplifications, additionally to that of the minimal common region.
Technically, in the consensus segmentation step we use the segmented log-ratios from
a set of arrays for estimating an optimal partition into consensus regions. The problem
is very challenging, due to the complex structure of the noise, which can be attributed
to either misalignment of the breakpoints between regions or passenger alterations, which
appear at random in the set of arrays. In Chapter 4, we propose several algorithms for
consensus segmentation, which are adapted to the special structure of copy number data.
To our knowledge, we are the first to address this problem. The only related method in this
respect is CGHregions (van de Wiel and van Wieringen, 2007), which performs consensus
segmentation, however on called data. Parenthetically, the authors of CGHregions have
introduced the term ‘almost constant region’.
The region selection step of the pipeline uses supervised classification and regression
models for feature selection, in order to select the most predictive genomic regions for
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a particular tumor phenotype. We choose interpretable models such as sparse logistic
regression and random forest, in order to be able to quantify the contribution of each
feature to the prediction. The main difficulties arise from the high dimensionality of the
data and the large correlations between features. In Chapter 5 we present the problems
and our solutions in great detail.
The region selection step provides with a list of genomic regions, the copy number of
which is informative of the tumor phenotype. For the sake of interpretation, aberration call
is necessary at this final stage of the pipeline. We distinguish two subtasks: the single-array
call and consensus call. Given a genomic region of interest R, the single-array call refers to
assigning a state of this region – neutral, gain or loss – for each array independently. The
consensus call consists of assigning a state – neutral, gain, loss or mixed – to the region
itself. The mixed state corresponds to regions that are lost in a subset of arrays and gained
in another subset.
The novelty of our pipeline and the main contribution of this thesis is the consensus seg-
mentation step. Throughout this manuscript, we will highlight its benefits for downstream
analysis.
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4. Methods for Consensus Segmentation
Truth is ever to be found in the
simplicity, and not in the multiplicity
and the confusion of things.
Sir Isaac Newton
4.1. Introduction
Array Comparative Genomic Hybridization has been established as a cheap technology for
high-resolution measurement of DNA copy number aberrations in large cohorts of tumors.
The very high resolution of the experiments ensures an accurate estimation of the location
of breakpoints and of copy number changes across the genome, however the dimension-
ality of the data is so large that basic statistical tools become ineffective. For example,
the search for predictive markers meets all the challenges related to clustering in high-
dimensional spaces (the curse of dimensionality). One must handle the high correlations
between predictors or correct for multiple testing without assuming independence of the
tests. Fortunately, the structure of copy number changes facilitates substantial dimension
reduction. Specifically, adjacent genomic loci are likely to share the same copy number,
unless a breakpoint occurs in between. Single-array segmentation is one of the algorithms
that exploits this property for array denoising and dimension reduction (see Chapter 3).
Thus, by applying segmentation to every array in a given set, the copy number data can be
represented in a reduced space of dimension equal to the number of breakpoints identified
in the collection.
In this chapter, we introduce the methodology for a further step for dimension reduction,
called consensus segmentation, which is a generalization of the single-array segmentation
to a set of arrays. Specifically, we segment the genome further into regions of almost con-
stant copy number over the set of arrays. This way, consensus segmentation can be used
to delineate regions of consistent alteration from regions with none or very few passen-
ger alterations. Thus, the search for biomarkers can be narrowed down to smaller DNA
intervals and the downstream statistical analysis is simplified.
Like the single-array segmentation, consensus segmentation can be approached in two
equivalent ways: either by determining regions of almost constant copy number, or by
identifying transition locations between regions. These are genomic locations characterized
by an enrichment in breakpoints observed in the set of arrays. Such genomic locations
are biologically interesting, probably related to cancer phenotype, as they are positively
selected for during tumor development.
In this context, we mention the work of van de Wiel and van Wieringen (2007), who
introduce method called CGHregions, which uses called data in order to infer regions of
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almost constant copy number. The authors search for genomic regions with the property
that the L1 distance between any two loci is smaller than a given constant c, thus ensuring
that there are not many breakpoints within a region. Our main criticism of this approach
is that it uses called data, which applies hard thresholding for classifying the log-ratios
into loss, neutral or gain. In general, called data is a very rough approximation of the raw
data, often leading to loss of critical information.
A more recent related approach by Ritz et al. (2011) is dedicated to the identification of
recurrent breakpoints in sets of arrayCGH experiments. The method is called Neighbor-
hood Breakpoint Conservation (NBC) and it is applied directly to the raw log-ratios. The
authors devise a special single-array segmentation algorithm, which assigns to each pair
of adjacent probes a probability of a breakpoint being located between them. Then, loca-
tions of recurrent breakpoints are analytically estimated and returned as a list, sorted by
significance (p-value). The main shortcoming of the NBC algorithm is its high complexity,
the segmentation step using a dynamic program quadratic in the number of array probes,
which probably means that NBC is not an attractive solution for high-resolution arrayCGH
data or for copy number data from NGS experiments. In comparison, the fastest current
approach for segmentation is almost linear (CBS by Venkatraman and Olshen (2007)).
In this Chapter, we will introduce several methods for consensus segmentation, based on
identification of either recurrent breakpoints or of regions of almost constant copy number.
These methods use segmented data as input. We assume the segmentation to be carried
out using the most efficient and scalable approach available (e.g., CBS). We also introduce
a measure of evaluating the quality of consensus segmentation on real cancer data and use
this measure for comparing the algorithms. Importantly, we present and discuss interesting
genetic and epigenetic properties of the recurrent breakpoints and regions identified by our
methods.
This Chapter is organized as follows: in the Preliminaries section, we introduce the
notations, terminology and model assumptions, which are necessary for presenting the
methodological contributions. Sections 4.3, 4.4 and 4.5 present algorithms for consensus
segmentation. The Data section introduces the cancer datasets on which we validated the
algorithms. The Results section summarizes the performance of the methods and offers
insights into the biological relevance of our findings. We conclude the chapter with a
Discussion.
4.2. Preliminaries
Assume given a set of N arrays (tumors), consisting of segmented log-ratio measurements
at p genomic loci L1, ...Lp. For simplicity, we assume that all loci are located on the same
chromosome and ordered. In practice, the methods will be applied to each chromosome
independently. We represent the data by a matrix A ∈ RN×p, where row ai corresponds
to array i and column aj contains all segmented log-ratios at genomic locus j. By aij , we
denote the element of A located on row i and column j. Throughout this chapter, the
same style of notations for rows, columns and elements of matrices will apply.
Definition We call region a set of consecutive loci {Li, Li+1..., Li+j}, for some 1 ≤ i ≤
i+ j ≤ p.
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Let A be a data matrix as above. We make here a key model assumption, namely that
the data have been generated by a stochastic model of the form:
aij =
m∑
k=1
xik1Rk(Lj) + εij , 1 ≤ i ≤ N, 1 ≤ j ≤ p, (4.1)
where R1, ..., Rm are m non-overlapping regions which cover the whole chromosome, xij
is an element of a matrix X ∈ RN×m and εij represents stochastic noise. The number
of regions m, the regions R1, ..., Rm and the constants X are parameters of this model.
Intuitively, (4.1) describes a piecewise constant model with noise, which is assumed to be
the generator of the observed arrays. In contrast to the piecewise constant model from
single-array segmentation (see (3.1)), the model from (4.1) enforces the same partition of
the genome to all arrays. Also unlike the single-array segmentation, the noise components
{εij} 1≤i≤N
1≤j≤p
do not follow a particular parametric distribution and it do not have to be i.i.d.
The problem of consensus segmentation consists of estimating the parameters of
model (4.1) from the observed data matrix A, by optimizing some quality criterion.
Equation (4.1) can be written in an equivalent matrix form as follows:
A = XI + Ξ, (4.2)
where I ∈ {0, 1}m×p is an indicator matrix with entries Ikj = 1Rk(Lj) and Ξ ∈ RN×p is
a noise matrix with components εij . We define matrix Aˆ = XI. It follows that Aˆ is an
approximation of the initial data matrix A, determined by the segmentation into m regions
R1, ..., Rm. The matrix X is a representation of matrix A in an m dimensional space, with
m ≤ p. Each column xj of X summarizes the copy number data of a certain region and
will be called the centroid or representative of the region.
Definition MatrixX ∈ RN×m is called the reduced representation of the copy number
data after consensus segmentation.
Definition Regions R1, ..., Rm given by model (4.1) are called consensus regions. The
consensus regions are assumed to be ordered according to their genomic location.
Definition Let Rk be the kth consensus region, such that Rk = {Li, ..., Li+j}, for some
0 ≤ i ≤ i+j ≤ p. Then Li is the left boundary of region Rk. We call this genomic location
the kth consensus breakpoint, and we denote it by Bk.
Observe the duality of the notions of consensus breakpoints and consensus regions: any
of the two uniquely determines the other.
Example In Figure 4.1a, we show N = 20 arrays consisting of segmented log-ratios
at d = 45 genomic loci. Increased copy number is consistently observed in the region
R2 = {L13, ..., L30}, while the other two regions R1 = {L1, ..., L12} and R3 = {L31, ..., L45}
contain very few changes. Therefore, R1, R2, R3 are good candidates for consensus segmen-
tation. The corresponding consensus breakpoints are B1 = L1, B2 = L12 and B3 = L30.
For the estimation of the parameters of model (4.1), some optimality criterion must
be satisfied. For minimal loss of information, the approximation Aˆ must be as close to
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(a) (b)
Figure 4.1.: Dimension reduction via consensus segmentation. a) Example of 15 seg-
mented arrays (y-axis) measured at 45 genomic loci (x-axis). Intense red marks regions
of gain, white corresponds to neutral copy number and blue indicates loss. b) Regions
R1 = {L1, ..., L12}, R2 = {L13, ..., L30} and R3 = {L31, ..., L45} are consensus regions and
B1, B2, B3 are consensus breakpoints. c) Reduced representation after consensus segmen-
tation. The copy number within each region is summarized by its mean value over the
region.
A as possible, therefore the expected distance between A and Aˆ, E[d(A, Aˆ)], must be
minimized, for some chosen distance function d. Intuitively, we require that the set of
centroids represented by the columns of X approximate the data matrix A well. Clearly, if
each locus is considered to be its own region (thus m = p), then a perfect fitting is possible,
with d(A, Aˆ) = 0. For achieving some dimension and noise reduction however, the number
of intervals must be kept small and a trade-off between the quality of approximation and
the magnitude of m should be considered.
For simplification, the problem can be broken into two subtasks: first, the number of
regions m and the regions R1, ..., Rm are to be estimated. The second task assumes the
regions given and computes the centroids X that provide a good approximation Aˆ of A.
The first problem is notoriously difficult and we approach it in two ways, by estimating
consensus regions or by estimating consensus breakpoints. We call the second task estimat-
ing the reduced representation. In the rest of this chapter, we introduce algorithms for each
of these problems. We start with the simpler task: estimating the reduced representation.
4.3. Methods for estimating the reduced representation
Assume that regions R1, ..., Rm are given. We search for a set of region representatives
Xopt = (x1, ..., xm) which approximates best the data matrix A. Let d be a loss function
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which defines the distance between two matrices. Then Xopt is given by:
Xopt = arg min
X
E[d(A,XI)] (4.3)
The target E[d(A,XI)] depends on the distribution of the stochastic noise Ξ (see (4.2)).
Any attempt at solving (4.3) analytically would require parametric assumptions on noise
distribution. We believe that such endeavor should be avoided, because there are complex
spatial dependencies in the noise which cannot be expressed by any model in a realistic
manner. For example, around the genomic locations of consensus breakpoints more vari-
ation is expected, since there are transitions between different copy numbers. Another
source of variation are the passenger aberrations, which may occur at any location of the
genome, probably with higher likelihood around positions where the DNA is more fragile
and prone to breakage (Agarwal et al., 2006). False changes, which correspond to false-
positive breakpoints reported by the single-array segmentation, can also be considered
noise.
In this chapter we do not attempt to characterize the distribution of the noise com-
ponent. Instead, we propose several heuristic approaches to constructing representatives
X = (x1, ..., xm), which may not be optimal in terms of accuracy but afford interpretability.
We discuss each of them below, as well as their implications from biological perspective.
Let Rk be a fixed region, Rk = {Li+1, ..., Li+j}. The representative xk summarizes the
set of columns ai+1, ..., ai+j .
Summary by mean
xk = (x1k, ..., xNk), xqk = mean{aq(i+1), ..., aq(i+j)}, q = 1, ..., N.
The sample mean is the most common choice for summarizing of a set of observations.
It has the property that it minimizes the expected L2 distance to the observations under
normality assumptions (maximum likelihood estimator). This means that if d is chosen to
be the L2 distance and the noise Ξ follows a Gaussian distribution, then the mean is the
appropriate representative. However, the mean is not appropriate if the log-ratios within
region Rk contain outliers, or follow a multimodal distribution. For example, if most
log-ratios within region Rk are positive, indicating gain, but there are several negative
log-ratios (attributed to noise), the mean value can be close to zero. As a consequence,
this region would appear neutral in the reduced representation and important information
would be lost.
Summary by median
xk = (x1k, ..., xNk), xqk = median{aq(i+1), ..., aq(i+j)}, q = 1, ..., N.
The sample median is a robust summary of the log-ratios within a region. It has the
property of minimizing the expected L1 distance to the observations, under the assumption
that the noise Ξ follows a Laplace distribution (maximum likelihood estimator) (Koenker
and Bassett, 1978). The median is not influenced by outliers, therefore the negative effects
described above would not occur. However, robustness to outliers is only useful if the
outliers do not carry important information and need to be discarded. In our particular
application, the following may happen: assume that most log-ratios of region Rk are neutral
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(close to zero), except for a few larger values, indicating a focal gain. In this case, the
median would be close to zero, ignoring the gain. For downstream analysis, a slightly
elevated summary value (such as the mean would give) would perhaps be more informative,
indicating that the region does contain a small alteration.
Summary by principal component
A popular technique for summarizing multivariate data is principal component analysis
(PCA). It consists of exploring the variability of the set of multivariate observations by
projecting them onto the first principal components. These are obtained by computing
the eigenvalues and eigenvectors of the covariance matrix of the set. In our application,
let v1, ..., vj be the principal components of the set of observations ai+1, ..., ai+j , ordered
decreasingly by the magnitude of their corresponding eigenvalues. Then, vector v1 ∈ RN is
the direction which best explains the variability of set of observations. However, principal
components have two shortcomings. First, they are known to be influenced by outliers.
Methods for robust principal component analysis have been proposed by De la Torre and
Black (2001) and Jackson and Chen (2004) and should be preferred. Second, incremental
update of the representative xk as new tumors are added to the input set is difficult. The
first principal component of the augmented region Rk needs to be recomputed from scratch.
In contrast, the mean and the median can be easily updated by adding the mean or the
median of the new observations to the representative.
Summary by medoid
The medoid is defined as the column of region Rk which minimizes the sum of the dis-
tances to all other columns of region Rk. The distance is user-defined and does not have to
come from a metric space, a dissimilarity matrix suffices. Using the medoid as a summary
may improve the interpretability of the reduced representation, because each representa-
tive would correspond to the copy number measurements at a particular location on the
genome. In contrast, the mean, median, extreme value or the principal component are
aggregates. Choosing the medoid as representative can also be dangerous, because it es-
sentially means that one particular genomic position (think gene) from a region with low
variability is preferred to the other positions in the region. There is a good chance that
the driver gene is discarded by this procedure. Even worse, attention is focused on an
‘imposter’ – a neighboring gene that is very similar.
We recommend that the choice of the representative is application-specific. For rea-
sons including computational efficiency and interpretability, we prefer the mean and the
median. The advantages of one over the other have been the subject of long disputes in
the statistical community. We recommend an insightful article by Koenker and Bassett
(1978), which comments on the implicit parametric assumptions associated with the mean
and median statistics. In our applications we tried both methods. Because the results were
not substantially different, we only present the results using the mean.
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4.4. Algorithms for estimating consensus breakpoints
Following the definition given in the Preliminaries of this chapter, consensus breakpoints
are the genomic locations that mark the start of new consensus regions. Consequently,
consensus breakpoints are positions around which a large number of breakpoints occur in
the set of arrays. Observe the stochastic nature of a consensus breakpoint: it is generally
not exactly determined by a perfect alignment of breakpoints, but it is a summary of a set
of breakpoints accumulating around a certain position in a way that is unlikely by chance.
In Figure 4.1, breakpoints B2 and B3 at locations L12 and L30 respectively, are consensus
breakpoints because breakpoints occur frequently around these locations. Neighboring
locations like L11 and L13 or L29 and L31 are good alternatives for consensus breakpoints
B2 and B3, respectively. In contrast, location L6 is probably not a consensus breakpoint,
since evidence shows that only one array contains a breakpoint at this location.
We propose two approaches towards finding consensus breakpoints. First, we present a
parametric approach called Consensus Breakpoints via Mixture of Uniform and Gaussians
(CB-MUG) and second, a non-parametric approach called Consensus Breakpoints via
Kernel Smoothing (CB-KeS).
4.4.1. The CB-MUG algorithm
The parametric approach is based on the following model assumption. Let V be the
random variable representing the genomic location of a breakpoint in an arbitrary array. If
B1, ..., Bm are all consensus breakpoints, then we model the distribution of V as a mixture
of m Gaussians centered at B1, ..., Bm, with different standard deviations. Also, we include
in the mixture a uniform distribution U(cstart, cend), where cstart and cend are the start and
end positions of the chromosome. That is to say, a breakpoint is either generated by one
of the Gaussians, in which case it contributes to the corresponding consensus breakpoint,
or it is generated by the uniform distribution, in which case it is a noisy breakpoint.
Formally, the density of V is given by:
gV (v) =
m∑
k=1
pikφ(v;Bk, σk) + pi0u(v; cstart, cend), (4.4)
where φ(·;Bk, σk) is a Gaussian distribution of mean Bk and standard deviation σk,
u(·; cstart, cend) is a uniform distribution over the interval [cstart, cend] and {pik}mk=1, pi0 are
the mixture probabilities,
∑m
k=0 pik = 1. The means, standard deviations of the Gaussians
as well as the mixture probabilities are not known. The number m of Gaussians in the
mixture is considered a fixed parameter of the model, however in practice it is also not
known and automated methods are needed for computing its value in a data-driven way.
For now, assume m is given and let V be the multiset1 of breakpoint locations observed
in the set of arrays. For simplicity of notation, we used V to denote both the random
variable and its observations:
1In mathematics, a multiset is a generalization of a set, such that each member of a multiset can be
present in multiple instances.
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V =
N⋃
i=1
Vi, where Vi is the set of breakpoints of array ai.
Let |V | = T and the components of V be denoted by v1, ..., vT .
The purpose of the CB-MUG algorithm is to estimate the parameters of the mixture
model (4.4) from the observations V . The algorithm uses the classical Expectation-
Maximization (EM) technique.
First introduced with this name in an article by Dempster et al. (1977), the EM algorithm
is used to estimate maximum likelihood parameters of statistical models from observed
data. Additionally, the models typically depend on unobserved latent variables. The EM
procedure iterates between an expectation step (E) and a maximization step (M). In the
expectation step the missing data are estimated, given the observed data and the current
estimates of the model parameters. In the maximization step, the parameters of the model
are updated such that the likelihood function is maximized, by using the estimates of
missing data from step E. The likelihood of the model is guaranteed to increase with each
iteration and the algorithm converges to a local optimum.
The EM procedure is a very general tool for addressing difficult tasks of maximum
likelihood estimation. Here, we describe the particular EM algorithm that can be used to
estimated the parameters of model (4.4).
Given an observation V ∼ gV , it is not known which of the m+ 1 mixture components
has generated V . For this purpose, a latent random variable ∆ is introduced, with values
∆ ∈ {0, 1, ...,m} at probabilities {pi0, pi1, ..., pim}. The role of the latent variable is to
indicate which mixture component is responsible for observation V . Specifically, if the
value of ∆ is k > 0, the Gaussian distribution φ(·;Bk, σk) is responsible for observation
V . If k = 0 then V has been generated by the uniform distribution u(·; cstart, cend). If
Xk ∼ φ(·;Bk, σk) and X0 ∼ u(·; cstart, cend) are random variables, then V can be written
as:
V = δ(∆, 0)X0 + δ(∆, 1)X1 + ...+ δ(∆,m)Xm, (4.5)
where δ is Kroneker’s delta, with δ(i, j) = 1 if i = j and 0 otherwise. Direct observations
on ∆ are not available, however estimating the parameters of the mixture model becomes
substantially easier if inference on the latent variable is performed.
The parameters of the model are θ = (pi0;pi1, ..., pim;B1, ..., Bm;σ1, ..., σm). The log-
likelihood of θ based on the observations V = {v1, ..., vT } is :
L(θ;V ) =
T∑
i=1
log
[
m∑
k=1
pikφ(vi;Bk, σk) + pi0u(vi; cstart, cend)
]
(4.6)
Estimating θ that maximizes the log-likelihood is difficult because of the sum inside the
logarithm. The problem becomes simpler if we assume that the values of the latent variable
∆ are known for each of the observations v1, ..., vT . Indeed, let ∆1, ...,∆T be those values.
The log-likelihood can be re-written as:
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L(θ;V,∆) =
T∑
i=1
[
m∑
k=1
δ(∆i, k) log φ(vi;Bk, σk) + δ(∆i, 0) log u(vi; cstart, cend)
]
(4.7)
+
T∑
i=1
[
m∑
k=1
δ(∆i, k) log pik + δ(∆i, 0) log pi0
]
.
However, the values {∆i}i=1,...,T are not known. In order to evaluate the log-likelihood
given by equation (4.7), the values δ(∆i, k) are needed, for each i = 1, ..., T and k =
0, ...,m. In other words, for each observation vi, the distribution of the mixture which
has generated it needs to be found. These quantities cannot be estimated directly, but
their expected values can, if the parameters θ are assumed to be known. In order to avoid
a cyclic argument – remember that the goal is to estimate θ – let θold be some already
available estimate for θ, with θold = (piold0 ;piold1 , ..., pioldm ;Bold1 , ..., Boldm ;σold1 , ..., σoldm ). Then
the following holds:
γki
def
= E(δ(∆i, k)|vi, θold) =
posterior
Pr(∆i = k|vi, θold) Bayes=
prior
Pr(∆i = k)Pr(vi|∆i = k, θold)
Pr(vi|θold) =
(4.8)
=

pioldk φ(vi;B
old
k , σ
old
k )∑m
j=1 pi
old
j φ(vi;B
old
j , σ
old
j ) + pi
old
0 u(vi; cstart, cend)
, if k > 1,
pi0u(vi; cstart, cend)∑m
j=1 pi
old
j φ(vi;B
old
j , σ
old
j ) + pi
old
0 u(vi; cstart, cend)
, if k = 0.
In the derivations (4.8), we first used the fact that δ(∆i, k) is a Bernoulli variable, which
takes value 1 with probability pik and value 0 with probability 1 − pik. The expectation
of a Bernoulli distribution is given by its probability of success. In the subsequent step,
we used Bayes’ theorem in order to calculate the posterior probability of the distribution
to be the kth component of the mixture, given vi and θold. The value γki is called the
responsibility of component k for observation vi. Observe that for each observation vi, the
following property holds:
m∑
k=0
γki =
m∑
k=0
Pr(∆i = k|vi, θold) = 1. (4.9)
Given the responsibilities, new parameters θnew can be computed to maximize the con-
ditional expectation of the log-likelihood E∆|V,θoldL(θ;V,∆) from equation (4.7):
θnew = (pinew0 ;pi
new
1 , ..., pi
new
m ;B
new
1 , ..., B
new
m ;σ
new
1 , ..., σ
new
m ) = arg max
θ
E∆|V,θoldL(θ;V,∆).
(4.10)
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E∆|V,θoldL(θ;V,∆) =
T∑
i=1
[
m∑
k=1
γki
[
− log(
√
2piσk)− (vi −Bk)
2
2σ2k
]
+ γ0i log
1
cend − cstart
]
(4.11)
+
T∑
i=1
[
m∑
k=0
γki log pik
]
The parameters θnew are computed in a straightforward way, by differentiating the func-
tion E∆|V,θoldL(θ;V,∆) with respect to all Bk, σk and pik variables and making use of the
relation (4.9). For the Gaussians in the mixture, we obtain:
Bnewk =
∑T
i=1 γ
k
i vi∑T
i=1 γ
k
i
, k = 1, ...,m;
σnewk =
√√√√∑Ti=1 γki (vi −Bnewk )2∑T
i=1 γ
k
i
, k = 1, ...,m.
The mixture probabilities are given by:
pinewk =
∑T
i=1 γ
k
i
T
, k = 0, 1, ...,m.
In Equation (4.10), the Expectation and Maximization steps are apparent. The algo-
rithm (see Algorithm 1) iterates between the Expectation step, in which the parameters
θ of the mixture are assumed known and the responsibilities are computed (4.12) and the
Maximization step, in which model parameters are estimated (4.13) so as to maximize the
conditional expected log-likelihood.
Convergence of the algorithm
By convergence of the EM algorithm we mean that the likelihood of the model approaches
arbitrarily close some finite value after a finite number of iterations. The theoretical aspects
involved in the convergence of the EM algorithm are not trivial. We do not reproduce here
these arguments, but refer the interested reader to the work of Mclachlan and Krishnan
(1996), who include a comprehensive discussion on this topic. A key result in presented
by Wu (1983), who show that if the space of model parameters and the likelihood function
respect certain regularity conditions, then the EM algorithm is guaranteed to converge to
a stationary point of the log-likelihood (which can typically be either local maximum or
a point of inflection). Intuitively, under these regularity conditions, it can be proven that
both the Expectation and Maximization steps improve the likelihood (meaning, they do
not decrease its value), by updating alternatively the latent parameters and the model
parameters in the direction of the stationary point.
It is important for this thesis to mention that the regularity conditions by Wu (1983) do
not necessarily hold for our particular instance of the EM algorithm. Specifically, the space
of model parameters is required to be compact, which does not hold because the space of
possible values that the standard deviations of a Gaussian can take is not compact. Indeed,
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Algorithm 1 CB-MUG(m)
Require: T ∈ N, V = {v1, ..., vT }, cstart < cend
Ensure: Estimated parameters of the mixture density: {Bk}mk=1, {σk}mk=1, {pik}mk=1, pi0.
1. Take initial guesses for the parameters {Boldk }mk=1, {σoldk }mk=1, {pioldk }mk=1, piold0 (see text)
2. Expectation step: compute the responsibilities
γki =
pioldk φ(vi;B
old
k , σ
old
k )∑m
j=1 pi
old
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old
j , σ
old
j ) + pi
old
0
1
cstart − cend
, i = 1, ..., T, k = 1, ...,m
(4.12)
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3. Maximization step: compute new weighted means and standard deviances
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4. Set Boldk = B
new
k , σ
old
k = σ
new
k , for all k ≥ 1 and pioldk = pinewk , for all k ≥ 0. Iterate
steps 2 and 3 until convergence.
5. Output Bk = Bnewk , σk = σ
new
k , for all k ≥ 1 and pik = pinewk , for all k ≥ 0.
the standard deviation σ of a Gaussian N (µ, σ) takes values in the interval (0,+∞), which
is not compact. It is easy to see that a finite upper limit to σ can be assumed, since the set
of training observations is finite and hence has finite support. However, the real problem
arises from the constraint σ > 0. Specifically, assume that at some iteration of the EM
algorithm, the mean of a Gaussian, let it be Bk, is equal to one of the observations Bk = vj .
Then, as the corresponding standard deviation σk tends to zero, the likelihood tends to
infinity. The EM algorithm would indefinitely improve the likelihood by decreasing the
standard deviation σk and thus never converge. In practice, this problem can be solved by
imposing limits on the standard deviations, such as for all k ≥ 1, σk ≥ , for some small
positive , as suggested by Mclachlan and Krishnan (1996). In our implementation, we
apply this method and as soon as some σk < , at some iteration of the algorithm, we fix
σk to .
Another aspect regarding convergence is when to stop the algorithm, because the iter-
ative process can no longer improve the log-likelihood significantly. Usually, a very small
constant ξ is chosen and when the increase in log-likelihood is smaller than ξ, the algorithm
stops. In cases in which the set of observations is very large (T large), the EM algorithm
can be very slow and thus a superior limit on the number of iterations is also necessary.
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Initialization of the parameters
The quality of the solution of the EM algorithm depends strongly on the starting values of
the parameters (see step 1 of Algorithm 1). For example, if the starting point is close to
the global optimum of the log-likelihood, then the algorithm will probably find a solution
that is close to optimal. If in contrast, the starting point is close to the boundary of the
parameter space, for example if some initial standard deviation of a Gaussian is close to
zero, then convergence may not be guaranteed.
A simple approach to initializing parameters for our particular algorithm is to ran-
domly generate m means B1, ..., Bm in the interval spanned by the training observations
[min{vi|i = 1, ..., T},max{vi|i = 1, ..., T}] and then set all standard deviations to the over-
all sample standard deviance (Hastie et al., 2003). The mixing probabilities can be set all
equal. However, we believe that the centers of the Gaussians (consensus breakpoints) are
not uniformly distributed over the genome, but tend to accumulate in certain regions.
A data-driven approach is to use k-means clustering for grouping the observations into
m clusters. The initial means and standard deviations of the Gaussians are given by the
means and standard deviations of the observations in each cluster. The mixing probabilities
of the Gaussians are set to be proportional to the cluster sizes and the mixing probability of
the uniform component is set to a fixed constant. Using k-means for the initial parameter
assignment is supported by the close relation between the EM and the k-means clustering in
this case. The k-means procedure is similar to the EM approach, but uses hard assignments
of observations to clusters, instead of the soft responsibilities.
In our applications, we use the latter approach. We assign a mixing probability of 5% to
the uniform component and divide the rest of 95% among the Gaussians, proportionally
to the size of the m-means clusters.
Example In Figure 4.2, we show the result of applying CB-MUG algorithm withm = 2 to
the artificial data presented in Figure 4.1. The top figure shows the breakpoints occurring
in the set of arrays. Below, the univariate histogram of the breakpoints appears bimodal,
indicating two locations where breakpoints accumulate. The two Gaussians in the mixture
capture the bimodality and the uniform distribution is used to generate breakpoints that
are not likely to have been generated by the Gaussians. The bottom plot illustrates the
responsibilities of each mixture component for the observed breakpoints. The output of the
CB-MUG method in this case consists of two consensus breakpoints at locations B1 = L12
and B2 = L28.
Estimation of the optimal number of Gaussians in the mixture
Estimating the optimal number of consensus breakpoints m in a chromosome is a problem
of model selection which is discussed in Section 4.6.
4.4.2. Algorithm CB-KeS
The second approach to identifying consensus breakpoints is non-parametric. It uses a
kernel smoothing technique for identifying locations around which unexpectedly large ac-
cumulations of breakpoints occur. By sliding a location pointer along the genomic se-
quence, we observe the breakpoints located within the vicinity of the current location and
4.4 Algorithms for estimating consensus breakpoints 63
(a)
(b)
Figure 4.2.: Example illustrating the CB-MUG algorithm. a) The breakpoints in the set of
20 arrays are marked with black dots. b) The outcome of the CB-MUG algorithm with two
Gaussians and one uniform distribution. In red, the densities from the mixture model are
shown, proportionally scaled by the corresponding mixture probabilities. In the bottom
panel, the responsibilities are shown.
estimate the z-score of the observation under a null model. The null model assumes that
the locations of the breakpoints of each array are uniformly distributed along the genomic
sequence and do not depend on the arrays. The locations at which the estimated z-score
is large enough are reported as candidates for consensus breakpoints. In what follows, we
give a detailed description of this procedure.
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4.4.3. Summarizing breakpoints
Let V be the set of breakpoints observed in the N arrays, represented as triples as follows:
V = {(vi, si, wi) | 1 ≤ i ≤ T},where: (4.14)
vi is the genomic location of the ith breakpoint ,
si is the index of the sample on which the ith breakpoint was observed, si ∈ {1, ..., N},
wi is the magnitude of copy number change at breakpoint vi and it is called its weight.
The weight component wi of a breakpoint is computed as the difference between the
log-ratio at position vi and the log-ratio at position vi − 1. It can be positive or negative,
depending on whether the copy number decreases (negative weight) or increases (positive
weight). The start position of each chromosome is considered a natural breakpoint for each
sample and it is a member of V . Because at the start of the chromosome there is no copy
number change, the weight of this breakpoint is considered zero.
4.4.4. Scoring genomic locations
Let x be a location on the genome and K(·; µ, σ) be a Gaussian kernel with mean µ and
standard deviation σ > 0. We define the score function Γ as follows:
Γ(x;σ) =
T∑
i=1
|wi|K(vi; x, σ) (4.15)
The scoring functions Γ quantifies the abundance of breakpoints around location x. The
location kernel ensures that the breakpoints in the immediate vicinity of x contribute more
to the score than the distant breakpoints. The size of the neighborhood is controlled by the
standard deviation of the kernel, σ. The scoring function Γ admits weights. The absolute
value of the wi component of the breakpoint (vi, si, wi) is used as weight, in order to
increase the contribution of very large changes in log-ratio and to reduce the contribution
of small changes. Consequently, a high Γ(x, σ) score is attained either by the contribution
of many breakpoints of low-weight around location x, or by few breakpoints of high weight.
Additionally, the use of weights helps reduce the influence of small copy-number changes
which can be false breakpoints, corresponding to errors of the single-array segmentation
procedure (false positives).
We use Γ to score all genomic positions (in practice, only locations {vi | 1 ≤ i ≤ T} are
scored) and find local maxima which are significantly large. Such locations are returned
as consensus breakpoints. Their significance is assessed by a permutation test which will
be described later on in this section.
Example Figure 4.3 illustrates the Γ scoring function on the example data from Figure
4.1, computed for σ = 2. The score (in blue) yields several local maxima around genomic
positions 12, 24 and 29, which point to consensus breakpoints.
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Figure 4.3.: Example illustrating the Γ scoring function. The breakpoints are marked with
black dots, the Gaussian kernel of standard deviation σ is shown at arbitrary location x,
with brown color. Function Γ is depicted with blue curve. The weights of the breakpoints
are marked by the size of the points in the top subfigure.
An obvious problem of the Γ scoring functions is that, in the regions close to either end
of the chromosome, fewer breakpoints have non-negligible contribution to the score, due to
data censoring on the left (towards the start of the chromosome) and on the right (towards
the end of the chromosome), respectively. This effect is well known in the field of signal
smoothing with kernel functions. We do not correct the scoring function explicitly, but we
consider the effect in the last step of the algorithm, when deciding the significance of the
score under a null model.
The scoring function Γ has one parameter, namely the standard deviation σ of the
location kernel. We will call this parameter the kernel width. The choice of kernel width
specifies how ‘tightly’ the breakpoints should align in order to be considered as aggregated
evidence of a consensus breakpoint. In what follows, we will call diameter of the consensus
breakpoint the standard deviation of the individual breakpoints that form the consensus
breakpoint. Based on the observation that in real data breakpoints aggregate in varying
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degrees of tightness, we apply the scoring function multiply, with different kernel width
values. Specifically, in our experiments kernel widths take values form the set:
SD = {103, 104, ..., 108}.
4.4.5. The null model
Let the kernel width σ be fixed. Clearly, not all local maxima of the scoring function Γ(·;σ)
are candidates for consensus breakpoints. For example, in Figure 4.3 there exists a local
maximum at location 43, but the score is too small and probably not significant. In order
to infer statistical significance, we compare the observed score to a null reference, which is
obtained by randomly re-arranging the breakpoints, such that the dependencies between
the locations of breakpoints over the set of arrays arrays are destroyed. This way, any
accumulation of breakpoints around a certain genomic location can be only due to chance.
The random re-arrangement is carried out as follows: for each array independently, its
breakpoints are re-located to random genomic positions which are generated by an uniform
distribution over the entire chromosome. Their weights are preserved. After all arrays have
been processed, a null instance of the consensus breakpoint detection problem is generated,
of the same size as the initial problem. Let V 0 = {(v0i , si, wi) | 1 ≤ i ≤ T} be the null
instance. The Γ(·;σ) score is computed at the null locations {v0i | 1 ≤ i ≤ T}. This
procedure is repeated P times (in our experiments, P=50), enough for obtaining a large
population of null scores covering the chromosome. After convenient sorting w.r.t. genomic
position and re-indexing, let v01, ..., v0PT be the genomic locations at which the null scores
γ01 , ..., γ
0
PT are estimated.
The significance of the observed score at location x for kernel width σ is given by a
z-score as follows:
z-score(x, σ) =
Γ(x;σ)−mean{γ0i+1, ..., γ0i+j | v0i+1, ..., v0i+j are j nearest neighbors of x}
sd{γ0i+1, ..., γ0i+j |v0i+1, ..., v0i+j are j nearest neighbors of x}
The z-score indicates how large is the observed Γ score at a certain location, measured
in standard deviations from the mean of the null scores. The local maxima of the scoring
function Γ with z-score smaller than some positive threshold ζ > 0 are considered not
significant. Therefore, for each fixed σ, the CB-KeS algorithm returns a list of local
maxima with positive z-scores, sorted in decreasing order by z-score.
Example In Figure 4.4, we show how the null model performs on our running example.
The kernel width is fixed to the value 2. The z-scores yield four local maxima, however
only two of them are strictly positive. These are candidates for consensus breakpoints. The
corresponding locations are 30 (z-score 3.59) and location 12 (z-score 3.76). Additionally,
note how the mean null score drops towards the ends of the chromosome, due to data
censoring. This phenomenon affects therefore both the null model and the true model,
which ensures a fair local comparison.
4.4.6. Summarizing the output of all kernel widths
For each particular value of the kernel width, significance z-scores are available at all
breakpoint locations (vi, si, wi) ∈ V . For all kernel widths, we retrieve the local maxima
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Figure 4.4.: Procedure for assessing significance of the Γ score. In the upper panel, gray
dots represent the null Γ scores and the red line estimates the average null score by a moving
average. The true scores are represented in blue. In the lower panel, the z-scores associated
to each location are presented. The local maxima of the z-scores are marked with vertical
green lines. These are consensus breakpoint candidates. The dotted lines mark candidates
which do not exceed the significance threshold. The final consensus breakpoints for the
particular kernel width are marked with solid green lines.
which yield a z-score larger than some positive cutoff. This procedure gives the list of
consensus breakpoints, to which significance z-scores are associated. The situation can
occur that a certain genomic location is reported as significant consensus breakpoint by
two kernel widths. In this case, the larger z-score is considered.
For example, in Figure 4.5 we show the list of consensus breakpoints with positive z-
scores resulting from applying the CB-KeS algorithm to our running example with kernel
widths σ = 1.5, σ = 2 and σ = 4. There are seven local maxima of the corresponding
z-scores which are positive, five after removing duplicates. In the bottom panel of Figure
4.5, the breakpoints are shown, at locations 12 (z-score 4.18), 13(z-score 1.80), 24(z-score
0.95), 29(z-score 2.96) and 30(z-score 3.59).
The final output of the CB-KeS algorithm is a list of consensus breakpoint candidates
of various width, sorted decreasingly by z-score. Choosing an optimal top-k consensus
breakpoints is discussed in Section 4.6.
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Figure 4.5.: Summarizing the output of all kernel widths with Cb-KeS algorithm. In the
upper panel, the z-scores are shown for three choices of kernel width σ. In the bottom
panel, the positive local maxima of the z-scores are marked with vertical lines, the color
of which correspond to the kernel width that yields the largest z-score.
4.4.7. The algorithm
Algorithm 2 summarizes the steps of the CB-KeS algorithm.
4.5. Algorithms for finding consensus regions
The goal is to find groups of neighboring probes (consensus regions), the copy number of
which is almost constant over all arrays. This task can be addressed by clustering the
probes represented in the space of the arrays, where the distance between two probes is
small if the copy number profile across the arrays is very similar.
However, clustering the probes along the chromosome does not guarantee that each clus-
ter is composed of a sequence of consecutive probes (a region, according to the terminology
from this manuscript). In fact, a cluster can be broken into several regions. A simple solu-
tion for obtaining a partition into regions is to run a normal clustering procedure (using any
clustering approach) and then express each cluster Ck as a union of regions Ck =
⋃
iR
i
k.
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Algorithm 2 CB-KeS
Require: The input breakpoints V = {(vi, si, wi) | 1 ≤ i ≤ T}; the number of null
instances to generate P ; a set of kernel widths SD.
Ensure: A set of consensus breakpoints B1, ..., Bm.
1. For each kernel width σ in SD do
1.1. Compute the scores Γ(vi;σ), for all 1 ≤ i ≤ T .
1.2. Set null.locations := NULL and null.scores := NULL
1.3. Repeat P times
1.3.1. Generate null problem setting: V 0 = {(v0i , si, wi) | 1 ≤ i ≤ T}.
1.3.2. Set null.locations := null.locations
⋃ {v0i | 1 ≤ i ≤ T}.
1.3.3. Compute null scores Γ(v0i ;σ), for all 1 ≤ i ≤ T .
1.3.4. Set null.scores := null.scores
⋃ {Γ(v0i ;σ) | 1 ≤ i ≤ T}.
1.4. For each location vi do
1.4.1. Compute a significance z-score zi(σ) by comparing Γ(vi;σ) to the
null.scores at null.locations which are close to vi (for example, 500 nearest
null.locations to vi).
1.5. Set z(σ) := {z1(σ), ..., zT (σ)} and define the set of candidate consensus break-
points C(σ) := {i | zi(σ) is a local maximum of sequence z(σ) and zi(σ) > 0}.
2. Set C :=
⋃
σ∈SDC(σ). Denote the elements of C by B1, ..., Bm.
3. Output B1, ..., Bm as consensus breakpoints.
The final set of regions is given by the set {Rik}i,k.
In order to perform clustering, a distance function between the probes needs to be
defined. For some clustering methods, a distance matrix (dissimilarity matrix) between any
pair of probes suffices. The choice of the distance influences the quality of the clustering,
namely the shape of the clusters and the optimal number of clusters. In this manuscript we
compute the distance between two probes by means of the Euclidean distance (L2 norm).
Among the most widely used clustering methods we mention the K-means, K-medoids
or PAM (Partitioning Around Medoids, Kaufman and Rousseeuw (1990)) and hierarchical
clustering.
The goal of the K-means algorithm is to find a set of K clusters, such that the sum
of square distances from the observations to the means of the clusters is minimized. The
problem is NP-hard, therefore K-means adopts an iterative approach which guarantees
convergence to a local minimum. The K-medoids algorithm is similar to K-means in the
sense that it returns K clusters with the property that each observation belongs to the
cluster with the nearest centroid. In the case of K-medoids, the centroid of a cluster
is not the mean, but the observation that minimizes the sum of dissimilarities within
the cluster. Hence, K-medoids requires only the dissimilarity matrix of the observations
as input. In terms of shape, both algorithms return spherical clusters. From the point
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of view of computational efficiency, both K-means and K-medoids are slow, especially
since in practice a large set of values of K need to be evaluated. For large datasets, a
faster algorithm for K-medoids called clara (Kaufman and Rousseeuw, 1990) is available,
however it is slower than hierarchical clustering (discussed below).
In contrast to K-means and K-medoids, which are based on optimizing a loss function,
hierarchical clustering is a heuristic approach for building a hierarchy of clusters in the
shape of a binary tree. At level K of the tree, the observations are clustered into K
groups. The leaves are singleton sets, each containing one observation. Each parent node
is the cluster given by the union of its two children. In order to compute the hierarchical
clustering, a bottom-up approach is typically used. The algorithms starts with each cluster
being a singleton and proceeds by merging at each step the two closest clusters. As a
consequence, apart from the distance between observations, hierarchical clustering requires
a distance between clusters to be defined (also called linkage). We present the most
commonly used linkage distances. Complete-linkage is defined as the maximum distance
between two observations belonging to the two clusters. It tends to determine compact
clusters of similar size and it is sensitive to outliers. Average-linkage is given by the average
distance between all pairs of observations in the two clusters. It is fairly robust. Single-
linkage is the distance between the two closest observations of the two clusters. It is more
suitable than the other methods for cases in which clusters are not spherical or elliptical
in shape (Everitt et al., 2001). The function hclust from the R package stats can be
used for performing all variants of hierarchical clustering. Hierarchical clustering is also
attractive because of its computational efficiency – all clusterings with number of clusters
ranging from one to the number of observations being accessible in constant time.
In order to choose a suitable combination of clustering algorithm and cluster validity
measure, we visually investigated the spatial structure of the probes in cancer datasets.
Figure 4.6 shows 2-dimensional representations of the probes in the space of samples, via
multidimensional scaling. The data are from a collection of arrays on breast cancer and
we selected four chromosomes for illustration. It is apparent that the probes do not form
spherical or elliptical-shaped groups, but chain-like structures. This appearance is easy
to explain: neighboring probes are very similar due to the local constancy of DNA copy
number, but far-away probes are distinct through the accumulation of many subtle local
changes.
At first glance, the chain-like structure suggests the single-linkage approach of hierarchi-
cal clustering. However, we argue in what follows that centroid-based clustering algorithms
is more appropriate. Indeed, our ultimate goal is to find a set of representatives that ap-
proximate well the data and achieve dimension reduction. If we choose single-linkage, each
chain-like cluster will have to be represented by its centroid, which will probably lie very far
away from the ends of the chain. We believe that several representatives will summarize
better the information contained within chain-like clusters. A centroid-based clustering
would probably break the cluster into smaller elliptical-shaped groups, which serves well
our goal.
Following the above reasoning and also considering computational efficiency, we chose
hierarchical clustering with complete linkage as clustering method. The resulting approach
for finding consensus regions will be called CR-FC in this manuscript (Consensus Regions
via Feature Clustering).
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(a) (b)
(c) (d)
Figure 4.6.: Multidimensional scaling of probes represented in the space of samples. Spa-
tial structures in shape of chains are apparent. Data are from a collection of arrayCGH
experiments on breast cancer. a) chromosome 2, b) chromosome 11, c) chromosome 13, d)
chromosome 17.
For the problem of selecting the optimal number of clusters, see the discussion on model
selection from Section 4.6.
4.6. Model selection: evaluating the quality of consensus
segmentation
In the following, we discuss the problem of selecting the optimal number of consensus
regions m. We distinguish two classes of methods: supervised and unsupervised.
The supervised approach consists of fitting a consensus segmentation model (with any
algorithm) for each value of m from a range {mmin, ...,mmax}. For each consensus segmen-
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tation, the reduced representation is computed, consisting of the set of representatives.
Then, the representatives are used as meta-features in a supervised learning task, where
the predicted variable is any indicator of tumor phenotype available. The accuracy of
prediction is used as a criterion for selecting the best value of m. Two observations are
important here: first, note that the selection of the optimal number of regions depends
on the phenotype used and on the prediction model chosen. Therefore, the optimal set of
consensus regions may not be useful for other unrelated tasks. Second, if cross validation is
used for estimating the prediction accuracy, then a different consensus segmentation must
be performed for each fold separately, only on the training data. Hence, the computational
effort is larger. In Chapter 5, we present methods based on supervised learning which
include the selection of the optimal number of consensus regions.
In this chapter, we introduce an approach to unsupervised model selection. To this end,
we regard the problem of selecting the optimal number of regions as similar to the task
of selecting the optimal number of clusters in a classical clustering setting. The latter
task is often called assessment of cluster validity. It is notoriously difficult and it has
been approached by a multitude of methods over the last decades. Dunn’s index (Dunn,
1974) and the Davies-Bouldin index (Davies and Bouldin, 1979) are widely-used measures
for cluster validity which express the trade-off between within-cluster and between-cluster
distances. Bezdek and Pal (1998) present a generalization of Dunn’s index which outper-
forms the baseline on spherical-shaped clusters. Rousseeuw (1987) proposed the so-called
silhouette values, which provides a standardized measure of how well each observation fits
the current cluster assignment. The number of clusters is chosen such that the average
silhouette over all observations is maximized. Tibshirani et al. (2001) introduce the gap
statistic, which compares the average distance between the observations and the cluster
centroids to a null clustering in which the observations are uniformly distributed within a
bounding box. The number of clusters resulting in the largest difference between the ob-
served and null distance is optimal. The gap statistic is computationally expensive. Jung
et al. (2003) introduce clustering balance, a measure that combines intra-cluster distance
and inter-cluster distance in such a way that allows for an efficient computation over the
levels of a hierarchical clustering dendogram.
Most of the cluster-validity measures appreciate positively clusters that are compact and
well separated. As we showed in Figure 4.6, in our application the probes do not form well
separated clusters, but rather elongated chains with smooth transitions. In such cases,
our experiments show that the very popular silhouette values, but also Dunn’s index and
the Davies-Bouldin index increase monotonically until each probe forms its own cluster.
For the sake of dimension reduction, we aim at finding a small number of clusters and
representatives. To this end, we used and adapted the clustering balance measure of Jung
et al. (2003) as explained below.
4.6.1. Weighted clustering balance
Assume a clustering into m clusters given. The original clustering balance measure (Jung
et al., 2003) involves two quantities: the intra-cluster error (Λ(m)) and the inter-cluster
error (Γ(m)). The intra-cluster error is the sum of the Euclidean distances between the
observations and the centroids of the clusters to which they belong. The intra-cluster
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error decreases monotonically as the number of clusters increases. The intra-cluster error
is computed as the sum of distances between the centroids of the clusters to a global
centroid, which is given by the mean of the cluster centroids. The inter-cluster error
increases monotonically as the number of cluster increases and it can be interpreted as
a penalty on the number of clusters (or model complexity, if the model is given by the
centroids of the clusters). The authors Jung et al. (2003) claim that a good clustering is
minimizing a weighted sum of the two errors:
Ωα(m) = (1− α)Λ(m) + αΓ(m),
mopt = arg min Ωα(m)
for some choice of α ∈ [0, 1]. Jung et al. (2003) choose α = 0.5 in their experiments but
we conducted a simulation study which showed that a larger value of α is more suitable
for dealing with structures similar to those shown in Figure 4.6. Specifically, we show
that a very large penalty on the number of clusters (or indirectly Γ) can retrieve a more
meaningful clustering.
We simulated datasets consisting of N = 50 samples and p = 1000 probes along an
artificial chromosome. For various values of m, m ∈ {1, ..., 10}, we randomly selected m
independent locations (values between 1 and p), which are set to be consensus breakpoints.
We generate piecewise constant log-ratios for each of the N samples independently, with
changes occurring around the consensus breakpoints. The precise locations of the changes
are obtained by randomly sampling from Gaussians centered at the locations of the con-
sensus breakpoints and with standard deviation randomly selected from the set {5, ..., 30}.
A probability of change is also associated to each consensus breakpoint, randomly selected
from the set {10%, ..., 70%}. In this manner, we simulate different recurrence frequencies
of copy number change at the consensus breakpoints.
To make the data more realistic, random copy number changes were also added to the
artificial tumor samples. For each sample, a number from the set {0, 1, 2, 3} is generated at
random and as many random locations are selected on the artificial chromosome to yield
copy number changes.
Figure 4.7a shows a two-dimensional embedding of one of the artificial datasets, using
the same multidimensional scaling method as in 4.6. One can easily notice the same chain-
like structure, which provides a minimal visual assurance that the artificial data resembles
the real data.
For each value of m, we simulated 100 artificial chromosomes with the procedure above.
For a fixed m, the true consensus segmentation consists of m+1 regions (clusters), starting
at the beginning of the chromosome and with each of the consensus breakpoints, respec-
tively. We applied hierarchical clustering to each of the datasets, then transformed the
clustering into consensus segmentations and then selected the number of regions minimiz-
ing the weighted clustering balance Ω. The value of the penalty α was set to range from 0
to 1 at increments of 0.01. Figure 4.7b shows the absolute error of the estimator of number
of regions as a function of α. The value α = 0.98 yields the smallest error, on average.
In our experiments on real data, we use the weighted clustering balance measure with α =
0.98 (Ω0.98) for estimating the number of regions of consensus segmentation. Specifically,
we minimize Ω0.98 in order to select the optimal number of Gaussians in the case of CB-
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(a) (b)
Figure 4.7.: a)Multidimensional scaling of the probes of one artificially generated chro-
mosome with the procedure described in Section 4.6.1. b) Relation between the penalty
parameter α and the accuracy of estimation of the true number of clusters. Each of the the
gray lines indicates the performance w.r.t. the one particular value of the true number of
clusters m. The solid black line averages the performance over all values of m. A minimal
error corresponds to the value α = 0.98.
MUG, in order to select the top-k consensus breakpoints with CB-KeS and in order to
select the optimal number of clusters with CR-FC.
4.7. Results
4.7.1. Datasets
We have applied the consensus segmentation algorithms on several datasets, consisting of
arrayCGH experiments performed on various types of cancer tissue (see Table 4.1 for a
summary). Below we describe the datasets.
Breast cancer datasets
According to recent world-wide statistics published by the International Agency for Re-
search on Cancer (IARC1), breast cancer has the largest incidence among cancers (ac-
counting for 22.9% of all cancers in women) and the highest mortality rate (13.7% of all
deaths caused by cancer). As a consequence, breast cancers are being intensely investi-
gated, and so far progress has been made in the direction of subtype identification. The
subtypes are characterized by specific clinicopathological and molecular signatures, such as
patient’s age, tumor grade, tumor stage, estrogen or progesterone receptor status, patterns
of altered gene expression, patterns of copy number aberrations (Sørlie, 2004; Fan et al.,
1http://globocan.iarc.fr
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2006; Kapp et al., 2006; Yang et al., 2007; Lund et al., 2010; Dawood et al., 2011). Large
efforts are made to find suitable treatments targeting specific subtypes, however several
subtypes remain poorly understood and the mortality rate in the corresponding groups
stays high.
André et al. (2009) performed a large study on the impact of chromosomal aberrations
on breast cancer. The authors find that specific patters of aberrations characterize different
tumor subtypes and also correlate with levels of gene expression, which may point to driver
genes and possible drug targets. The study concludes that the analysis of copy number
aberrations in breast cancer can be an important complement to the frequently approached
expression analysis.
We have obtained from the Gene Expression Omnibus (GEO2) three cohorts of DNA
copy number experiments on breast cancer, all using the same microarray platform, namely
Agilent Human Genome CGH Microarray 244A. The microarrays consist of 236 000 60-mer
oligonucleotide probes, covering coding and non-coding sequences with high resolution.
The first cohort consists of 54 breast tumors with amplification at the ERBB2 gene
locus (17q12-q21). The experiments and a preliminary analysis have been described in Sir-
coulomb et al. (2010). The particular interest in the ERBB2-amplified cancers is motivated
by their poor prognosis and molecular heterogeneity, as well as by their frequent resistance
to targeted treatment. Available phenotypes for this dataset are: age, estrogen receptor
(ER) status, progesterone receptor (PR) status, tumor grade, tumor subtype: IBC (inflam-
matory breast cancer) or NIBC (non-inflammatory breast cancer). In this manuscript, we
call this dataset breast54.
Another set of arrayCGH experiments comprises 173 breast tumors, out of which 49 are
inflammatory breast cancers and 124 are non-inflammatory breast cancers. The experi-
mental data were published by Bekhouche et al. (2011). Inflammatory breast cancer is a
very aggressive form of breast cancer, almost always lethal because of its high potential to
metastasize. Moreover, they are poorly characterized from a molecular perspective. We
call this dataset breast173. Annotated phenotypes to this cohort are age, ER status and
PR status.
The third set of array CGH experiments consists of 167 breast tumors, published by
Russnes et al. (2010). The dataset also contains annotation with age at diagnosis, ER
status, PR status, tumor stage, grade, lymph node status and histological subtype. We
will call this dataset breast167.
Colon cancer dataset
Colon cancer or colorectal cancer occurs mostly in older patients (commonly after the
age of 60) and has a higher incidence in developed countries (60% of the cases occur in
developed regions, according to the IARC1). As a consequence, environmental factors,
sedentary lifestyle and nutrition rich in processed food is considered to increase the risk of
colorectal cancer. Despite continuous improvement of therapy, the mortality rate remains
high at 40%.
The role of copy number aberrations in the prognosis of the disease has been a subject of
2http://www.ncbi.nlm.nih.gov/geo/
1http://globocan.iarc.fr
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Dataset No. samples Clinico-histopathological information
colon 98 no information available
breast54 54 Age(years): 31 (min), 48 (median), 80 (max)
Type: 21 (IBC), 30 (NIBC4)
ER status: 25 (negative), 22 (positive)
PR status: 28 (negative), 19 (positive)
breast173 173 Age(years): 24 (min), 53 (median), 84 (max)
ER status: 59 (negative), 114 (positive)
PR status: 71 (negative), 102 (positive)
breast167 167 Age: 28 (min), 64 (median), 90 (max)
Grade: 11 (Grade 1), 109 (Grade 2), 43 (Grade 3)
Stage: 57 (Stage 1), 86 (Stage 2), 12 (Stage 3), 6 (Stage 4)
ER status: 65 (negative), 86 (positive)
PR status: 66 (negative), 98 (positive)
Histology: 108 (Ductal), 40 (Lobular)
Lymph node status: 73 (negative), 70 (positive)
ovarian 290 no information available
glioblastoma 539 no information available
neuroblastoma 162 Age(months): 0 (min), 13 (median), 299 (max)
Stage: 28(Stage 1), 19(Stage 2), 29(Stage 3),
57(Stage 4), 29 (Stage 4S)
Table 4.1.: Array CGH datasets for validation of consensus segmentation methods.
scientific dispute. Studies either report clear correlation between specific aberration pat-
terns and tumor development (Tsafrir et al., 2006), or fail to identify any such associations
(Nakao et al., 2004). In a meta-analysis by Walther et al. (2008), a large number of studies
have been compared with the conclusion that there exists a clear association between chro-
mosomal imbalances (aneuploidy or polyploidy) and clinico-pathological characteristics of
the tumors.
Veeriah et al. (2010) have investigated a cohort of 98 colon tumors in a study that
followed the goal of characterizing somatic mutations of the gene PARK2 in a variety
of human malignancies. The experiments based on the Agilent Human Genome CGH
Microarray 244A microarrays (as the breast cancer datasets presented above) have been
made public via the GEO. The resolution of the arrays is sufficiently high to allow the
detection of breakpoints with an average precision of 10 Kb. In this manuscript, we refer
to this dataset as colon.
Ovarian cancer dataset
Ovarian cancer accounts for 3.7% of all female cancers (according to the IARC). It is
difficult to diagnose and consequently, most tumors are already in an advanced stage
at the beginning of therapy. Survival in such cases is poor, only 30% of women being
expected to survive for five years (Cho and Shih, 2009). Copy number alterations have
been associated with clinico-pathological features of the tumors (Cho and Shih, 2009).
Specifically, sub-chromosomal (meaning short) amplifications and deletions are usually a
sign of poor prognosis.
A comprehensive collection of arrayCGH experiments on 290 ovarian cancer samples
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is publicly available via The Cancer Genome Atlas (TCGA3). TCGA is a large consor-
tium involving universities and laboratories in the USA that have as a common goal the
systematic investigation of molecular changes that characterize a variety of cancer types.
Experimental assays on copy number aberrations represent an important part of the data
collected at TCGA. The particular set of ovarian tumors have been analyzed using the Ag-
ilent Human CGH 1×1M G4447A arrays, with approximately one million probes covering
the genome. We call this dataset ovarian.
Glioblastoma dataset
Glioblastoma is the most common type of primary brain tumor, although it occurs in only
2 − 3 cases per 100, 000 people in Europe and North America (source: Wikipedia). It
is a very aggressive tumor and. despite the recent treatment improvements, the median
survival of the glioblastoma patient is only 14 months (Van Meir et al., 2010). In fighting
glioblastoma, surgery is the most efficient option, often achieving a reduction of up to 99%
of all tumor cells. Chemotherapy is limited due to the blood-brain barrier and radiotherapy
is often dangerous because it can damage healthy brain cells, which have very limited
capacity of repairing themselves. The causes of glioblastoma are not fully understood,
although recent results point to a viral agent (Vilchez et al., 2003).
Copy number aberrations are present in large number in glioblastoma tumors. Verhaak
et al. (2010) identified four different tumor subtypes based on transcriptional patterns and,
for each subtype, found characteristic copy number alterations. The authors conclude that
there exist key copy number aberrations which lead to altered transcription and therefore
play a role in tumor development. We have obtained of 539 glioblastoma arrays publicly
available via the TCGA, analyzed using Agilent Human Genome CGH 244A microarray
experiments. We refer to this dataset as glioblastoma.
Neuroblastoma dataset
Neuroblastoma is a tumor that affects the sympathetic nervous system. It occurs predom-
inantly in children of young age and infants, at an incidence rate of 1 out of 100, 000. For
the purpose of therapy selection several factors are currently considered, including classi-
cal staging and age at diagnosis. Neuroblastoma staging assigns the tumor to one of five
subgroups, defined by taking into account the histological features of the tumor, spread to
nearby organs and lymph node and importantly, age of the patient. The stages are 1, 2,
3 (good prognosis, in general localized tumors), 4S (metastasized, with spread limited to
liver, skin, or bone marrow and patient younger than one year) and 4 (metastasized, with
spread other than defined by 4S). Stage 4 neuroblastoma has a poor prognosis, in general,
despite aggressive chemotherapy, whereas stage 4S neuroblastoma has a good prognosis, in
general, regressing spontaneously. Age plays an important role in neuroblastoma, most in-
fants (younger than one year) having a very good prognosis, with regression under minimal
treatment. In contrast, older patients have poor prognosis, if the tumor is in an advanced
stage. Recent studies have suggested that a larger age cutoff (18 months) may be more
appropriate for neuroblastoma classification (London et al., 2005), which if applied in clin-
ical practice, could spare many young children from unnecessary aggressive chemotherapy.
3http://cancergenome.nih.gov/
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Copy number aberrations have been shown to influence the outcome of patients with neu-
roblastoma. Polyploidy is generally indicative of good outcome and is characteristic to
tumors occurring in infants. Amplification of the MYCN gene located on chromosome
2 is associated with poor outcome. However, this is not the only feature responsible for
aggressive phenotype, as it is not observed in all aggressive tumors. Deletion of 11p and
1p, amplification of 17q are also indicative of poor prognosis (Ambros et al., 2009).
Copy number aberrations are important for the diagnosis and treatment of neuroblas-
toma patients. The amplification of the MYCN oncogene or the loss of parts of chromo-
somes 1 and 11 have already been introduced in clinical practice as genetic markers.
Through a cooperation with the research lab of Prof. Frank Berthold from the De-
partment of Pediatric Oncology and Hematology from Köln University Clinic, we have
investigated a cohort of 162 neuroblastoma tumors. The experimental assays use several
arrayCGH microarray platforms form Agilent (44k and 100k resolution). A subset of the
tumors have been introduced and analyzed by Spitz et al. (2006). The neuroblastoma
dataset will be called neuroblastoma in this manuscript.
4.7.2. Evaluation of the algorithms for identification of consensus breakpoints
No. breakpoints No. consensus breakpoints
per tumor total CB-MUG CB-KeS CR-FC
neuroblastoma 54± 24 4047 70± 2(57) 62± 7(65) 119± 8(34)
colon 168± 62 16985 223± 6(76) 173± 11(98) 372± 21(45)
glioblastoma 261± 72 64729 329± 7(196) 492± 35(132) 818± 39(79)
breast173 339± 115 49266 425± 5(116) 320± 7(154) 1029± 34(48)
breast54 394± 85 20093 429± 15(47) 327± 8(62) 679± 44(30)
breast167 461± 182 37055 517± 8(72) 503± 11(73) 977± 59(38)
ovarian 806± 201 125000 605± 8(207) 662± 8(189) 2061± 48(61)
Table 4.2.: Number of breakpoints and consensus breakpoints identified in seven cancer
datasets – genome-wide statistics. The first column contains the average number of break-
points per tumor, with indication of standard deviation. The second column shows the
total number of distinct breakpoints in the cohorts. Columns three, four and five contain
the number of consensus breakpoints identified in the datasets by three consensus segmen-
tation algorithms. Standard deviation is computed based on cross validation. In brackets,
the magnitude of the dimension reduction by consensus segmentation is indicated.
We applied the CB-MUG, CB-KeS and CR-FC algorithms on all cancer datasets pre-
sented in the Data section. For estimating the optimal number of regions, with each algo-
rithm independently we optimized the Ω0.98 measure (see Section 4.6.1). We compared the
algorithms first quantitatively, based on three criteria: the quality of segmentation (given
by the minimum value of Ω0.98), the stability of segmentation with respect to perturbations
of the set of samples and the magnitude of dimension reduction as a result of segmentation
(ratio between initial number of probes and resulting number of regions).
Second, we analyzed the resulting consensus breakpoints qualitatively, by investigating
the genetic and epigenetic properties which characterize the respective DNA locations.
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(a) breast54 (b) breast167
(c) breast173 (d) colon
(e) ovarian (f) glioblastoma
(g) neuroblastoma
Figure 4.8.: Comparative evaluation of the CB-MUG, CB-KeS and CR-FC algorithms:
quality of consensus segmentation. Each box-plot summarizes 24 chromosome-wise ratios
between the Ω0.98 scores of two of the three algorithms. The subfigures correspond to
different datasets. The top axis shows p-values resulting from t-tests which compare the
mean of the population of ratios to one.
Figure 4.8 shows a comparison of the algorithms based on the quality of consensus
segmentation. We considered each chromosome of each dataset a separate instance of
consensus segmentation and we considered the optimal Ω0.98 value of each algorithm as a
measure of performance. Smaller values indicating better performance, we conclude from
our results that the CB-MUG approach is significantly superior to CB-KeS on all datasets.
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The significance p-value is annotated on the upper horizontal axis and is the result of a
t-test that compares the mean of the population of ratios between the Ω0.98 values of two
algorithms with one. The CB-MUG algorithm is also superior to CR-FC, significantly in
all applications, except for the breast173 dataset. The comparison between CR-FC and
CB-KeS favors to the latter in five out of eight applications, out of which only three yield
significant p-values. On the neuroblastoma and colon datasets, CR-FC appears slightly
better, but not significantly better.
Table 4.2 shows several statistics on the number of breakpoints observed in the tumors
investigated and the number of consensus breakpoints identified by our algorithms. The
first column indicates the mean and standard deviation of the number of breakpoints
per tumor in each cohort, which is a good indicator of the respective degree of genomic
instability. Neuroblastoma stands out from the rest of the cancer types with very few
breakpoints per tumor, a striking difference probably related to the fact that neuroblastoma
appears early during infancy and DNA aberrations do not accumulate over a long time as
in the case of all adult tumors. Moreover, segmental gains or losses are not characteristic
to neuroblastoma, more frequent events being polyploidy or aneuploidy. These are not
delimited by breakpoints located strictly within chromosomes, hence the small counts.
The second column of Table 4.2 contains the total number of distinct breakpoints occur-
ring in the tumor cohorts. This is the number of dimensions necessary for representing the
datasets, respectively, independently of the resolution of the microarrays. We compare this
number with the number of consensus breakpoints resulting from each algorithm (columns
three, four and five) for evaluating the dimension reduction by consensus segmentation. As
shown in brackets in Table 4.2, the dimension reduction achieved by CB-MUG and CB-KeS
is of similar magnitude and is substantial. The number of consensus breakpoints identi-
fied by CB-MUG is more stable than CB-KeS with respect to variations of the input set,
obtained via 10-fold cross validation. CR-FC outputs significantly more consensus break-
points than the CB-MUG and CB-KeS and there is also proportionally higher variance
among cross-validation folds.
Stability is an important issue in cluster analysis. Therefore, we discuss in the context
of the closely related problem of consensus segmentation. More precisely, it is desired
that the segmentation does not vary much when the set of observations (tumor samples)
is perturbed. Analysis of stability is usually carried out by sampling techniques such as
bootstrap or cross validation. We chose cross validation because it is also necessary for
downstream analysis (see Chapter 5). We estimate the stability of consensus segmentation
via the following procedure. First we split the samples into ten non-overlapping bins. Then,
ten times in a row we hold out one bin and we run the consensus segmentation on the data
corresponding to the remaining nine bins. This way, we obtain perturbed input sets with
89% overlap. We compare the resulting consensus segmentations by using the Jaccard
index (Jaccard, 1912), a similarity measure between two partitions of the same dataset.
Given two consensus segmentations of the same dataset (chromosome) C1 = {R11, ..., R1m1}
and C2 = {R21, ..., R2m2}, the Jaccard index J(C1, C2) is computed as:
J(C1, C2) =
a
a+ b+ c
,
where a denotes the number of pairs of probes that belong to the same region from C1 and
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(a) breast54 (b) breast167
(c) breast173 (d) colon
(e) ovarian (f) glioblastoma
(g) neuroblastoma
Figure 4.9.: Comparative evaluation of CB-MUG, CB-KeS and CR-FC: stability of con-
sensus segmentation. Each box-plot summarizes Jaccard indices comparing segmentations
between different cross-validation training sets, for each of the 24 chromosomes separately.
The tables show p-values resulting from Wilcoxon tests which compare the mean of the
Jaccard indices between pairs of algorithms.
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also belong to the same region in C2, b represents the number of pairs of probes assigned
to the same region in C1 but belong to different regions in C2 and c is the number of pairs
of probes assigned to the same region in C2 but belong to different regions in C1. The
Jaccard index yields a value between 0 and 1, with larger values for similar segmentations.
Given the outputs of the consensus segmentation on each 10 folds, we compute pairwise
similarities between them using the Jaccard index, resulting in 9∗102 = 45 scores. We
repeat this procedure for each chromosome separately and summarize the scores for each
consensus-segmentation algorithm. Figure 4.9 shows boxplots resulting from the procedure
described above. It is clear that the CB-KeS algorithm is most stable, on all datasets
investigated. CR-FC ranks second and CB-MUG ranks last with respect to stability,
the differences between the average Jaccard index being significant between all pairs of
algorithms. We performed Wilcoxon tests and show the significance p-values in the tables
annotated in Figure 4.9.
4.7.3. Genomic and epigenomic characteristics of consensus breakpoint
locations
We have investigated the genomic and epigenomic properties of the genomic locations at
which consensus breakpoints are reported. For this purpose, we used EpiExplorer 2, an
in-house web-based application for interactive exploration of sets of genomic regions. Epi-
Explorer requires as input a set of genomic regions, which we defined as follows. From each
consensus breakpoint, we constructed a genomic region which is likely to cover the mass of
individual breakpoints that form the consensus breakpoint. We only considered consensus
breakpoints given by the CB-KeS algorithm, because CB-KeS is fast, non-parametric and
outputs a ranked list of breakpoints, sorted by significance.
We define a consensus breakpoint region as the genomic interval centered at the location
of the consensus breakpoint with a width which is twice the kernel width that gave as
output the consensus breakpoint. Additionally, the regions are supported by a significance
z-score, which is the z-score associated with the consensus breakpoint.
EpiExplorer facilitates for a fast summary of the properties of the set of consensus
breakpoints, which include: DNA sequence patterns, overlap with genes and gene elements,
overlap with CpG islands, overlap with conserved DNA regions, overlap with known histone
marks in various tissue types, etc. Two regions are considered overlapping if they have at
least one basepair in common.
For meaningful conclusions, EpiExplorer also facilitates a direct comparison with a set
of control regions, which can be randomly generated from the genome, for example. We
generated a set of reference genomic regions by randomly selecting genomic intervals, with
the constraint that the lengths of the intervals should be the same as the lengths of the
consensus breakpoint regions. We have generated only one reference set, containing as
many regions as the union of all consensus breakpoint regions from all cancer datasets.
Figure 4.10 summarizes our findings. We observe an enrichment of genes and gene pro-
moters, which indicates that the DNA breakpoints target functional elements and probably
disrupt their function. We also notice an enrichment of overlap with CpG islands, which
has been reported previously (Tsai et al., 2008; Abeysinghe et al., 2003; Gordon et al., 2007;
2http://epiexplorer.mpi-inf.mpg.de/
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Figure 4.10.: Genetic and epigenetic properties of consensus breakpoint regions by Epi-
Explorer. On the x-axis, we show the percentage of consensus breakpoints overlapping
with some genetic or epigenetic element. On the y-axis, various genetic and epigenetic
properties are listed. In gray, the consensus breakpoints from each dataset is represented.
In red, the random reference is shown.
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Lemaitre et al., 2009). Because the GC-rich content can be attributed to the increased
overlap with genes, we excluded the regions overlapping with genes and re-evaluated the
overlap with CpG islands (result not showed here). Interestingly, the CpG enrichment
persisted. Several studies use evolutionary arguments for explaining the enrichment in
CpG islands around breakpoint locations in the genome (Gordon et al., 2007; Lemaitre
et al., 2009). Specifically, breakpoints and rearrangements in CpG-rich regions are un-
likely to have catastrophic consequences for the cell, given their repetitive patterns. Thus,
the cells that acquired such breakpoints survive. At the same time, breakpoints provide a
mechanism of functional change affecting the genes and promoters located nearby (Gordon
et al., 2007) and contribute to genomic evolution. Lemaitre et al. (2009) suggests that
the frequency of breakpoints may be related to the more accessible chromatin in CpG-rich
regions, especially in unmethylated CpG islands. Methylation measurements correspond-
ing to the breakpoint hotspots that our algorithms report can be used to confirm this
hypothesis. For some of the datasets we use in this thesis, namely the ovarian and the
glioblastoma datasets, public methylation data are available and can be the basis of an
interesting follow-up study.
We observe an enrichment of DNA hypersensitive sites (DNaseI Sites in Figure 4.10).
These are genomic locations with very high sensitivity to enzyme cleavage and they have
been associated before with breakpoint clusters and translocation events in cancer (Zhang
and Rowley, 2006). Our results also show slight enrichment of insulator regions overlapping
with consensus breakpoints. Insulators are proteins that bind to DNA in specific locations
in order to establish transcription boundaries. A famous example is the CTCF insulator
protein, the function of which is often disrupted in cancer, for example by hypermethylation
(Feinberg and Tycko, 2004). In several datasets, we also detect an enrichment of enhancer
regions. These are genomic regions to which proteins bind, with the role of promoting
transcription of a cluster of genes. Disregulation of enhancers via copy number aberrations
has been reported before (Ford et al., 1985). Finally, we discuss the enrichment of histone
marks (H3K4me1, H3K4me3, H3K27me3 and H3K36me3). Histones are proteins that
regulate the access to chromatin and thus modulate gene transcription. DNA breaks
located at positions regulated by histones probably disrupt the function of the histones
and consequently that of the co-localizing genes.
In summary, the properties of the consensus breakpoint locations indicate not surpris-
ingly that the DNA breakpoints target functional genomic regions. We analyzed in the
same way the set of all DNA breakpoints (not only those located in breakpoint hotspots)
and we could not identify the same enrichment of functional elements. Clearly, recurrent
breakpoints target specific cellular function in order to render the cell immortal. The re-
sults presented in this section constitute a qualitative validation of the CB-KeS consensus
segmentation method.
4.8. Applicability to high-throughput sequencing data
The next generation sequencing (NGS) techniques afford more accurate (fewer false posi-
tives) and more precise (w.r.t. genomic location) identification of breakpoints in individual
tumors. However, the diversity of CNAs among tumors is a biological reality, therefore
consensus analysis still meets the challenge of discriminating between driver regions and
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passenger alterations. From this perspective, the task of consensus segmentation applies
also to high-throughput sequencing data.
Segmentation of individual arrays is a common task for copy number analysis with NGS
data, which ensures the input data format that our algorithms need. Efficient algorithms
like CBS (Venkatraman and Olshen, 2007) require close to linear running time and have
been successfully adapted to NGS data analysis (Campbell et al., 2008). The complexity of
the CB-MUG and CB-KeS algorithms depends only on the number of breakpoints identified
in the collection of tumors, which is not expected to be much larger than the number of
breakpoints given by high-resolution arrays. Therefore, our methods are expected to scale
to NGS data.
4.9. Discussion and conclusions
In this chapter, we defined the task of consensus segmentation of a set of DNA copy number
experiments and we presented several algorithms that address this task. The CB-MUG
and CB-KeS algorithms are targeted towards identifying consensus breakpoints, which are
genomic locations characterized by an enrichment in breakpoints. The CB-MUG fits a
mixture of Gaussians and one uniform to the population of breakpoints and takes the
number of components in the mixture as parameter. The CB-KeS uses Gaussian kernel
smoothing with various kernel widths for finding peaks in the population of breakpoints.
The CB-KeS uses the amplitude of copy number change as weight for each breakpoint.
The qualitative advantages of CB-MUG over the CB-KeS approach are that it can adapt
to consensus breakpoints of various diameter and that is it more robust. The advantages
of CB-KeS algorithm are its robustness, the fact that it can admit weights and it gives a
z-score for each consensus breakpoint.
We argued that the problem of determining the optimal number of regions for consensus
segmentation is difficult due to the chain-like structures that probes form if mapped into a
space of samples. Most traditional methods address the identification of spherical groups,
which means they are not applicable to our data. We propose to use a more flexible measure
for estimating the number of regions, which consists of a weighted sum of the intra-cluster
and inter-cluster distances. We tune the weight such that the clustering model fits best
chain-shaped clusters.
We introduced seven public datasets from arrayCGH experiments on five cancer types.
We applied our consensus segmentation algorithms to these datasets and we compared
them based on several criteria: the quality of segmentation, given by the Ω0.98 measure,
the magnitude of dimension reduction and the stability of segmentation with respect to
variations of the sample set. The CB-MUG is superior w.r.t. the Ω0.98 measure, CB-KeS
achieves the largest dimension reduction and CB-KeS is the most stable of the algorithms.
From the point of view of computational complexity, CB-MUG is the slowest algorithm,
whereas the CB-KeS and CR-FC are as fast in practice.
For the purpose of identifying recurrent breakpoints, we recommend CB-KeS over CB-
MUG because it is faster, non-parametric and returns a list of breakpoints sorted by
significance. In practice, detailed investigation can be performed on a convenient top k set
of recurrent breakpoints. In contrast, CB-MUG is slow and requires the estimation of the
optimal number of consensus breakpoints. Moreover, if CB-MUG is applied with m and
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m+ 1 mixture components, respectively, there is no hierarchical relation between the two
resulting sets of consensus breakpoints (in the sense, the latter includes the former). This
means that as the number of components increases, there is no incremental improvement of
the set of consensus breakpoints towards the optimal m, but rather a set of wrong models
until the optimal model is attained. Therefore, finding a good estimate of the number of
breakpoints appears more critical for CB-MUG than for CB-KeS.
Based solely on the study presented in this chapter, we cannot state that CB-KeS is
superior to CR-FC or CR-FC is superior to CB-KeS. In Chapter 5, we show that if used
together with methods for tumor classification, CR-FC slightly outperforms CB-KeS.
We used EpiExplorer to investigate several genetic and epigenetic properties of the con-
sensus breakpoint locations, identified by the CB-KeS algorithm in the cancer datasets.
We found that consensus breakpoints are enriched in functional elements such as genes,
gene promoters, enhancers, CpG islands, DNA hypersensitive sites and several available
histone modifications. Some of these properties have been noted previously in the litera-
ture. Therefore, our approach for identification of consensus breakpoints can help discover
relevant biological properties of DNA break hotspots.
5. Methods for Identifying Relevant CNAs
The purpose of models is not to fit
the data but to sharpen the questions.
Samuel Karlin
5.1. Introduction
The accelerated development of microarrays and, more recently, of high-throughput se-
quencing techniques affords genome-wide measurements of molecular changes in the cell
that have an impact on cancer onset and progression. High-resolution experiments target-
ing gene expression, DNA copy number or DNA methylation in tumors can be the basis
for discovering patterns informative of diagnosis, prognosis and therapy selection (Hicks
et al., 2006; Mikeska et al., 2007; van’t Veer et al., 2002). Machine learning techniques for
classification and feature selection are often used for automated identification of variables
associated with particular tumor phenotypes. In this Chapter, we are concerned with two
widely discussed aspects of microarray classification: handling high dimensionality and
ill-conditioning.
The high dimensionality of microarray-based experiments contrasting with the small
number of samples easily leads to overfitting. Regularized linear models such as logistic
regression with ridge (Hastie et al., 2003) or Lasso penalty (Tibshirani, 1996) are popular
solutions to fitting sparse models in which only a small subset of features plays a role. More
sophisticated penalties for sparse model selection are discussed by Zou and Li (2008).
The problem of ill-conditioning refers to the existence of groups of highly correlated
features. The high correlations often have a biological basis, for example if the correlated
features relate to the same molecular pathway (co-regulated genes in expression data),
are in close proximity in the genome sequence (neighboring genes in copy number data) or
share similar methylation profile (consecutive CpG dinucleotides in CpG islands). Methods
using simple penalties like Lasso typically discard most of the correlated features: only
one or a few arbitrary representatives from every group of correlated features enter the
model, provided they are relevant for the outcome. As a consequence, the models become
unstable: small changes in the training set result in dramatic changes in the selected
subset of features. If the purpose of feature selection includes biological interpretation of
the model, then stability must be ensured. A successful approach used in many recent
articles is that of selection of groups of features. For example, the group Lasso model
(Meier et al., 2008) consists of Lasso selection of predefined groups of features. The fused
SVM (Rapaport et al., 2008) combines a Lasso and a fused penalty for enforcing similar
weights on correlated features, this way performing group discovery and group selection
simultaneously. Another approach to group selection adopted in a large class of methods
87
88 5 Methods for Identifying Relevant CNAs
uses clustering procedures to discover feature groups, compute super-features to summarize
every cluster and apply feature selection on the set of super-features. For example, in
Park et al. (2007), the features are grouped with a hierarchical clustering procedure and
the cluster centroids are used for training linear models. The Metagene method (Huang
et al., 2003a,b) consists of k-means clustering of the features, followed by computing the
principal components of the clusters, called metagenes, which are used for model training.
Jäger and Sengupta (2003) use fuzzy clustering to determine groups of features and then
select a limited number of representatives from each cluster for training SVM models. Yu
et al. (2008) search for dense groups of features by kernel density estimation. The pelora
method (Dettling, 2004) performs supervised grouping of features, by iteratively updating
the groups such that the accuracy of a penalized logistic regression model is increased.
A nonparametric model often used in microarray classification is the random forest
(Breiman, 2001; Díaz-Uriarte and Alvares de Andrés, 2006; Pang and Zhao, 2008). In a
recent study, Strobl et al. (2008) observe that correlated variables are used interchangeably
in the decision trees of the random forest models. The authors analyze the consequence
of this phenomenon by simulating artificial datasets containing few correlated variables
with different predictive values. They notice that the less relevant variables often replace
the predictive ones (due to correlation) and thus receive undeserved, boosted importance.
Strobl et al. (2008) introduce a new variable importance measure that better reflects the
predictive power of each feature within a correlated group. In contrast to the study by
Strobl et al. (2008), we assume that the correlated features in a group share the same
predictive value (due to a common underlying biological event) and we investigate how
correlation affects the feature importance given by random forest.
Another study showed that, if predictors are categorical, both feature importance mea-
sures are biased in favor of variables assuming values from larger sets of categories (Strobl
et al., 2007). The authors of the article ascribe the bias to the use of bootstrap sampling
and Gini split criterion for training CART trees (Breiman et al., 1984). In the literature,
the bias induced by the Gini coefficient has been reported for years (Bourguignon, 1979;
Pyatt et al., 1980), and it affects not only categorical variables but also grouped variables
(i.e. values of the variable cluster into well separated groups – e.g. multimodal Gaus-
sian distributions), in general. In biology, predictors often have categorical or grouped
values (e.g. microarrays, sequence mutations). In the particular case of DNA copy num-
ber aberrations, the distribution of log-ratios at each locus is expected to be multimodal,
corresponding to loss, normal, gain, amplification, etc.
The first contribution of this Chapter is to raise awareness of a specific effect involving
feature correlation in several of the methods mentioned above that can misguide model
interpretation. We observed that the Lasso penalized logistic regression, the group Lasso,
the fused SVM and the random forest report feature weights which are affected by a type
of bias which we call correlation bias. Specifically, the features which belong to larger
groups of correlated features receive smaller weights, proportional to the group size, due to
a shared responsibility in the model. Therefore, if the group is large enough, all features
may appear irrelevant, even if they yield high correlations with the outcome. This effect is
expected in the case of the sparse Lasso logistic regression, but is surprising in the case of
group Lasso and fused SVM, which are specifically designed to afford selection at the group
level and improved model interpretation. Moreover, such bias has not been reported for
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random forest models previously. We show using simulations that correlation bias exists
and affects several widely used classification models for microarray data. We also show
that group selection based on consensus segmentation methods can be successfully used
for removing the correlation bias. We test and compare the methods investigated on two
biological datasets.
The second contribution of this chapter is an algorithm for estimating an unbiased
significance of features in random forest models. The algorithm is called PIMP and is
based on a permutation test involving re-shuﬄing of the outcome variable. We show with
simulations that PIMP can help reduce the bias of random forest towards variables with
more categories (if categorical) or multimodal features (if continuous). We also show how
PIMP can be used for variable selection in random forest models.
5.2. Preliminaries: supervised feature selection methods
Given is a classical supervised learning problem: (xi, yi), i = 1, ..., N are N i.i.d. observa-
tions of a p-dimensional vector xi ∈ Rp and a binary response variable yi ∈ {0, 1}. Denote
by X = (x1, ..., xN ) ∈ RN×p the input matrix and y ∈ {0, 1}N the binary outcome. The
goal of supervised feature selection methods is to select a subset of features which can
predict well the outcome variable, or to rank the variables with respect to their relevance
for the outcome prediction. Guyon and Elisseeff (2003) present an overview of the methods
for supervised feature selection, including the following: wrapper methods, filter methods
and embedded methods, etc. Wrapper methods use prediction models as black-box tools
for assessing the predictive power of subsets of features. These methods tend to be slow in
practice, because many subsets of features need to be evaluated. Filter methods are based
on a preprocessing step which eliminates useless features prior to model training. Popular
filters are based on univariate assessment of variable relevance (such as correlation with the
outcome), which can sometimes lead to the elimination of features which are useful only
in combination with other features. Embedded methods perform feature selection during
model training, for example by optimizing a penalized loss function. In this manuscript we
will use embedded methods almost exclusively, and one filter method based on the mutual
information measure of relevance. The reasons for this choice will become clear later on.
Notations: in this chapter we will use small letters to refer to samples x1, ..., xN and
capital letters to refer to features X1, ..., Xp of the input matrix X. Also, we will use the
notion feature importance to refer to the measures of feature relevance commonly used for
model interpretation, such as feature weights in linear models or variable importance in
random forest.
Lasso-penalized logistic regression
Logistic regression is a popular method for classification of biological data. It models
the logarithm of the posterior probabilities of the classes as linear functions of the input
features. The parameters w ∈ Rp of the model are estimated by maximizing the log-
likelihood L(w;X, y) over the observations in the training set. Model sparsity is obtained by
adding a Lasso penalty λ (see Equation 5.1), which can be optimized with cross validation.
Feature importance is given by the model weights wLLR:
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wLLR = arg max
w
L(w;X, y)− λ
p∑
j=1
|wj | (5.1)
In this chapter, we will call this model Lasso Logistic Regression (LLR). In our experi-
ments, we used the R package glmnet (Friedman et al., 2010) for training LLR models.
Group Lasso
(Meier et al., 2008) uses the logistic regression model with a more specialized penalty, which
takes into account some natural grouping of the features. Assume there are G groups of
predictors and each group must in its entirely be included in the model by receiving non-
zero weights, or be discarded as irrelevant. The group penalty is a combination of a Lasso
penalty acting at the group level and a ridge penalty on the predictors within each group.
If Ig is the index of the features belonging to group g, then the weights of the logistic group
Lasso (GL) model are given by:
wGL = arg max
w
L(w;X, y)− λ
G∑
g=1
‖wIg‖2 (5.2)
We use the R package grplasso (by Lukas Meier) for training GL models and cross
validation for estimating the optimum penalty λ.
Fused Lasso Support Vector Machines
The fused SVM (Rapaport et al., 2008) has been proposed for the special case that the
features can be ordered such that neighboring features are expected to be correlated. This
is the case with data on copy number aberrations, where the features are genomic sites
ordered by position in the genome. Fused SVM (FSVM) is a linear SVM model with two
supplementary penalties: a Lasso penalty for model sparsity and a fused penalty, which
acts as a smoother of the weights, in such a way that weights of neighboring features
are forced to be similar. The weights of the model wFSVM are obtained by minimizing a
penalized hinge loss, as follows (see Rapaport et al. (2008) for details):
wFSVM =arg min
w
N∑
i=1
[1− yiwTxi]+ + λ
p∑
i=1
|wi|+ µ
p∑
i=2
|wi − wi−1| (5.3)
The optimization problem given by System 5.3 can be solved by a linear program. We
implemented this method using Matlab and the CVX optimization toolbox (Grant and S.,
2008). Cross-validation for both penalty parameters λ and µ is necessary, which makes
fitting an FSVM model slower than fitting the other methods.
Random forest
Random forest (RF) models (Breiman, 2001) are nonparametric and non-linear models,
attractive due to their interpretability. They use bagging (bootstrap aggregating) of deci-
sion trees in order to reduce variance of single trees and thus improve prediction accuracy.
Typically, a collection of T decision trees using CART methodology Breiman et al. (1984)
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are trained on T bootstrap samples of the data, respectively. At each node of each tree, a
random subset of fixed size is selected from the features and the one yielding the maximum
decrease in Gini index is chosen for the split. The trees are fully grown and left unpruned.
The class of a new sample is determined by the majority of the votes of all trees in the
random forest. This aggregate model has lower variance and is less susceptible to overfit-
ting than a single decision tree. The test error of random forest models is estimated on
the out-of-bag (OOB) data, as follows: after each tree has been grown, the inputs that did
not participate in the training bootstrap sample are used as test set, then averaging over
all trees gives the test error estimate.
Breiman (2001) proposes two measures for feature importance, the Variable Importance
(VI) and the Gini Importance (GI). The VI of a feature is computed as the average decrease
in model accuracy on the OOB samples when the values of the respective feature are
randomly permuted. The GI uses the decrease of Gini index (impurity) after a node split
as a measure of feature relevance. In general, the larger the decrease of impurity after a
certain split, the more informative the corresponding input variable. The average decrease
in Gini index over all trees in the random forest defines the GI. It should be observed
that the Gini index is closely related to the entropy, both being measures of impurity. In
this manuscript, we will analyze mainly the GI measure. The VI was shown to be highly
correlated with the GI (Strobl et al., 2007).
We use the R package randomForest (Liaw and Wiener, 2002) for training RF models.
There are two parameters that influence the performance of RF: the number ntree of trees
in the collection and the number mtry of variables considered for each tree split. In our
experiments we use the recommended value mtry =
√
number of features and we select the
optimal value for ntree via cross validation. Díaz-Uriarte and Alvares de Andrés (2006)
evaluate the performance of RF models for various parameter settings in ten real-world
learning instances. Their results suggest that the default value of mtry affords either
optimal or close to optimal performance.
Mutual Information
Mutual information (MI) originates from information theory and measures how much a
random variable X is informative about another random variable Y . It is closely related
to the concept of entropy. The entropy of a random variable X, denoted traditionally by
H(X), measures the level of uncertainty in variable X. It is computed as:
H(X) = −
∑
x
PX(x) logPX(x) (5.4)
where PX(x) is the probability distribution of X. The conditional entropy H(X|Y ) mea-
sures the average of the uncertainty in X given the observed variable Y . Then the mutual
information MI(X,Y ) is defined as the decrease in uncertainty about X after observing Y :
MI(X,Y ) = H(X)−H(X|Y ) (5.5)
Low, close to zero, MI means that the variables are close to independent. The larger the
MI, the larger the reduction of uncertainty in X when Y is known. Mutual information is
often used for a quick search of relevant features, when training statistical learning models
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requires too much computational effort due to the large number of features, e.g. in the
case of artificial neural networks (Battiti, 1994). Typically, the MI between each feature
and the outcome is computed and a ranking of the inputs results.
For estimating the MI of two vectors, we use the following formula, which is an immediate
equivalent transformation of Equation 5.5:
MI(X,Y ) = H(X) +H(Y )−H(X,Y ) (5.6)
Since the probability distributions of X and Y are unknown, in general, we compute
frequency-based estimators (Guyon and Elisseeff, 2003).
5.3. Correlation bias and correction methods
The research presented in this section has been published in Toloşi and Lengauer (2011).
For classification of high-dimensional data containing (large) groups of correlated fea-
tures, the requirements of model sparsity and of retrieving of all predictive features are in
direct competition. In applications in which assessment of feature importance is the main
objective, models that give priority to the latter requirement should be preferred. In what
follows, we formulate three key properties that we believe a classification model should
meet in order to be a good instrument for assessment of feature importance.
Assume that two independent biological events P1 and P2 (e.g. the deletion of a chro-
mosome arm can be an event) influence the binary phenotype Y (e.g. tumor stage) and
let us denote the magnitude of their effects on Y with E(P1) and E(P2), respectively and
assume that E(P1) > E(P2). Assume that, by means of an experimental technology, vari-
ables associated with each of the two events are measured (e.g. all genes located within
a deleted chromosome arm). Let us denote with U1, ..., Uq the variables associated with
P1 and with V1, ..., Vp, the variables associated with P2, p, q ≥ 1. Consequently, {Ui}1≤i≤q
and {Vj}1≤j≤p form two groups of correlated variables. Assume a classification modelM
is used to predict Y from a set of N observations on features U1, ..., Uq, V1, ..., Vp and this
model assigns importance values to features: w11, ..., w1q , w21, ..., w2p. Without losing gener-
ality, assume all the importance values are positive and a larger value indicates a more
predictive feature. The following three properties should hold:
1. The importance values of the correlated features are similar: w11 ≈ w12 ≈ ... ≈ w1q
and w21 ≈ w22 ≈ ... ≈ w2p.
2. The importance of the variables reflect the magnitude of the effect of the correspond-
ing process on the outcome: w1i ≥ w2j , ∀i = 1..q,∀j = 1..p.
3. The importance of the variables {w1i }1≤i≤q and {w2i }1≤i≤p does not depend on the
corresponding group sizes, namely q and p, respectively.
We require that property 1) holds because, in absence of a true model, it is wise to give
fair chances to all correlated variables for being considered as causative for the phenotype.
In this case, supplementary evidence from other sources should be used for identifying the
causative variable from a correlated group. Property 2) is based on the assumption that
E(P1) > E(P2) and hence any of the features {Ui}i≤q contributes more to the outcome
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than any of the features {Vj}j≤p. Thus, the property ensures a fair ranking of the vari-
ables, which is important in applications because often only a few top ranking groups are
considered for further investigation. Property 3) demands that the importance of the fea-
tures does not change as more evidence (more variables) about the corresponding events
is added to the data.
In this chapter we show that in classification problems with groups of correlated fea-
tures, the assignment of feature importance by LLR, RF, GL and FSVM does not meet
requirements 2) and 3). Specifically, the reported feature importance varies with the sizes
of the correlated groups of features and results in biased feature ranking. In the context of
the example above, the feature weights {w1i }1≤i≤q and {w2i }1≤i≤p depend on the values of
q and p, respectively, in a way that larger group size leads to smaller importance values.
As a consequence, if q is much larger than p, variables {Ui}1≤i≤q can falsely appear less
predictive than variables {Vj}1≤j≤p and P2 is considered more relevant than P1.
In sparse models like LLR, correlated features are generally discarded in favor of a single
representative. Instability of feature importance is a known issue in such models (Park
et al., 2007; Jäger and Sengupta, 2003), and it is easy to observe that the larger the group,
the smaller the chance of each particular variable within the group is to be selected by the
model. Therefore, under repeated perturbations of the training set, the average weights
of the features decrease as the size of the group increases. In the case of FSVM, the
weights of correlated features are forced to be equal (or similar). Consequently, if the
group of correlated features becomes larger, the common weights need to be decreased, in
order to accommodate all features in the model and not violate the Lasso penalty. This
rescaling of the weights is possible without decreasing the accuracy of the model, since
correlated features provide only redundant information. In the Section 5.3.1 we show how
the interaction between the two penalties of FSVM can cause correlation bias. A similar
effect can be observed in GL models. In RF, the correlation bias is caused by the bootstrap
sampling of the observations and by the sampling of the features at each node of the trees,
which causes correlated features to be used interchangeably in the tree components.
In this chapter, we say that models that do not meet requirements 2) and 3) are affected
by correlation bias.
5.3.1. Example of correlation bias
In what follows, we demonstrate the phenomenon of correlation bias on a simplified version
of FSVM. For convenience, we will consider a simple linear regression with Lasso and fused
penalties, similar to model (5.3). Assume U ∈ Rp and V ∈ Rp are two independent
standardized random variables, E(U) = E(V ) = 0, Var(U) = Var(V ) = 1. Consider now
the variable Y given by the linear model:
Y = aU + bV + , a, b ∈ R,  ∼ N(0, σ) (5.7)
Consider variables U1, ..., Uq, for some integer q ≥ 1, mutually correlated and with U .
Assume they are also standardized. Formally:
E(Ui) = E(U) = 0, Var(Ui) = Var(U) = 1, ∀i ∈ {1, ..., q}
Cor(U,Ui) ≈ 1, ∀i ∈ {1, ..., q}, Cor(Ui, Uj) ≈ 1, ∀i, j ∈ {1, ..., q} (5.8)
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Similarly, let V1, ..., Vr be r (r ≥ 1) standardized variables, mutually correlated and with
V :
E(Vi) = E(V ) = 0, Var(Vi) = Var(V ) = 1, ∀i ∈ {1, ..., r}
Cor(V, Vi) ≈ 1, ∀i ∈ {1, ..., r}, Cor(Vi, Vj) ≈ 1, ∀i, j ∈ {1, ..., r} (5.9)
Assume that any pair Ui, Vj is not correlated, i.e.
Cor(Ui, Vj) ≈ 0, ∀i ∈ {1, ..., q}, ∀j ∈ {1, ..., r}
We formulate a regression problem with two groups of correlated variables, GU =
{U1, ..., Uq} and GV = {V1, ..., Vr} and response Y . Linear regression with fused and Lasso
penalties for this particular problem minimizes the following expected penalized residual
sum of squares (PRSS):
wopt = arg min
w
PRSS(w;λ, µ),
PRSS(w;λ, µ) = E
(
(Y −
q∑
i=1
wiUi −
r∑
i=1
wq+iVi)
2
)
+
+λ
q+r∑
i=1
|wi|+ µ
q+r∑
i=2
|wi − wi−1|
(5.10)
and λ > 0, µ > 0. Solving the fused regression given by Equation 5.10 will ideally yield
optimum weights w˜ of the form w˜1 = ... = w˜q = α and w˜q+1 = ... = w˜q+r = β. This
corresponds to a model that correctly identifies two independent groups of features and
assigns identical weights to correlated features, which provide same information to the
model. Assume that for some λ > 0 and µ > 0, the model has the ideal form specified
above. Below we perform successive transformations on Equation 5.10:
Denote with ERSS the expected residual sum of squares. Then
ERSS(w) = E
(
(Y −
q∑
i=1
wiUi −
r∑
i=1
wq+iVi)
2
)
Then it follows, under the model assumptions given by Equation 5.7:
ERSS(w˜) = E
(aU + bV + − q∑
i=1
w˜iUi −
r∑
i=1
w˜q+iVi
)2
= E

(aU − α
q∑
i=1
Ui︸ ︷︷ ︸
A
) + (bV − β
r∑
i=1
Vi︸ ︷︷ ︸
B
) + 

2
= E(A2) + E(B2) + 2E(AB)
We further transform the ERSS, using the assumptions (5.8) and (5.9) and the fact
that the correlation and covariance notions are equivalent when applied to standardized
variables:
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E(A2) = E
( q∑
i=1
(
a
q
U − αUi)
)2
=
∑
1≤i,j≤q
E
(
(
a
q
U − αUi)(a
q
U − αUj)
)
≈ q2(a
q
− α)2
E(B2) ≈ r2( b
r
− β)2 (as above)
E(AB) = E(abUV − aβ
r∑
i=1
UVi − αb
q∑
i=1
UiV − αβ
q∑
i=1
r∑
j=1
UiVj)
= abE(UV )− aβ
r∑
i=1
E(UVi)− αb
q∑
i=1
E(UiV )− αβ
q∑
i=1
r∑
j=1
E(UiVj)
= abCov(UV )− aβ
r∑
i=1
Cov(UVi)− αb
q∑
i=1
Cov(UiV )− αβ
q∑
i=1
r∑
j=1
Cov(UiVj)
= 0.
This gives the final formula:
ERSS(w˜) ≈ q2(a
q
− α)2 + r2( b
r
− β)2
Evidently, the penalty terms can be written as
λ
q+r∑
i=1
|w˜i| = λ(q|α|+ r|β|)
µ
q+r∑
i=2
|w˜i − w˜i−1| = µ|α− β|
Therefore, the optimization target can be re-written as:
PRSS(w˜;λ, µ) ≈ q2(a
q
− α)2 + r2( b
r
− β)2 + λ(q|α|+ r|β|) + µ|α− β| (5.11)
Consider two weight vectors w′ and w′′
w′1 = ... = w
′
q = a, w
′
q+1 = ... = w
′
q+r = b
w′′1 = ... = w
′′
q =
a
q
, w′′q+1 = ... = w
′′
q+r =
b
r
Then:
PRSS(w′;λ, µ) = q2(
a
q
− a)2 + r2( b
r
− b)2 + λ(q|a|+ r|b|) + µ|a− b| and
PRSS(w′′;λ, µ) = λ(|a|+ |b|) + µ
∣∣∣∣aq − br
∣∣∣∣
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It follows that if a, b, q, r are chosen such that
a > b > 0,
a
q
<
b
r
and
∣∣∣∣aq − br
∣∣∣∣ < |a− b| (5.12)
then PRSS(w′;λ, µ) > PRSS(w′′;λ, µ) , for any arbitrary fixed λ > 0 and µ > 0. The set
of conditions (5.12) are feasible and yield an infinite number of solutions: for any positive
b ∈ R and positive integer r, any choice of q > r and a ∈
[
q(r + 1)
r(q + 1)
b,
q
r
b
]
satisfy all
conditions. In conclusion, w′′ yields a smaller value of the objective function and therefore
w′ can never be a solution of the optimization problem (5.10). In contrast, the objective
function is improved by shrinking the weights proportionally to the group size, which
corresponds to reversed ranking of the two groups of features, if the conditions (5.12) hold.
We use simulation experiments to prove that under similar conditions, the weights given
by FSVM are indeed such that the relative importance of the two groups of correlated
features is incorrect.
5.3.2. Methods for reducing correlation bias based on feature grouping
Intuitively, a good strategy for reducing the correlation bias is to group the correlated fea-
tures prior to model fitting and derive corresponding feature representatives as a summary
of each group. The importance of the original features can be defined as the importance of
the corresponding representatives. To this end, the consensus segmentation methods pro-
posed in Chapter 4 can be used. In a cross-validation framework, the methods we propose
follow the following steps:
1. Assign the samples randomly to 10 cross-validation bins.
2. For i from 1 to 10, repeat:
a) Use as training set all samples that are not in the ith bin.
b) Perform consensus segmentation on the training set and obtain a set of feature
representatives.
c) Fit a model (LLR or RF) on the training set using the feature representatives.
d) Test the model on the remaining samples.
3. Based on the CV data, perform model selection by estimating optimal Lasso penalty
for LLR or optimal number of trees for RF. Optionally, the optimal number of re-
gions for consensus segmentation can be also estimated. Report test accuracy of the
optimal model.
4. With the optimal parameters, fit a model on all samples and report feature impor-
tance (model weigths for LLR, variable importance for RF).
We show in this chapter that the procedure above can help eliminate correlation bias.
The key step is feature grouping with consensus segmentation, which can be carried out by
either of the three methods proposed in Chapter 4: CB-MUG, CB-KeS, CR-FC. In order
to demonstrate that the correlation bias has been removed, in this chapter we only used
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CR-FC, which is the fastest method in practice. In Chapter 6, we used and compared all
three algorithms.
Through the rest of this thesis, we will use the following nomenclature for our models:
Model - CS Method - CS Selection Method,
where Model can be either ‘LLR’ or ‘RF’, CS Method is one of the consensus
segmentation methods ‘MUG’, ‘KeS’ or ‘FC’ and CS Selection Method can be
either ‘Sup’ or ‘Unsup’, depending on whether the number of regions of consensus
segmentation is selected by cross validation or unsupervised, by Ω0.98 criterion (see
Chapter 4).
5.3.3. Model evaluation
We compare the performance of classification methods on training sets with (large)
groups of correlated features. In particular, we analyze the measures of feature
relevance provided by the models investigated and seek for evidence of correlation
bias. Additionally, we report and discuss the prediction accuracy of the models
(estimated via 10-fold cross validation) and the stability of the respective feature
importance measures.
The stability of feature importance is defined as the variability of feature weights
under perturbations of the training set. When the goal of classification is to select
the most relevant features, small modifications in the training set should not lead to
considerable changes in the set of important covariates. When the true distribution
of the training set is not known, stability can be inferred via repeated sampling
from the available training observations. In Kalousis et al. (2006) classical 10-fold
cross validation is used in order to create 10 overlapping training sets and model
stability is estimated by comparing the 10 resulting feature weightings. For this
purpose, the authors propose several measures of similarity between two vectors
of feature weights. For our purposes, the Pearson correlation coefficient is most
suitable. Overall model stability is given by the average of all pair-wise Pearson
correlations between feature weight vectors provided by the models fitted on the 10
variations of the training set. The stability score has a value between −1 and +1,
with higher values for more stable models.
5.3.4. Validation data sets
We introduce below two artificial datasets which we use for demostrating the corre-
lation bias. In both settings, we construct groups of correlated features of different
cardinalities and compare their importance with respect to the classification models
introduced in this chapter. For each dataset we constructed a binary classification
instance based on an underlying linear model with noise. The datasets differ by
complexity, in the sense that the second dataset has significantly more features and
groups of features.
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G1 G2 R y
G1 0.86 0 -0.02 0.63
G2 0 0.86 0 0.42
R -0.02 0 0.87 0
Table 5.1.: Simulation A. Pairwise Pearson correlation between features, averaged within
and between groups. The last column shows the average correlation between each feature
group and the outcome y.
Simulated data
Simulation A. We generated datasets with N = 100 samples and p = 250 fea-
tures. The features are divided into three groups: G1, G2 and R. Group R has
50 features and the cardinality of group G2 is 200 − |G1|, for different values of
|G1| ∈ {100, 120, 140, 160, 180}. The features in each group are mutually correlated
and any two features belonging to different groups are independent. The features in
group G1 are generated from the prototype vector U , which is sampled from a mix-
ture of two Gaussians with equal probabilities: g0 = N (0, 0.2) and g1 = N (1, 0.3).
The particular choice for a Gaussian mixture stems from gene copy number data,
where g0 corresponds to those samples with normal copy number and g1 indicates
aberrations (copy number gains, in this case). We generate features U1, ..., U|G1| with
the following procedure: randomly select 20% of the components of U and alter them
by adding Gaussian noise N (0, 0.5), then repeat |G1| times. The features generated
this way are correlated with U and with each other and resemble segmented copy
number data, which are piecewise constant with occasional changes. Using the same
algorithm we generate a prototype vector V independent from U and correspond-
ing features V1, ..., V|G2|, which form group G2, and then repeat the procedure to
simulate group R. Last, we generate a binary outcome y with the following linear
classification rule:
y =
{
1, if 5U + 4V − (5U + 4V ) + ε > 0,
0, otherwise.
where ε∼N (0, 0.1) and 5U + 4V denotes the average of 5U + 4V . From the sim-
ulation parameters, it follows that features in group G1 are most relevant to the
outcome (being correlated to U), features in group G2 are less predictive and fea-
tures in group R are irrelevant. Table 5.1 shows the within group and between group
average correlations, summarized over 100 simulated datasets.
Simulation B. We generated more complex artificial datasets by considering 10
groups of predictive featuresG1, ..., G10 and 20 groups of irrelevant features, R1, ..., R20.
The number of samples is N = 100. Each of the the groups G2 to G10 and
R1 to R20 contains 10 correlated features and the cardinality of group G1 takes,
in turn, one of the values {10, 50, 100, 200}. The groups of correlated variables
G1, ..., G10, R1, ..., R20 are generated from the prototype variables U1, ..., U10, V1, ..., V20,
respectively. The simulation procedure is similar to that of Simulation A, with dif-
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Figure 5.1.: A) Boxplot showing the average correlations between features within each
group in Simulation B, summarized over 100 simulations. B) Boxplot showing the average
correlation of features within each group with the outcome in Simulation B, summarized
over 100 simulations.
ferent parameters: we alter all components of the corresponding prototype vector
by adding Gaussian noise N (0, 0.6). The binary outcome y is given by the linear
rule:
y =
{
1, if 10U1 + 9U2 + ...+ 1U10 − (10U1 + 9U2 + ...+ 1U10) + ε > 0,
0, otherwise.
The groups G1 to G10 are ordered decreasingly by their relevance to the outcome.
In Simulation B, the within-group correlations are smaller than in Simulation A
and the number of features is larger, which makes the identification of the groups
of features more difficult. In Figure 5.1, we show the average correlations between
features and the average correlations between features and the outcome variable,
for each group, summarized over 100 simulations. The correlation between pairs of
features within each group is positive and large, with mean value 0.47 (Figure 5.1A).
The average correlation between the outcome variable and the features belonging
to each group decreases, as the index of the group increases. This means that in a
univariate sense, features from group G1 are expected to be most informative of the
outcome, followed by features from G2, etc.
Real data
Bladder tumors. We tested our methods on a set of 98 CGH arrays measuring
copy number aberrations in bladder tumors. The experimental settings and data
have been described in Blaveri et al. (2005). DNA copy number has been measured
for 2142 probes distributed over all autosomes. The correlation between adjacent
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Figure 5.2.: Histograms show high correlations between neighboring probes (w.r.t. genomic
position) in the a) bladder dataset and b) breast dataset.
probes is very high (median 0.82), see Figure 5.2a. We considered two binary clas-
sification problems, by tumor grade and by tumor stage. For grade classification we
used 19 samples with low grade (Grade 1) and 77 samples with high grade (Grade
2 or 3). For stage classification, 84 samples were grouped into two classes: stage
Ta (29 samples) and stage T2+ (55 samples). We excluded the intermediary stage
T1 (as in Rapaport et al. (2008)). For each classification scenario, we train RF,
LLR, FSVM and GL models. We also fit RF and LLR in combination with FC and
FC-Sup. For each model we report accuracy (using 10-fold cross validation), area
under the curve (AUC) and feature importance.
Breast tumors. In Climent et al. (2007), 185 early-stage breast tumors were
analyzed using arrayCGH technology (UCSF Hum Array 2.0). Copy number aber-
rations are measured for 2369 BAC probes (chromosomes X and Y excluded). High
correlations between neighboring probes are observed, with median value 0.69 (see
Figure 5.2b). The authors of the study use statistical tests and report significant
associations between certain genetic alterations and ER status (oestrogen receptor)
and PR status (progesterone receptor) of the tumors. Using the methodology intro-
duced here, we identify genetic lesions which help discriminate between ER positive
and ER negative tumors, and PR positive and PR negative tumors, respectively. In
the cohort, there are 60 ER negative and 101 ER positive tumors, and 65 PR nega-
tive and 96 PR positive tumors. For all models considered, we report classification
accuracy and AUC (using 10-fold cross validation) and feature importance.
5.4. Bias of the Gini Importance measure with random forest and
correction
The research presented in this section is the result of a collaboration with André
Altmann and was published in Altmann et al. (2010).
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With respect to random forest classifiers, Strobl et al. (2007) showed that when
predictors are categorical, both GI nand VI are biased in favor of variables taking
more categories. The bias is caused by the Gini split criterion for training CART
trees (Breiman et al., 1984). More generally, the Gini coefficient itself is biased in
the same way (Bourguignon, 1979; Pyatt et al., 1980), and the bias affects not only
categorical variables but also grouped variables (for example variables with values
following some multimodal Gaussian distributions).
Here we introduce a heuristic for correcting biased measures of feature importance,
called permutation importance (PIMP). The method normalizes the biased measure
based on a permutation test and returns significance p-values for each feature. In
order to preserve the relations between features, we use permutations of the outcome.
We show that this method can be used to correct for the bias of feature importance
computed with random forest. Moreover, our method can be used together with any
learning method that assesses feature relevance, providing significance p-values for
each predictor variable. In the particular case of random forest, our method is very
useful because it can provide with an automated model selection procedure. Indeed,
despite their interpretability, random forest can only provide with a ranking of the
features, but not with a significance cutoff for the ranks. Our method assignes p-
values to the features and thus allows for a straight-forward significance assessment.
5.4.1. Permutation Importance
The permutation importance (PIMP) is a heuristic for correcting for the bias of the
GI of random forest models.
In a general setting, assume given an algorithm that assesses the relevance of a
set of features with respect to a response vector. The PIMP algorithm permutes the
response vector s times. For each permutation of the response vector the variable
importance for all predictor variables is assessed. This leads to a vector of s impor-
tance measures for every variable, which we call the null importances. The PIMP
algorithm fits a probabilty distribution to the population of null importances, which
the user can choose from the following: Gaussian, lognormal, or gamma. Maximum
likelihood estimators of the parameters of the selected distribution are computed.
Given the fitted distribution, the probability of observing a variable importance of
v or higher using the true response vector, can be computed (PIMP p-value). If
the user does not know which distribution is most suitable for his or her problem,
the PIMP algorithm uses Kolmogorov-Smirnov (KS) tests in order to automatically
identify the most appropriate distribution. However, if the tests show little resemb-
lence to any of the three proposed distributions, a non-parametric estimation of the
PIMP p-values is used, simply by determining the fraction of null importances that
are more extreme than the true importance v (see Algorithm 3 for an illustration of
the PIMP method with Gaussian distribution).
In practical applications the variance of the null importances may be very small
and therefore small deviations from the mean lead to artificially boosted variable
importances. In order to prevent this artifact, we apply a simple heuristic: variances
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that are smaller than the mean variance of all variable importances are set to the
mean variance.
Permuting the response vector has several advantages. First, the dependence be-
tween predictor variables remains unchanged. Second, the number of permutations
(s) can be much smaller than the number of predictor variables (p). Third, the ap-
proach is general, it can be used together with any method that generates measures
for variable importance (biased or unbiased). In this study we demonstrate that
PIMP is effective if used with the GI of random forest.
Algorithm 3 Permutation importance (PIMP)
Require: P ∈ Rn×p (matrix of predictors), p (the number of features), l (response vector),
V arImp (function to calculate variable importance), s (number of permutations)
Ensure: β, a vector of p-values corresponding to the features
1. −→α = V arImp(l, P ), R ∈ Rs×p
2. for (i = 1; i ≤ s; ++ i)
l′ = permute(l)
Ri,∗ = V arImp(l′, P )
3. −→µ ∈ Rp,−→σ ∈ Rp
4. for (j = 1; j ≤ p; ++ j)
µj = mean(R∗,j)
σj = sd(R∗,j)
5. σµ = mean(−→σ ), −→β ∈ Rp
6. for (j = 1; j ≤ p; ++ j){
σ′ = max{σj , σµ}
βj = pnorm(αj , µj , σ
′)
7. return(
−→
β )
Note: the notation Ri,∗ and R∗,j refers to the ith row and jth column of the matrix R, respectively.
The variable p denotes the number of different features (the number of columns of matrix P ). The
function pnorm refers to the R function that computes the probability of observing an importance
of αj or larger given a Gaussian distribution with mean µj and standard deviation σ′.
5.4.2. Corrected RandomForest models
The CART methodology uses the Gini index as a criterion for choosing best splits
during tree construction and thus the resulting model incorporates the bias of this
measure. As a consequence, both the CART and the random forest models are
biased themselves, not only their derived feature importance measures. Here, we
propose a method for improving the random forest models that uses the PIMP
algorithm. The method has the following steps: 1) training a classical random
forest model on the training data; 2) computing the PIMP scores of the covariates;
3) training a new model with the classical random forest but now using only the
significant variables (w.r.t. PIMP scores), by applying for example the classical
0.05 significance threshold. We will call the improved model PIMP-RandomForest.
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The idea of using the most predictive features for re-training random forest model
in order to reduce variance and improve accuracy has been proposed previously.
For instance, Díaz-Uriarte and Alvares de Andrés (2006) investigate its benefits on
several real-world datasets. The authors show that in some of the instances, the
procedure gives good results. However, it may also occur that the random forest
models built on the reduced set of features exhibit a slightly decreased performance
compared to full random forest model.
In order to assess the improvement in prediction accuracy of the PIMP-RandomForest
model, we use an independent test set and we compute the corresponding error rates.
Since the PIMP-RandomForest model uses fewer features than the initial random
forest, an increase in accuracy can be solely due to decrease of model variance. Thus,
we also compare PIMP-RandomForest with classical random forest models trained
using only the top ranking features of the initial method (biased) as well as with
the (corrected) cforest model proposed by Strobl et al. (2007) on all features.
5.4.3. Validation data sets
Simulated data
Simulation C. For demonstrating the degree of bias in the established measures
of importance a dataset comprising 1000 instances was simulated. The predictor
variables consist of 31 categorical variables with 2 to 32 categories. We chose cat-
egorical variables for simplicity. A similar scenario with continuous variables could
be realised, for example by drawing from multimodal distributions with k modes,
2 ≤ k ≤ 32. The response is a binary variable. Predictor variables and response
were independently sampled from a uniform distribution. Since input and output
were randomly generated, no predictor variable is informative. Given an unbiased
measure of variable importance all variables should receive equally low values. For
verification, the GI was computed for each variable. Then, the PIMP of all measures
was computed using s = 100. The simulation was repeated 100 times.
Simulation D. The second simulation was targeted at the question of how effi-
ciently predictive variables can be recovered among a large set of non-predictive
variables. We generated an artificial dataset with a large number of predictors (p)
and a small number of samples (n), with p = 500 and n = 100. The variables
had 1 to 21 categories. The number of categories for every variable was randomly
determined, and variables with few categories were more likely than positions with
many amino acids. Precisely, a variable with m categories had likelihood 1/m ·C−1,
with C =
∑21
i=1 1/i. Moreover, for every variable the categories were not equally
likely, but were sampled from a randomly generated distribution as follows: for each
category j ∈ {1, ...,m} of a variable, an integer xj between 1 and 100 was uniformly
sampled. Then the probability of category j of that variable was set to xj/
∑m
k=1 xk.
The output vector comprises two classes that are randomly sampled with probability
0.5. In order to challenge the ability of the feature importance methods to discover
the relevant covariates, a number of relevant variables with a small number of cat-
104 5 Methods for Identifying Relevant CNAs
egories were intermixed among the non-informative positions as follows: the first
12 variables comprised the same two categories and were conditionally dependent
(to different degrees) on the binary response variable. Precisely, if the outcome was
positive (negative) the category ”a” was sampled with probability 0.5 + r (0.5 − r)
and category ”b” was sampled with probability of 0.5 − r (0.5 + r), where r varied
from 0.24 to 0.02 in steps of 0.02. Apart from the first 12 variables all variables
were ordered increasingly with respect to the number of corresponding categories.
GI and PIMP scores with s ∈ {10, 50, 100, 500, 1000} were applied for generating
feature rankings. An optimal feature ranking method would rediscover all 12 vari-
ables that were associated with the outcome. However, since the relation of some
variables with the outcome was very weak, these variables were likely to be ranked
too low. The simulation was repeated 100 times.
5.5. Results I - Correlation bias
5.5.1. Simulated data
Simulation A.
|G1| 100 120 140 160 180
RF 0.913±0.03 0.906±0.02 0.911±0.02 0.912±0.02 0.901±0.03
RF-FC-Unsup 0.915±0.03 0.921±0.03 0.916±0.03 0.921±0.02 0.915±0.02
RF-FC-Sup 0.928±0.03 0.930±0.02 0.925±0.02 0.924±0.02 0.922±0.02
LLR 0.940±0.03 0.941±0.02 0.939±0.02 0.940±0.02 0.938±0.02
LLR-FC-Unsup 0.966±0.01 0.966±0.02 0.987±0.02 0.970±0.02 0.964±0.02
LLR-FC-Sup 0.972±0.01 0.972±0.02 0.973±0.02 0.973±0.01 0.969±0.01
FSVM 0.967±0.02 0.966±0.02 0.963±0.02 0.965±0.02 0.951±0.02
GL 0.970±0.01 0.965±0.02 0.959±0.02 0.941±0.02 0.884±0.03
Table 5.2.: Accuracy of classification models on data from Simulation A. The values are
averaged over 100 simulations.
|G1| 100 120 140 160 180
RF 0.56±0.14 0.52±0.17 0.55±0.16 0.55±0.16 0.55±0.18
RF-FC-Unsup 0.99±0.01 0.99±0.01 0.99±0.01 0.99±0.01 1.00±0.01
RF-FC-Sup 0.88±0.14 0.89±0.14 0.86±0.15 0.88±0.15 0.90±0.14
LLR 0.72±0.08 0.72±0.08 0.71±0.08 0.73±0.08 0.75±0.07
LLR-FC-Unsup 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00
LLR-FC-Sup 0.87±0.21 0.86±0.20 0.91±0.17 0.91±0.18 0.93±0.14
FSVM 0.96±0.03 0.98±0.02 0.96±0.07 0.95±0.04 0.95±0.04
GL 0.95±0.02 0.94±0.02 0.94±0.01 0.94±0.01 0.91±0.02
Table 5.3.: Stability of feature importance of classification models on data from Simulation
A. The scores are averaged over 100 simulations.
We evaluated the performance of RF, LLR, FSVM and GL with respect to the
criteria described in Section 2.4. Figure 5.3 summarizes the importance values as-
signed to features from the three groups G1, G2 and R. The average feature weights
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Figure 5.3.: Average importance of features for classification of data from Simulation A.
The importance is averaged over groups G1, G2 and R.
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Figure 5.4.: Boxplot summarizing the number of feature groups selected by FC-Unsup and
FC-Sup (in combination with RF and LLR) for a) Simulation A and b) Simulation B. The
red horizontal line shows the true number of groups. On the x-axis, the cardinality of G1
is given.
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over 100 simulations are shown for each chosen cardinality of group G1, with indi-
cation of standard deviation added. The correlation bias is clearly demonstrated by
the decreasing importance of group G1 as its cardinality increases and conversely,
the increasing relevance of G2 as its cardinality decreases.
In the case of RF, when the number of features in group G1 is larger than 140
(|G1|/|G2| > 2.3), the ranking of the groups given by GI and VI is incorrect in that
features in G2 falsely appear most relevant for the model (Figures 5.3a and b). On
average, the same effect is observed in LLR models (depicted in Figure 5.3c).
In the case of FSVM and GL, the correlation bias is noticeable even if G1 = 120
(|G1|/|G2| = 1.5) (Figure 5.3e). In the context of the formal example from the
Supplementary material (see Example of correlation bias, Supplementary material),
note that our experimental results agree with the set of conditions (6) (a = 5, b = 4,
q = 120, r = 80).
We trained our models based on feature grouping LLR-FC-Sup, LLR-FC-Unsup,
RF-FC-Sup, RF-FC-Unsup. The unsupervised selection of the number of regions
of consensus segmentation (FC-Unsup FC-Unsup) almost always lead to the correct
number of groups of features (three). In contrast, if the number of regions is selected
via cross validation, more often than not the number of groups are overestimated.
Moreover, the RF models select a larger number of groups than the LLR models.
Figure 5.4a shows a summary of the selected number of feature groups by FC-Sup
and FC-Unsup. Importantly, none of the methods LLR-FC-Sup, LLR-FC-Unsup,
RF-FC-Sup, RF-FC-Unsup is affected by correlation bias, which is evident from
Figure 5.3f-i.
The prediction accuracy of all models is summarized in Table 5.2. All linear
models outperform RF, which is expected because the simulations are based on a
linear model. With FC-Unsup, both baseline methods RF and LLR achieve higher
accuracy. FC-Sup always outperforms FC-Unsup, which is surprising, given that FC
discovers the true number of feature groups and FC-Sup does not. Most probably,
the classification is improved if each group is further split into several subgroups.
This is possible because the feature groups are not spherical, but rather elongated,
thus a single centroid is not the best representation of the group. As the cardinality
ratio |G1|/|G2| increases, the accuracy of FSVM and GL decreases and thus the
LLR-FC-Unsup and LLR-FC-Sup become significantly better than FSVM and GL.
Table 5.3 shows the stability estimates for the various models. The RF are most
unstable, probably due to their increased complexity and thus tendency to overfit-
ting. As expected, the LLR models are most unstable among the linear models. FC
improves dramatically the stability of RF and LLR. FC-Sup is always more stable
than the baseline methods. Interestingly, FC-Unsup is more stable than FC-Sup.
This is the case because the grouping of the features by FC-Unsup is driven only by
the features themselves, while in the case of FC-Sup, the outcome also plays a role.
The results show that FSVM and GL are also very stable models.
108 5 Methods for Identifying Relevant CNAs
Simulation B.
Figure A.1 clearly demonstrates the correlation bias affecting a) RF (Gini Index), b)
RF (Variable Importance), c) LLR, d) GL and e) FSVM models. Most dramatically,
in the case of FSVM, as the cardinality of group G1 increases to 200 features, the
features in G1 appear almost irrelevant. When the size of G1 exceeds 100 features,
the GL model selects only group G1 and disregards all other predictive groups. As in
the case of Simulation A, FC-Unsup and FC-Sup succeed to remove the correlation
bias (Figures A.1f-i). FC-Unsup in general finds the true number of groups (thirty),
but as the number of correlated features in G1 increases, the number of groups is
sometimes underestimated (Figure 5.4b). FC-Sup often selects a larger number of
feature groups.
The accuracy of the models is given in Table 5.4. The models show similar relative
performance as seen in Simulation A: FC-Unsup and FC-Sup always outperform the
baseline models and FC-Sup slightly outperforms FC-Sup. LLR always outperforms
RF, probably due to the underlying linear model. The FSVM and GL lose accuracy
as the size of the group G1 increases.
Table 5.5 shows the stability scores of all models. FC-Unsup and FC-Sup improve
the stability of the baseline models, with FC-Unsup being more stable than FC-Sup.
|G1| 10 50 100 200
RF 0.741±0.05 0.744±0.03 0.724±0.04 0.714±0.04
RF-FC-Unsup 0.754±0.05 0.758±0.05 0.758±0.05 0.753±0.05
RF-FC-Sup 0.756±0.05 0.758±0.05 0.758±0.05 0.761±0.05
LLR 0.777±0.06 0.787±0.05 0.783±0.05 0.788±0.05
LLR-FC-Unsup 0.857±0.03 0.874±0.03 0.868±0.04 0.863±0.03
LLR-FC-Sup 0.870±0.03 0.890±0.03 0.883±0.03 0.880±0.03
FSVM 0.894±0.03 0.898±0.03 0.891±0.03 0.889±0.04
GL 0.828±0.05 0.739±0.04 0.693±0.05 0.690±0.05
Table 5.4.: Accuracy of classification models on data from Simulation B. The values are
averaged over 100 simulations.
|G1| 10 50 100 200
RF 0.79± 0.05 0.76± 0.05 0.67± 0.10 0.62± 0.10
RF-FC-Unsup 0.93± 0.03 0.95± 0.03 0.96± 0.03 0.97± 0.03
RF-FC-Sup 0.90± 0.05 0.87± 0.14 0.88± 0.12 0.92± 0.07
LLR 0.78± 0.07 0.75± 0.07 0.75± 0.07 0.73± 0.07
LLR-FC-Unsup 0.97± 0.01 0.99± 0.01 0.99± 0.01 0.99± 0.01
LLR-FC-Sup 0.93± 0.05 0.93± 0.08 0.93± 0.09 0.93± 0.10
FSVM 0.97± 0.04 0.94± 0.05 0.93± 0.06 0.93± 0.05
GL 0.92± 0.03 0.89± 0.05 0.94± 0.03 0.93± 0.03
Table 5.5.: Stability scores of classification models on data from Simulation B. The scores
are averaged over 100 simulations.
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5.5.2. Real data
Bladder tumors.
By applying FC-Unsup to the bladder data, we obtained 113 ± 11 feature groups
with grade labelling and 140±31 groups with stage labeling. The varying number of
groups corresponds to the 10 training sets of the cross-validation procedure. When
applied with RF, FC-Sup method finds 107 groups (with grades labeling) and 20
groups (with stages labeling), respectively. When applied with LLR, FC-Sup par-
titions the set of features into smaller number of groups: 24 (with grade labeling)
and 19 (with stage labeling).
In both classification scenarios (with grades and stages labeling), the LLR with
FC-Sup yields best accuracy. RF with FC-Unsup and FC-Sup improve the baseline
model in the case of tumor grade prediction but decrease it slightly when tumor
stage is predicted (Table 5.6).
The stability scores of the prediction models (Table 5.7) lead to the same conclu-
sions as the experiments on the simulated data: the RF and LLR models are most
unstable, however using FC-Unsup and FC-Sup results in significant improvements.
FC-Sup is more unstable than FC-Unsup.
Figure 5.5 shows the feature importance reported by some of the methods in-
vestigated. For comparison purposes, to the set of prediction methods analyzed,
we added a univariate measure of feature relevance, consisting of t-test p-values
(log-transformed) (Figure 5.5e). A t-test was applied to each feature independently,
in order to evaluate the significance of the difference between the means of the
two classes. We do not perform multiple testing correction because we use the
log-transformed p-values as scores, and not as indicators of relevance. Concerning
interpretability, FC-Unsup and FC-Sup with LLR and RF or FSVM are the better
models, reporting clear groups of features with identical weights. GL is also suitable
for finding relevant groups, however there is high variance among the weights within
groups.
In the absence of a true model, it is difficult to show how correlation bias af-
fects classification models. However, in the case of classification with stage labeling,
we speculate that correlation bias is observable in the feature importance given by
FSVM. A large group of 175 correlated features on chromosome 7 is ranked fifth
(w.r.t. absolute value of the weights) by FSVM (Figure 5.5a). However, a large
subgroup of this group of features located towards the short arm of the chromo-
some is indicated as most relevant by RF-FC-Unsup, LLR-FC-Unsup, as well as by
univariate t-tests (Figures 5.5b-d). It is possible that the lower rank of this group
of features in the FSVM model can be caused by the correlation bias. The FSVM
includes the entire group of correlated features, at the price of lower average weights.
In order to verify this hypothesis, we constructed a new dataset, by assigning one
feature representative to each group with identical weights in the FSVM model.
The representatives are computed by averaging over the corresponding group. All
features with null weights were excluded. This procedure essentially uses FSVM for
discovering groups of correlated features and computes the centroid of each group
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selected by the FSVM model. The resulting reduced dataset has 11 features. We
trained and evaluated a FSVM model on the new dataset, this time without fused
penalty (µ = 0 in (5.3)), since most probably there are no further groups to be
discovered. We call the new model reduced FSVM. In Figure 5.5e, the weights of the
features in the original FSVM model are represented (in absolute value and only the
regions with non-zero weights). Figure 5.5f shows the weights of the reduced FSVM
(in absolute values), extended for convenience so as to be aligned to the original
weights. The representative feature corresponding to the group located on chromo-
some 7 receives highest absolute weight, which could indicate that the correlation
bias has been removed.
Breast tumors.
FC-Unsup identifies 130±37 groups of features with ER labeling and 127±32 groups
of features, with PR labeling. FC-Sup in combination with RF selects an optimal
partitioning into 195 groups (with ER labeling) and 163 groups (with PR labeling),
respectively. Table 5.8 summarizes the accuracy of the different algorithms on ER
and PR classification. FC-Unsup improves the accuracy of the RF in both cases and
of LLR in the case of PR labeling, but decreases slightly the accuracy of the LLR
model when ER status is predicted. In the case of ER classification, all RF and
LLR models outperform FSVM and GL, however by a small margin. In the case of
the PR classification, FSVM performs best.
The models investigated have similar stability scores as in the case of bladder
tumors: RF and LLR are most unstable, FC with LLR and RF have increased
stability, comparable to that of GL and FSVM models and FC-Sup is less stable
than FC-Unsup (Table 5.9).
The feature importance reported by the various methods investigated in general
confirms the findings reported in the original study (Climent et al., 2007). An
interesting aspect is shown in Figure 5.6: FC-Unsup and FC-Sup in combination
with RF and LLR select a group of features in chromosome 13 as highly relevant
for classification of PR status. In the original study (Climent et al., 2007), none
of these features were reported significant, based on univariate association with
the outcome (corrected t-test p-value). Allelic loss at chromosome 13 is known to
be associated with poor prognosis in breast cancer, due to the loss of the tumor
suppressor gene BRCA2, located in this region. Associations with low progesterone
content have been reported previously in the literature (Eiriksdottir et al., 1998),
which we confirm in our study.
5.6. Results II - Correction of the GI importance of random forest
with PIMP
Simulation C demonstrated clearly that random forest GI is biased such that vari-
ables with a large number of categories receive a higher variable importance (Figure
5.7, left). In contrast, the PIMP scores (p-values) computed using a gamma distri-
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Grades Stages
Acc AUC Acc AUC
RF 0.792±0.02 0.827 0.833±0.03 0.882
RF-FC-Unsup 0.833±0.01 0.878 0.810±0.02 0.882
RF-FC-Sup 0.833±0.01 0.885 0.810±0.03 0.884
LLR 0.823±0.01 0.800 0.798±0.01 0.821
LLR-FC-Unsup 0.854±0.02 0.838 0.774±0.01 0.757
LLR-FC-Sup 0.865±0.01 0.771 0.845±0.02 0.873
FSVM 0.813±0.02 0.642 0.810±0.05 0.780
GL 0.833±0.02 0.775 0.833±0.04 0.780
Table 5.6.: Performance of different classifiers on the bladder data.
Grades Stages
RF 0.55±0.03 0.60±0.03
RF-FC-Unsup 0.80±0.04 0.83±0.04
RF-FC-Sup 0.78±0.06 0.69±0.12
LLR 0.61±0.12 0.66±0.11
LLR-FC-Unsup 0.86±0.04 0.87±0.08
LLR-FC-Sup 0.72±0.11 0.66±0.18
FSVM 0.75±0.16 0.88±0.05
GL 0.72±0.13 0.87±0.09
Table 5.7.: Stability of feature importance of classification models on the bladder data.
ER status PR status
Acc AUC Acc AUC
RF 0.658±0.01 0.664 0.677±0.02 0.673
RF-FC-Unsup 0.670±0.06 0.635 0.682±0.08 0.660
RF-FC-Sup 0.665±0.02 0.663 0.671±0.02 0.667
LLR 0.683±0.03 0.692 0.683±0.03 0.733
LLR-FC-Unsup 0.671±0.02 0.718 0.689±0.04 0.723
LLR-FC-Sup 0.696±0.02 0.676 0.714±0.01 0.691
FSVM 0.658±0.02 0.660 0.745±0.02 0.800
GL 0.658±0.01 0.692 0.702±0.02 0.698
Table 5.8.: Performance of different classifiers on the breast data.
ER status PR status
RF 0.53± 0.04 0.49± 0.03
RF-FC-Unsup 0.70± 0.07 0.74± 0.08
RF-FC-Sup 0.78± 0.05 0.76± 0.07
LLR 0.65± 0.07 0.68± 0.06
LLR-FC-Unsup 0.89± 0.05 0.71± 0.14
LLR-FC-Sup 0.68± 0.08 0.61± 0.12
FSVM 0.77± 0.07 0.85± 0.03
GL 0.54± 0.14 0.72± 0.13
Table 5.9.: Stability of classification models evaluated on the breast data.
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Figure 5.5.: Feature relevance (in absolute value) by different classification models on the
bladder dataset with stage labeling. The features are sorted according to genomic position
and the chromosomes are shown along the x-axis.
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Figure 5.6.: Feature relevance (in absolute value) by different classification models on the
breast dataset with PR labeling. The features are sorted according to genomic position
and the chromosomes are shown along the x-axis.
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Figure 5.7.: Simulation C: GI variable importance in dependence of number of categories.
Figure 5.8.: Discovery of relevant features in simulation scenario D.
response variable at a 5% threshold (dashed red line).
Figure 5.8 shows box plots of the RF variable importance computed in the simula-
tion scenario D. The features were ranked with respect to their mean importance in
all simulations. For the sake of visualization only the top 25 of the 500 features were
displayed. In the first setting, the first 12 variables were selected to be predictive.
Using GI (top left), only the first five variables (r = 0.24 to r = 0.16) were recovered
perfectly. By comparison, using the PIMP (gamma distribution) of GI with s = 10,
the first six variables (r = 0.24 to r = 0.14) were recovered perfectly and variables
seven to nine were ranked eighth to tenth. Larger values of s led to perfect recovery
of the first eight variables (r = 0.24 to r = 0.10) and the ninth feature (r = 0.08) is
always among the top 13.
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RF baseline PIMP-RF RF Top 1% RF Top 5% RF Top 10% cforest
0.35± 0.06 0.25± 0.05 0.27± 0.08 0.26± 0.06 0.28± 0.06 0.32± 0.09
Table 5.10.: Performance of different random forest models. The baseline is the classi-
cal RandomForest (RF). For comparison, the average error rates are shown for PIMP-
RandomForest(PIMP-RF), for RandomForest models trained on the top ranking 1%, 5%
and 10% features and for the cforest algorithm.
5.6.1. Model improvement
We used simulation D to validate our improved PIMP-RandomForest model. We ran
100 simulations and we compared the accuracy of RandomForest, PIMP-RandomForest,
RandomForest re-trained only using the top ranking features and the cforest model.
The error rates were computed on an independent test set. Table 5.10 shows the im-
provements of accuracy of different methods over the classical RandomForest. The
PIMP-RandomForest model performs significantly better than the RandomForest,
with an average decrease of OOB error rate of 10%. The RandomForest trained
on the top-ranking 1%, 5% and 10% of the features also yields better models, due
to the decrease in variance. Choosing the top 5% results in a model with accuracy
comparable (although still inferior) to the PIMP-RandomForest. However, it is not
clear a priori how many top ranking features should be selected for a refined model.
With the p-values provided by the PIMP algorithm, one can simply use the classi-
cal 0.05 significance threshold for selecting the most relevant variables. Notably, the
cforest algorithm is superior to the classical RandomForest, but the average decrease
of error rate is significantly smaller than the one achieved by PIMP-RandomForest.
5.7. Discussion and conclusions
We have shown that several widely-used classification algorithms can generate mis-
leading feature rankings when the training datasets contain large groups of correlated
features. This can confound model interpretation, since large groups of predictive
features can be masked and falsely appear irrelevant. Such an effect is likely to occur
because variables relating to a biological process or genomic location of high inter-
est (w.r.t. a phenotype) are over-represented in the probes set of microarray-based
experiments. In this article, we have described the correlation bias and have shown
that it affects random forest, Lasso logistic regression, group Lasso and fused SVM
models. We used two artificial datasets based on linear models to show that the ex-
pected importance of the features in a correlated group decreases as the size of the
group increases. We also illustrated the correlation bias caused by the combination
of fused and Lasso penalties by means of a theoretical example, which considers the
particular case of two groups of correlated features. We showed that correlation bias
can be reduced using a feature grouping prior to model fitting. For this purpose,
we used consensus segmentationbased on feature clustering, with two methods for
selecting the number of regions: supervised (by cross validation)and unsupervised
(by minimizing Ω0.98).
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We showed using simulated data experiments that FC-Unsup and FC-Sup success-
fully remove the correlation bias, improve the stability of feature importance and
increase the accuracy of the baseline methods. FC-Sup outperforms FC-Unsup in
terms of accuracy, but FC-Sup is faster and has higher stability. The classification of
the real data shows that FC-Unsup dramatically increases the model interpretabil-
ity and stability of feature importance. Moreover, in five out of eight classification
tasks, FC-Unsup improved the accuracy of the baseline models. FC-Sup improves
the accuracy of the baseline models in six out of eight classification tasks. FC-Sup
used in combination with Lasso logistic regression yields highest accuracy in three
out of four cases.
We also proposed an algorithm for correcting for the bias of variable importance
given by random forest. The method permutes the response vector for estimating
the random importance of a feature. Under the assumption that the random im-
portance of a feature follows a normal distribution, the likelihood of the measured
importance on the unpermuted outcome vector can be assessed. The resulting p-
value can serve as an unbiased measure of variable relevance. We showed how this
method can successfully adjust the feature importance computed with the classical
RandomForest algorithm and how it can be used for feature selection with random
forest. We also introduced an improved random forest model that is computed
based on the most significant features determined with the PIMP algorithm, which
validates the feature selection method.
Simulation C demonstrated that the Gini importance of the RandomForest favor
features with large number of categories and showed how our algorithm alleviates
the bias. Simulation D demonstrated the usefulness of the algorithm for generat-
ing a correct feature ranking. For all methods, the feature ranking based on the
unprocessed importance measures could be improved.
We proposed a corrected random forest model based on the PIMP scores of the
features and we demonstrated that it is superior in accuracy to the cforest model.
The major drawback of the method is the requirement of time-consuming permu-
tations of the response vector and subsequent computation of variable importance.
However, our simulations showed that already a small number of permutations (e.g.
10) provided improvements over a biased base method. For stability of the results
any number from 50 to 100 permutations is recommended. The algorithm can eas-
ily be parallelized, since computations of the random variable importance for every
permutation are independent, and therefore allow for an even better scalability with
respect to available computational resources. With parallelization, the running time
of our algorithm is only a few times longer than the running time of a classical Ran-
domForest, which is very fast even for large instances.
We argue that the PIMP algorithm can also be used as a post-processing step with
other learning methods that provide (unbiased) measures of feature relevance, such
as linear models, logistic regression, SVM, etc. The raw scores given by these models
provide with a feature ranking, but usually it is difficult to choose a significance
threshold. The PIMP p-values are easier to interpret and provide a common measure
that can be used to compare feature relevance among different models. In this work,
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we use the PIMP procedure only for selecting features with random forest.
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6. Applications: Prediction of Tumor
Phenotype for Breast Cancer and
Neuroblastoma
Nature even in chaos cannot proceed
otherwise than regularly and
according to order.
Immanuel Kant
In this chapter we discuss in detail two interesting applications of our method-
ological pipeline to the analysis of breast cancer and neuroblastoma tumors. The
datasets have been introduced in Chapter 4.
6.1. Prediction of breast cancer phenotype
In Chapter 4 we have introduced three cohorts of breast tumors corresponding to
different interesting subtypes of the disease. In this chapter, we present extensive
phenotype prediction based on each tumor cohort. The phenotype is always a binary
variable. The predictors are LLR and RF as baseline models and combinations with
CB-MUG, CB-KeS and CR-FC. We present prediction accuracies for each prediction
problem and comment on the feature importance resulting from the best models.
To our knowledge, there are not many studies that attempt supervised prediction
of tumor phenotype based on copy number aberrations. The main reason is that
expression profiles are thought to reflect the characteristics of a tumor more closely
than copy number aberrations. As a consequence, it is largely unknown how infor-
mative CNA profiles are of phenotype. In this chapter, we shed some light on this
question.
We would also like to clarify that the supervised modeling of a phenotypical indi-
cator based on copy number aberrations does not necessarily aim at the automatic
prediction of new cases. Take for example the prediction of the ER (estrogen recep-
tor) status of a breast tumor: it is the expression of the ESR1 binding factor in the
breast that determines the status of the tumor and it would be pointless to derive
a complex and potentially inaccurate diagnostic marker based on CNAs to evaluate
it. However, the groups of ER positive and ER negative tumors are very different
overall and probably have undergone distinct progression patterns, which should
be understood. Therefore, while being an important indicator of how different the
groups are, the prediction accuracy is not the only focus of this section. We will
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look at the feature importance to gain insight into the relation between CNAs and
phenotype.
Another important comment on our experiments refers to the difficulty of integrat-
ing two or more datasets for a more comprehensive analysis. For example, we could
combine the three datasets on breast cancer and thus obtain a richer sample set for
prediction and better performance. However, our experiments showed the contrary:
the performance decreases, due to systematic differences between the cohorts (batch
effect). The reproducibility of microarray results has long been an issue of debate
in the community (Ein-Dor et al., 2005). We adopted the following strategy in our
investigations on breast cancer: we fit different models to each dataset and then we
compare the models qualitatively. We comment on these aspects in the discussion
section at the end of the chapter.
6.1.1. Analysis of breast cancers from dataset breast173
The arrayCGH dataset breast173 was first introduced by Bekhouche et al. (2011).
The original analysis was focused on discriminating between copy number profiles
of IBC (inflammatory breast cancer) and NIBC (non-inflammatory breast cancer)
subtypes. However, the public repository does not contain the corresponding anno-
tation, so we were not able to repeat the analysis. Instead, we used the available
annotations in our experiments, consisting of estrogen receptor and progesterone
receptor status, which can be either positive (ER+, PR+) or negative (ER-, PR-).
Figure 6.1 shows the accuracy of our models (for model and axis annotations,
revisit Section 5.3.2). The accuracy of all models is slightly larger that 80% in the
case of ER status prediction and around 70% in the case of PR status prediction,
and significantly larger than the Bayes error (marked with red horizontal line in the
figure), indicating a non-negligible difference between copy number profiles of the
two groups.
The LLR-based models and RF-based models yield comparable accuracy, with
LLR slightly outperforming RF in the case of PR status prediction. The accuracy
of the LLR-based models remains similar after consensus segmentation, with worst
performance given by the CB-MUG algorithm. The baseline RF model outperforms
the models based on consensus segmentation in the case of ER status prediction,
but is outperformed in the case of PR status prediction. However, the differences
in performance are small (up to 3%). A much larger and convincing difference can
be noted in the stability plots (Figure 6.1). The LLR-based models with consensus
segmentation yield 1.5-fold larger stability than the baseline, while the RF-based
models with consensus segmentation are up to four times more stable.
It has been indicated before that ER positive and ER negative tumors have differ-
ent molecular characteristics, mostly by studies based on differential gene expression:
Gruvberger et al. (2001) and West et al. (2001) report very high prediction accuracy
of ER status based on gene expression signatures, of 100% and 90%, respectively
and point out that a long list of about a hundred genes is significantly associated
with ER status and equivalent models relying on different subgroups can achieve
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(a) ER status, accuracy (b) ER status, stability
(c) PR status, accuracy (d) PR status, stability
Figure 6.1.: Accuracy of prediction models trained on the breast173 dataset and stability
of the feature importance. The vertical bars show accuracy, with indication of variance.
Colors associate with the specific consensus segmentation method used. The two groups
of bars correspond to methods based on LLR (left) and RF (right) of each panel. The red
horizontal red line marks the Bayes error.
similar performance. Most of the studies that investigate the association between
copy number aberrations and ER status use simple t-tests for deciding whether a
probe is significantly associated or not with the hormone receptor status (Loo et al.,
2004; Fridlyand et al., 2006). Chin et al. (2007) and Horlings et al. (2010) are
among the very few articles that attempt supervised classification of tumor samples
based on copy number aberrations. Chin et al. (2007) report modest accuracies, of
up to 64%, while Horlings et al. (2010) only mention the features that were found
discriminative.
Figure 6.2a shows a consensus of the feature importance values of all methods
based on consensus segmentation with ER status as outcome. We combined the
various models because there was no method clearly outperforming the rest. The
combination is linear, with weights proportional to the accuracy of the corresponding
model. We find the following aberrations characteristic to ER negative tumors:
2p22-25 gain, 5q loss, 10p gain. The following were aberrations more commonly
associated with ER positive tumors: 1p deletion, 5q gain, 6q loss, 11q loss, 11q13
amplification, 16q loss.
The most discriminative features (according to most models) were regions located
on chromosome 10 and on chromosome 16. Figure A.2a from the Appendix shows a
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(a)
(b)
Figure 6.2.: Consensus feature importance of prediction models on breast173 dataset with
a) ER status and b) PR status as outcome.
(a) LLR (b) RF
(c) LLR-FC-Sup (d) RF-FC-Sup
Figure 6.3.: Consensus segmentation improves model interpretation. Figure shows fea-
ture relevance given by a) LLR coefficients, b) RF importance measure, c) LLR-FC-Sup
coefficients and d) RF-FC-Sup PIMP p-values. The x-axis orders the features according
to chromosome and genomic position. In red, significance thresholds are shown for the
RF-FC-Sup p-values.
detailed view of chromosome 10: the panel above contains the copy number data and
the panel below shows the feature importance values if our models (green for LLR-
based models, black for RF-based models). RF-based models assign a very large
feature importance to the 10p gain event. Figure A.2b from the Appendix shows
the deletion of 16q, highly associated with ER status as indicated by all models.
Our findings are supported by other authors (Horlings et al., 2010; Hungermann
et al., 2011).
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Figure 6.3 demonstrates the benefits of consensus segmentation. In Figure 6.3a
and b, we show the baseline models LLR and RF. A couple of irrelevant genes
from chromosome 16 were selected by the LLR model (their function is unrelated to
carcinogenesis), while RF assign moderate constant importance values to the entire
chromosome arm 16q. After consensus segmentation, the relevance of chromosome
16q is greatly emphasized, in fact becoming the most predictive feature, for example
by FC-Sup (see Figure 6.3c and d). This is an indication that the correlation bias
affects the baseline models.
Figure 6.2b shows the consensus importance for the prediction of PR status. There
is a significant association between the ER and PR status in breast tumors, therefore
it is expected that the models are similar. It appears that the association between
the copy number at chromosome 10q is stronger with the PR status than with ER
status, as well as with the gain at 2q.
6.1.2. Analysis of breast cancers from dataset breast167
The cohort of 167 breast cancer samples investigated by (Russnes et al., 2010)
contains a large variety of tumors, of different histological subtypes, stages, grades
and hormone receptor status. The prediction accuracy and the stability of feature
importance is shown in Figure 6.4.
The accuracy after consensus segmentation is comparable to that of the baseline
models, being significantly worse only in rare cases. However, the overall prediction
performance is poor, the accuracy being often comparable to that of the Bayes
error. In the case of ER status and lymph node status prediction, a marginal
improvement is observed. The stability of feature importance increases dramatically
after grouping the correlated features in the case of the RF-based models, as observed
in the previous analysis (on dataset breast173).
We trained models with the ER status outcome and we obtained the consensus
feature importance shown in Figure 6.5a. Chromosome 16 stands out as one of
the most predictive regions, however it is not the same genomic region as given by
the similar models trained on breast173. The aberration indicated by the present
models is gain of 16p, which is more present in ER positive tumors (see Figure A.3a
from the Appendix), while the model trained on breast173 points to loss of 16q
as more predictive. Gain of 16p has been associated before with ER positiveness
(Rennstam et al., 2003; Fang et al., 2011), as well as loss of 16q. Possible bias in
the selection of the patients for the two cohorts may be responsible for the different
representation of the two markers. Chromosome 6 is also indicated as predictive,
with loss of 6q more often occurring in ER positive tumors, as also shown by Fang
et al. (2011) (see A.3b from the Appendix). Almost all the top ranking regions
have been shown to discriminate between the ER positive and negative tumors in
previous studies (Fang et al., 2011).
The most informative regions of PR status are located on chromosomes 6 and 7
(see Figure 6.5b). Gain of 16p (top ranking region) is characteristic to PR positive
tumors, as also noted by Rennstam et al. (2003). Also, regions located on chromo-
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(a) ER status, accuracy (b) ER status, stability
(c) PR status, accuracy (d) PR status, stability
(e) Lymph node status, accuracy (f) Lymph node status, stability
(g) Stage, accuracy (h) Stage, stability
(i) Histological subtype, accuracy (j) Histological subtype, stability
Figure 6.4.: Accuracy of prediction and stability of feature importance models trained on
the breast167 dataset.
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some 8 appear significant, especially the 8q arm. In general, the feature importance
is in discordance with the values obtained with breast173 as training dataset.
We discuss also the most predictive features for lymph node status, despite the
low prediction accuracy. Figure 6.5c illustrates the consensus feature importance,
computed as before. The methods agree less with each other, which results in ragged
consensus feature importance curve. The highest peak is observed at chromosome
9, corresponding to amplification at 9q13. This region contains the oncogenes P16
and PTC and has been associated with lymph node status and metastasis before in
the literature (Minobe et al., 1998). Figure A.4a from the Appendix illustrates this
region. The next highest peak according to our models is located on chromosome
3. Associations between CNAs at 3q gain is a very strong marker for aggressive
tumors and relapse (Janssen et al., 2003). Another very interesting feature is the
amplification of 11q13.1 (see Figure A.4b from the Appendix). Amplification of
11q13 is a known hallmark of breast cancers, harboring two oncogene candidates
CCND1 (coding for cell cycle regulatory gene cyclin D1) and EMS1 (coding for the
filamentous actin binding protein and c-Src substrate cortactin). Ormandy et al.
(2003) have described an extended locus of amplification consisting of four ‘cores’ at
11q13. Our peak is located at the first core (11q13.1), to which candidate oncogenes
are still to be assigned.
6.1.3. Analysis of breast cancers from breast54 dataset
An interesting study presented by Sircoulomb et al. (2010) is focused on investigating
the genetic and transcriptomic properties of breast cancers presenting amplification
of the ERBB2 gene locus. The ERBB2 gene (erythroblastic leukemia viral oncogene
homolog 2), also known as HER-2/neu codes for an epidermal growth factor receptor.
This focal amplification occurs in around 20% of the breast cancers, is often associ-
ated with overexpression and importantly, poor outcome of the patient. A common
therapy option for ERBB2-amplified tumors consists of administering the humanized
monoclonal antibody transtuzumab or the kinase-inhibitor lapatinib. Many tumors
however develop resistance to transtuzumab, through molecular mechanisms that
are not fully understood. Sircoulomb et al. (2010) try to tackle the apparent hetero-
geneity of ERBB2-amplified breast cancers by discovering subtypes and patterns of
genetic and transcriptomic aberrations that associate with the subtypes. Although
hierarchical clustering of samples based on DNA copy number suggests two sub-
types, the authors report that the clinicopathological indicators do not appear to
associate significantly with these subtypes.
We applied our methodology for prediction of various tumor indicators with the
hope that a supervised approach would reveal associations that Sircoulomb et al.
(2010) have failed to discover. We conducted the following analyses: prediction of
ER (estrogen receptor) status, of PR (progesterone receptor) status and tumor type
that can be either inflammatory (IBC) or non-inflammatory breast cancer (NIBC).
The number of samples available for each prediction case are: 47 samples for ER
and PR prediction and 51 samples for subtype prediction.
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(b)
(c)
Figure 6.5.: Consensus feature importance of prediction models on breast167 dataset
with a) ER status, b) PR status and c) Lymph node status.
Figure 6.6 shows the prediction accuracy of all prediction models, as well as the
stability of feature importance, as measures of quality of the prediction. It is im-
mediate to observe that LLR models are more accurate than the RF models, which
frequently fall frequently below the Bayes error threshold. Given the very small
number of samples available, we believe that the poor performance of the RF is due
to overfitting.
As seen in the previous two studies (breast173 and breast167), the prediction
accuracy is significantly larger than the Bayes error in the case of ER and PR status
prediction, confirming that copy number profiles tend to be dissimilar between the
two groups of tumors. In contrast, the discrimination between the IBC and NIBC
tumors is not very accurate.
In most of the cases, the prediction accuracy of the models with consensus seg-
mentation is comparable with that of the baseline models. Moreover, generally the
accuracy of LLR-based models improves after consensus segmentation. The stability
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(a) ER status, accuracy (b) ER status, stability
(c) PR status, accuracy (d) PR status, stability
(e) Type (IBC / NIBC), accuracy (f) Type (IBC / NIBC), stability
Figure 6.6.: Accuracy of prediction and stability of the feature importance for models
trained on the breast45 dataset. Colors associate with the specific consensus segmentation
method used. The two groups of bars correspond to methods based on LLR (left) and RF
(right). The red horizontal line on accuracy plots marks the Bayes error.
of feature importance is at least as large as that of the baseline models in all but
one model (RF-FC-Sup).
The consensus feature importance assigns the highest value to regions in chro-
mosome 8, specifically 8q gain is more present in ER positive than in ER negative
tumors (see Figure A.5 from the appendix for a detailed view). Although indications
of relevance of chromosome 8 were present in the breast167 cohort, it was not a
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(a)
(b)
Figure 6.7.: Consensus feature importance of prediction models on breast54 dataset with
a) ER status and b) PR status as outcome.
(a) LLR (b) RF
(c) LLR -FC-Sup (d) RF-FC-Sup
Figure 6.8.: Consensus segmentation improves model interpretation. Figure shows fea-
ture relevance given by a) LLR coefficients, b) RF importance measure, c) LLR-FC-Sup
coefficients and d) RF-FC-Sup PIMPp-values. The x-axis orders the features according
to chromosome and genomic position. In red, significance thresholds are shown for the
RF-FC-Sup p-values.
leading predictor. It is possible that for the particular subtype of ERBB2-amplified
cancers, the amplification of 8q is highly predictive, but not in general.
We stress again the advantage of using consensus segmentation for the purpose
of model interpretation. In Figure 6.8a, we show the baseline LLR model, which
chooses an arbitrary combination of several features for achieving an accuracy of
0.64. For example, the largest absolute relevance is assigned to a probe correspond-
ing to the CA1 gene (carbon anhydrase, at 8q21.2), which probably plays no direct
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role in breast cancer progression and is merely a hitch-hiker. The beneficial effect
of consensus segmentation is depicted in Figure 6.8c, in which we show the feature
importance given by LLR-FC-Sup. The entire 8q arm is selected as relevant, with
an increased prediction accuracy to 0.74. The latter predictor is more robust and
does not mislead the interpretation by wrongly pointing to one irrelevant marker.
In contrast to LLR, the feature importance given by the RF baseline (Figure
6.8b) is not sparse, neighborhoods sharing similar relevance as a consequence of
correlation. Features on chromosome 8 do not stand out as more relevant than the
rest. The PIMP-corrected feature importance given by RF-FC-Sup selects the whole
chromosome 8 as most predictive and the model achieves the same accuracy as the
baseline. Importantly, after consensus segmentation, the LLR and RF models agree.
The LLR-MUG selects a supplementary region located on chromosome 17 (17q23.3
cytoband). Association between ER status and amplification at 17q23.3 has been
reported previously in the literature (Han et al., 2006).
There exists a large overlap between the ER and PR status of tumors. Three
tumors are ER positive and PR negative, all the rest being either both ER and
PR positive or ER and PR negative. In consequence, the predictors are not very
different. Amplification at 8q is the most predictive region. Also, all RF-based
models point to the deletion of the long arm of chromosome 16 as useful for the
prediction (see Figure A.6a).
The most interesting regions indicated as relevant for the prediction of tumor type
are located around the ERBB2 amplicon in chromosome 17q. Figure A.6b from the
Appendix shows the feature importance given by all models at this location. The
majority of methods select the region to the ‘left’ of ERBB2 locus as predictive, in-
dicating that the the extension of the amplicon over the genes downstream ERBB2
discriminates between the two subtypes. Interestingly, this region is assigned a neg-
ative weight by LLR models, which suggests that in fact not having a large amplicon
makes type IBC more likely. This observation has been made also in the original
study (Sircoulomb et al., 2010), but based on visual inspection. The ability of our
models to assign importance to the ‘length of the aberration’ is a direct consequence
of the consensus segmentation principle. Indeed, if several consensus breakpoints
exist around an aberration, our method breaks the aberration into subregions, which
represent essentially the minimal common aberration and several extensions. If some
extension is relevant for prediction according to a classification model, then we can
draw the conclusion that a larger aberration is associated to the phenotype. In
contrast, approaches that only select minimal common regions cannot reveal such
associations.
6.2. Prediction of neuroblastoma phenotype
The neuroblastoma dataset was introduced in Chapter 4. The 162 samples belong
to five stage groups, as follows: 28 Stage 1, 19 Stage 2, 29 Stage 3, 57 Stage 4 and 29
Stage 4S (special). Stages 1 to 3 are localized cancers with generally good prognosis.
Stage 4 corresponds to aggressive tumors occurring in children older than one year,
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with poor prognosis. Stage 4S is specifically assigned to neuroblastoma tumors that
have distant spread (metastasis) to liver, skin or bone marrow and are younger than
one year. Stage 4S neuroblastoma is known to have good prognosis.
We used our methodology in order to model tumor phenotype based on copy
number profiles, as follows. We considered Stages 1, 2 and 3 as one group of good
prognosis neuroblastomas, Stage 4 as the second group and stage 4S as third group.
We trained models to discriminate between pairs of groups: Stage 1-3 vs. Stage 4,
Stage 1-3 vs. Stage 4S and Stage 4 vs Stage 4S.
As age is an important prognostic factor for neuroblastoma, we were interested
to what extent is age difference represented in the genome of the tumors. In order
to coerce the continuous age indicator into a binary response variable, we selected
a series of successive cutoffs at 2, 4, 6, ..., 30 and 32 months and for each cutoff, we
obtained one binary labeling corresponding to younger and older patients. The age
indicator being the age at diagnosis, we admit that there may exist imprecisions in
the response variable, due to late detection of the disease, for example.
Figure 6.9 summarized the prediction accuracy and the stability of the feature
importance for the cases in which the Stage groups are predicted. From the overall
accuracy values, it is immediate that the models can discriminate between Stage
1-3 and Stage 4 tumors with up to 80% accuracy (Figure 6.9c) and between Stage
4 and 4S tumors with up to 80% accuracy (Figure 6.9a). Stage 1-3 tumors and
Stage 4S tumors are not easy to dichotomize by our models, the accuracy being
comparable to the Bayes error. In this case, LLR-FC-Unsup and LLR-KeS-Unsup
are constant, hence the lack of information on stability, which is computed based on
Pearson correlation.
In the cases of successful prediction, the models using consensus segmentation
yield comparable accuracy (all but two cases, which are outperformed by the base-
line). RF-based models achieve comparable accuracy with the LLR-based models.
The stability of feature importance increases, as in the previous studies.
Figure 6.10a shows the consensus feature importance for the models that discrim-
inate between Stage 1-3 and Stage 4 tumors. Polyloidy appears to be characteristic
of lower Stage tumors, while Stage 4 tumors exibit segmental amplifications and
deletions. Figure A.7 shows the gain of chromosome 6, gain of chromosome 22,
loss of chromosome 4, gain of chromosome 17 and loss of chromosome 19 as main
evidence for abnormal number of chromosome copies characteristic to Stage 1-3 tu-
mors. In contrast, Stage 4 tumors have segmental gains of 6p, loss of 4p, gains of
2p, and amplification of 17q. Our models are in agreement with the study of Spitz
et al. (2006).
Figure 6.10b summarizes the features that discriminate between the Stage 4 and
Stage 4S tumors. Many of the the highest peaks are also good predictors of the
models Stage 1-3 vs. Stage 4 discussed above. Based on the fact that Stage 4S
and Stage 1-3 tumors could not be distinguished well, we speculate that they are
together very similar and substantially different from Stage 4 tumors. Gains of whole
chromosome 4, 6, 17 and losses of whole chromosome 4 and 11 associate with stage
4S and better prognosis. Segmental deletions of 1p, 4p, 11q and amplification of 1q
6.2 Prediction of neuroblastoma phenotype 131
(a) 4 vs. 4S, accuracy (b) 4 vs. 4S, stability
(c) 1-3 vs. 4S, accuracy (d) 1-3 vs. 4S, stability
(e) 1-3 vs. 4, accuracy (f) 1-3 vs. 4, stability
Figure 6.9.: Accuracy of prediction models trained on the neuroblastoma dataset. The
vertical bars show accuracy, with confidence intervals resulting from binomial tests. Colors
associate with the specific consensus segmentation method used. The two groups of bars
correspond to methods based on LLR (left) and RF (right). The red horizontal line marks
the Bayes error.
and 17q are associated with stage 4 and worse prognosis (see detailed views of the
copy number aberrations in Figure A.8 from the Appendix). All these aberrations
and associations have been noted elsewhere (Ambros et al., 2009).
Most our findings suggest that DNA polyloidy plays a role in discriminating be-
tween aggressive and non-aggressive forms of neuroblastoma. It has been repeatedly
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(a)
(b)
Figure 6.10.: Consensus feature importance of prediction models on neuroblastoma
dataset with response: a) Stage 1-3 vs Stage 4 and b) Stage 4 vs. Stage 4S 4.
observed that hyperdiploid genomes (with more than two pairs of chromosomes) have
a better prognosis and it has been suggested that different mechanisms of progres-
sion underlie the formation of the hyperdiploid and diploid tumors. Presently, DNA
polyloidy is already used in some clinics for diagnosis and prognosis of neuroblastoma
(Ambros et al., 2009).
A very important aspect of model interpretation arises from the examples above.
For easy illustration, let us consider the example of chromosome 17 and the task
of discriminating between Stage 4 and Stage 4S tumors. Figure 6.11 illustrates the
copy number data and the feature importance given by the models that we trained:
LLR-based (green) and RF-based (black). Very large importance is given to the
copy number of 17p (left in the figure). It is clear from the figure that the lack of
amplification or gain at 17p suggests a Stage 4 tumor and thus a worse outcome.
Therefore, it is the lack of an aberration that associates with a more progressive sta-
tus, which is unusual in cancer genomics studies. Moreover, searching for causative
genes in the discriminative region 17p would be clearly pointless. Even more worry-
ing is the task of classifying a new case: assume the extreme case that there are no
copy number aberrations in the genome of this new case, for example corresponding
to a healthy tissue. From the point of view of the features located on chromosome
17q, this new case is lacking aberrations and therefore it will be assigned to the
more aggressive subtype. Of course, the model was not presented with a control
case (healthy), so it cannot know what are its characteristics, however it is unex-
pected that it is assigned to the more aggressive subtype. This problem is due to
the wrong set of features included in the model: the better choice would include
the status of the entire chromosome 17 and the status of 17p as two overlapping
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Figure 6.11.: Chromosome 17 of the neuroblastoma cohort, Stages 4 and 4S.
features, motivated by the underlying biology. However, a general and automated
selection of features that make sense biologically is not possible presently, unless
supplementary knowledge is included in the model. Therefore, we believe that care-
ful model interpretation is required before computer-generated models can be used
in the clinics for diagnosis or treatment selection.
The association between age and disease aggressivity is known and used for clas-
sification of neuroblastoma. In clinical practice, the age of one year is used for
grouping the patients into low risk/good prognosis (younger than one year) and
high risk/poor prognosis (older than one year). In Figure 6.12a and 6.12b we show
the prediction accuracy of models in dependence of the age cutoff, which is changing
from 2 to 32 months. In order to avoid biases due to changing class cardinalities,
we computed a weighted accuracy, in which the class-specific accuracies are weighed
according to their cardinalities, following the formula:
1
2
(
|{x ∈ C1|fˆ(x) = 1}|
|C1| +
|{x ∈ C0|fˆ(x) = 0}|
|C0| ),
where C0 and C1 are the two response classes and fˆ is the prediction function.
The weighted accuracy has a concave shape, with a maximum around 14-16 months
(Figure 6.12c). This shows that the maximal contrast between two age subgroups
is achieved for a cutoff of 14-16 months and not 12 months. Other publications
have noted that 18 months may be a more appropriate choice for age cutoff for
neuroblastoma classification, motivated for different prognosis (London et al., 2005).
Our investigation is the first that supports a higher age cutoff based on maximal
genomic differences.
The features that discriminate between patients belonging to different age groups
are shown in Figure 6.13. Feature importance is depicted as a function of the age
cutoff. We show two LLR-based models and two RF-based models. The smooth
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(a) LLR (b) RF
(c) Age-optimal cutoff
Figure 6.12.: Prediction accuracy between various age subgroups. a) LLR-based models,
b) RF-based models
transitions between feature importance between consecutive age cutoffs is more ev-
ident in RF-based models: features ‘enter’ the model, then get progressively higher
importance and then they ‘disappear’. In contrast, the sparse LLR-based models
show occasional sharp changes, as for example around the cutoff of 18 months, after
which much less features are selected.
Overall, the models agree on the most useful features for discriminating between
age subgroups: 1p and 1q, 2q, 6q, 11p, 17p and 17q. The ‘predictivity’ of these re-
gions peaks at different age cutoffs. For example, chromosome 2q gain discriminates
best between patients younger and older than 8–10 months, whereas gain at 17p
becomes useful later on, when discriminating between patients younger and older
than 12–16 months. The copy number status of 11p is relevant for the separation
between patients younger and older than 20 months. Figure A.9 from the Appendix
visualizes the copy number arrays sorted by age at diagnosis, with focus on the
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Figure 6.13.: Features that discriminate between age subgroups. Dark red corresponds to
less significant features, yellow to medium significant and white to very significant features.
6.3. Discussion
We have presented the results of applying our analysis pipeline to four public ar-
rayCGH datasets with various phenotype annotations (about 15 prediction cases).
These results suggest that copy number changes are associated with the phenotyp-
ical characteristics of the tumors, some associations being stronger than others. In
the cases in which we fail to predict the response variable, it is not clear whether the
biological dependence does not exist at all or it is so subtle or complicated that our
simple models fail to capture it. However, our predictions were based on relatively
small sample sizes and on patient cohorts that could be subject to selection biases,
therefore all results should be carefully validated further, for confirmation.
We were not able to find a clear winner among the different consensus segmen-
tation methods, from the point of view of prediction accuracy. In Figure 6.14, we
show a summary of all prediction models that we trained, on breast and neurob-
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(a) Accuracy
(b) AUC
Figure 6.14.: Comparison of a) accuracy and b) AUC of all models over all datasets (violin
plots).
lastoma datasets with various phenotypes. Violin boxplots show that there is no
substantial difference between the consensus segmentation approaches. A small but
significant increase in accuracy favors the CR-FC method with supervised selection
of the number of regions (significantly outperforms LLR, LLR-KeS-Unsup, LLR-
MUG-Unsup and all RF-based methods, according to paired Wilcoxon tests). It is
interesting that the CB-MUG algorithm, which has best performance with respect
to the indicators that we used in Chapter 4 does not help improve classification
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accuracy more than the other two consensus segmentation methods. We believe
that CB-MUG fails to identify small regions, because the start and end breakpoints
of small CNAs do not form clearly two Gaussians. Being too close, they resemble
more one Gaussian. Consequently, MUG predicts a breakpoint in the middle of the
small region. This type of behavior is not penalized by the measure of segmentation
quality Ω0.98, which is robust to outliers (small number of probes that are incorrectly
assigned to regions). On the other hand, small regions are sometimes very relevant
for prediction, for example focal amplifications. Missing such small regions results
in loss of prediction accuracy. The other two segmentation procedures, especially
CR-FC, are not as robust as CB-MUG to outliers and identify small regions.
Our experiments show that LLR-based models are significantly more accurate
than RF-based models (Figure 6.14). Moreover, when the cohort is really small
(54 samples in breast54), RF perform really poor. For this reason we believe that
RF tend to overfit, which contrasts with the famous claim of the author (Breiman,
2001), that they cannot overfit. Another study by Segal (2004) supports our claim.
In Figure 6.14 we also show the accuracy and AUC of an ‘ensemble’ model, which
returns the majority vote of all participating models. The ensemble model has
similar accuracy and AUC as the LLR-based models.
The experiments show that consensus segmentation is beneficial: it affords dimen-
sion reduction, higher stability of feature importance and improved interpretability
while preserving model accuracy. The LLR-based models are in general different
than the RF-based models, even after consensus segmentation. However, some
agreement with respect to the feature importance peaks exists.
We commented on the most predictive features of each model and showed that
they are confirmed by existing literature. In the case of neuroblastoma, we showed
that different age subgroups are characterized by distinct copy number patterns,
especially when the groups are defined by a cutoff of 14–16 months, thus confirming
that a higher age cutoff than 12 months is more appropriate for diagnosis. We also
underlined interesting aspects on how different copy number aberrations are distinct
between various age subgroups.
In the case of breast cancer, we fitted models for predicting clinical indicators
including ER and PR status. Conflicting feature importance among these models
can be explained either by experimental biases or by cohort selection biases.
As supervised learning models based on copy number aberrations are rare in the
literature, we believe we are among the first to report on the accuracy of prediction
that is achievable based on copy number data only, in the case of breast cancer and
neuroblastoma. Predictors based on expression data gives generally good accuracy,
a natural next step is to integrate the two data types for improved performance.
Our substantial dimension reduction via consensus segmentation sets the premises
for data integration.
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7. Conclusions and Outlook
This thesis introduced a methodological pipeline for automated prediction of tumor
phenotype based on DNA copy number aberrations. The purpose of the pipeline is
twofold: first, it provides with a means of automated prediction of the phenotype of
new cases based on genotypic information, and second, it can reveal insights into the
biological association between the copy number status and phenotype. We discuss
here to what extent we succeeded to achieve each of these goals and what is the
relevance of our contribution in the context of cancer therapy.
The pipeline that we introduced provides models for supervised classification of
tumor phenotype based on genome-wide copy number aberration data. We devel-
oped and validated the pipeline on microarray-based data, but from a methodical
perspective, the algorithms can be applied to other data types, such as the next
generation sequencing data. The pipeline generates classification models which can
be considered complex biomarkers. They can be used for automated prediction of
important tumor and patient indicators such as lymph node invasion, presence of
metastasis, response to a specific treatment type, expected patient survival, etc.
Clearly, high prediction accuracy is an imperative requirement for the models in or-
der to enter clinical practice. Our applications to neuroblastoma and breast cancer
show that the prediction accuracy is good in general(up to 85%), but not suffi-
ciently high in order to recommend the prediction models for immediate practical
use. Below we explain why we think the accuracy is not good enough.
First, the current knowledge on the molecular mechanisms of cancer (partly sum-
marized in this thesis in Chapter 2) indicates that numerical aberrations are only
one player in the process of cancer progression, and other players such as epigenetic
changes, structural aberrations or mutations are tightly interconnected. It is there-
fore safe to assume that we base our prediction on incomplete information, which
could account for a fraction of the misclassification rate. Second, our models may
not have succeeded in capturing existing associations between the copy number pro-
files and the phenotype. Indeed, for the purpose of interpretability and in order to
avoid overfitting, we were forced to choose rather simple models such as linear lo-
gistic regression, and thus sacrifice the expressiveness of the models. We attempted
to compensate with more complex but interpretable models like the random forest,
but experiments indicate that they tend to overfit and were in general outperformed
by logistic regression. Third, there is compelling evidence that microarray batch
effects have a negative influence on the prediction, demonstrated in this thesis by
the large differences in accuracy of progesterone receptor status in different breast
cancer cohorts. A related problem is the lack of careful planning in the selection of
the patients participating in different public data cohorts: often, the most clinically
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‘interesting’ cases are selected, which constitute statistical outliers and make clas-
sification difficult. A carefully planned clinical trial is expected to result in higher
accuracy.
A notable achievement is the usage of prediction accuracy for selecting an optimal
age cutoff for the diagnosis of neuroblastoma patients. Based on current clinical
practice, childred younger than one year are assigned to a good prognostic group
and get well with minimal therapy. Patients older than one year are assigned to a
poor prognostic group and receive agressive chemotherapy. Recent clinical studies
show that even patients up to 16-18 months of age tend to have recessive tumors,
thus a higher cutoff of about 16-18 months would spare the evere side effects of
chemotherapy for many children. We used the prediction accuracy of our models
as an indicator of genomic difference and showed that groups separated by an age
cutoff of 14-16 months are most distinct. We thereby provide with the first evidence
supporting a different age grouping based solely on copy number data.
Our models are among the very few fully supervised prediction models based on
copy number aberrations. Some models exist on breast cancer but to the best of
our knowledge, ours are the first models on neuroblastoma data. The accuracies
of our models have therefore a state-of-the-art value, challenging the bioinformatics
community to propose better methods.
We were more successful in achieving the second goal of the computational pipeline.
Namely, we showed on simulated and read data that the interpretability and robust-
ness of our models are superior to that of baseline models. For this purpose we used
feature grouping, an efficient method for dimension reduction and for reducing cor-
relation between features, thus improving feature ranking and the stability of the
feature importance. Our contribution is important, because the instability of feature
ranking against variation of the training set is a well known problem and a reason
of concern in the field of microarray classification, leading to lack of reproducibility
and mistrust from the medical community. Moreover, since the instability is caused
by the high dimensionality and the biological heterogeneity of the tumor samples,
it is likely that the problem will persist in the analysis of DNA high-throughput
sequencing data.
The key concept of this thesis, namely feature grouping, is not our innovation,
as it has been applied in other forms to different data types. We adopt the main
principle, that of grouping features based on some criterion and then constructing
representatives or super-features that can be used for more meaningful modeling.
Technically, the feature grouping methods that we presented in the thesis are tailored
to the specific structure of DNA copy number profiles, specifically we speculate on
the property of the log-ratios of being locally constant. We called this approach ‘con-
sensus segmentation’. We introduced two approaches for consensus segmentation,
first based on identification of breakpoint hotspots (consensus breakpoints) and one
based on identifying regions of almost constant copy number (consensus regions).
Three corresponding algorithms were described: CB-MUG (consensus breakpoints
via mixture of Gaussians and one Uniform), CB-KeS (consensus breakpoints via ker-
nel smoothing) and CR-FC (consensus regions via feature clustering). A comparison
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of these approaches favors slightly the CB-FC method, which generally improves the
accuracy of the baseline model if used together with lasso-penalized logistic regres-
sion or random forest.
In Chapter 6, we commented on the most relevant aberrations that play an im-
portant role in predicting various tumor phenotypes of neuroblastomas and breast
cancers. We gained important insight into the biological mechanisms of copy num-
ber change that associate with various phenotype indicators. Two very interesting
examples demonstrate the strengths of our approach. First, the model for prediction
of tumor subtype based on the breast cancer breast54 dataset indicated that the
size of the amplicon around ERBB2 gene is an important predictor and it did so
by selecting the features located on extensions of the amplicon region in the neigh-
borhood and not at the gene itself. Most of the methods for copy number analysis
focus on the minimal common region of aberration and thus would fail to discover
the importance of their elongations. The consensus segmentation typically considers
the minimal common region and its elongations as different regions, for more expres-
sive modeling. The second example refers to the classification of neuroblastomas,
in which the ploidy status plays an important role. In neuroblastoma, chromosome
17q amplification is associated with poor prognosis and whole chromosome 17 gain
is associated with good prognosis. In consequence, our models select 17p as a very
relevant region for classification. It is unlikely that this region contains oncogenes
that are involved in neuroblastoma progression. Rather, it is the different molecular
mechanisms causing polyploidy and aplification that explain the distinct phenotype.
Thus, in contrast to our approach, most methods that are driven by the search for
causative genes or for segmental aberrations will fail to discover a very predictive
feature.
A different perspective on the above mentioned model on neuroblastoma is that,
even though the model indicates that 17p is a discriminative feature, it takes careful
interpretation and expertise in order to understand that it is a consequence of the
17q amplification/17 polyploidy. We thereby conclude that model interpretation is
of great importance and should be a priority not only to the biomedical community,
but to the bioinformatics community as well.
Outlook
Our applications were limited by the availability of phenotypic annotation in public
datasets. For this reason, we were not able to carry out prediction of drug response,
treatment outcome or patient survival, which are of major importance for improved
cancer therapy. Also, a necessary step forward is to apply the automated pipeline
to as many cancer types as possible, both for the purpose of validation, as well as
for gaining possibly novel biological insight into the association between numerical
aberrations and phenotype. Clearly, larger datasets are also necessary.
We payed special attention to the interpretability and stability of our prediction
models because these are properties that can make computational models attractive
to the biomedical community. However, an interesting approach would be to train
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very powerful and complex classification models, in order to compare their prediction
accuracy with that of our models.
Following the greater goal of introducing computational models into clinical prac-
tice, integration of copy number aberration data with other data types such as
somatic mutations, epigenetic modifications and transcriptomic data is needed.
Methodologically, integration of omics data is still a challenging problem, facing
the high dimensionality of each data type and the heterogeneity of the omics data.
We believe that the consensus segmentation of copy number profiles that we pro-
posed ensure substantial dimension reduction with no loss of important information,
which suggests this procedure as preprocessing step to data integration.
Introducing complex biomarkers – like the classification models presented in this
thesis – into clinical practice is a difficult endeavor. The lack of standards, the
poor validation or lack of reproducibility have been used as arguments against such
models. Interpretability remains a major requirement, as the biomedical community
appears more willing to accept a transparent, rule-based decision process, than a
black box oracle, regardless of how accurate. We believe the work presented in this
thesis has succeeded, at least conceptually, to get closer to these requirements.
In the future, the computational community needs to search for better ways of
presenting complex statistical models to the biomedical community and the biomed-
ical community needs to accept the help of non-intuitive but powerful computational
instruments, for the benefit of the patient.
A. Appendix
A.0.1. Supplementary figures and tables
In the following plots, we used the IGV application (Robinson et al., 2011) for
visualizing the copy number data and the feature importance simultaneously.
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Figure A.1.: Average importance of features for classification of data from Simulation B.
The importance is averaged over groups G1, ..., G10, R1, ..., R20.
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(a) ER status
(b) PR status
Figure A.2.: Feature importance of prediction models on breast173 dataset with ER status
outcome: a) chromsome 10, b) chromosome 16.
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(a)
(b)
(c)
Figure A.3.: Feature importance given by models trained on breast167 dataset with ER
outcome: a) chromosome 16, b) chromosome 6 and c) chromosome 20.
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(a)
(b)
Figure A.4.: Feature importance given by models trained on breast167 dataset with
lymph status outcome: chromosome 11.
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(a)
(b)
Figure A.5.: IGV view of feature importance given by models trained on the breast54
dataset with ER status outcome: a) genome-wide view; b) focus on chromosome 8. On the
top, the log-ratios are represented, with intense red corresponding to amplifications and
dark blue for deletions.
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(a)
(b)
Figure A.6.: Predictors of a) PR status on chromosome 16 and b) of tumor type on
chromsome 17 from the breast54 dataset.
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(a) (b)
(c) (d)
(e) (f)
Figure A.7.: Regions that discriminate between Stages 1-3 and Stage 4 neuroblastoma: a)
chromosome 6, b) chromosome 22, c) chromosome 4, d) chromosome 2, e) chromosome 17
and f) chromosome 19.
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(a) (b)
(c) (d)
(e) (f)
Figure A.8.: Regions that discriminate between Stage 4 and Stage 4S neuroblastoma a)
chromosome 1, b) chromosome 2, c) chromosome 4, d) chromosome 6, e) chromosome 11
and f) chromosome 17.
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(a) (b)
(c) (d)
(e)
Figure A.9.: Copy number arrays sorted by age of the patient at diagnosis: a) chromosome
1, b) chromosome 2, c) chromosome 6, d) chromosome 11, e) chromosome 17.
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